sales@intentmarketresearch.com

  +1 463-583-2713

Gene Therapy For Rare Disease Market By Therapeutic Area (Genetic Disorders, Metabolic Disorders, Hematologic Diseases, Muscular Dystrophies, Neurological Disorders), By Technology (Viral Vectors, Non-Viral Vectors, CRISPR/Cas9, RNA-Based Therapies), By Administration Route (Intravenous, Intramuscular, Subcutaneous, Intra-arterial, Local Administration), By End-User (Hospitals, Research Institutions, Biotechnology Companies, Contract Research Organizations), and By Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Gene Therapy For Rare Disease Market is expected to grow from USD 2.5 billion in 2023 at a CAGR of 8.1% to touch USD 4.3 billion by 2030. The Gene Therapy For Rare Disease Market is dominated by key players such as, Bluebird Bio, Inc., Spark Therapeutics, Regeneron Pharmaceuticals, Inc., Sangamo Therapeutics, Inc., and CRISPR Therapeutics AG.

Published: December, 2024
| Report ID: LI5249
| Life Sciences & Healthcare
Epidermolysis Bullosa Therapeutics Market By Drug Type (Gene Therapy, Protein Therapy, Cell-Based Therapy, Topical Treatments, Systemic Medications), By Application (Wound Care, Pain Management, Infection Prevention, Skin Regeneration, Genetic Correction), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Specialty Clinics), and By Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Epidermolysis Bullosa Therapeutics Market is expected to grow from USD 3.3 billion in 2023 at a CAGR of 12.2% to touch USD 7.5 billion by 2030. The Epidermolysis Bullosa Therapeutics Market is dominated by key players such as Amryt Pharma, Abeona Therapeutics Inc., Castle Creek Biosciences, Inc., Krystal Biotech, Inc., Fibrocell Science, Inc., Shire (now part of Takeda Pharmaceutical Company Limited), Regenerx Biopharmaceuticals, Wings Therapeutics, Eloxx Pharmaceuticals, ProQR Therapeutics N.V., PTC Therapeutics, Avita Medical, Mallinckrodt Pharmaceuticals, Anterogen Co., Ltd., Phoenix Tissue Repair

Published: December, 2024
| Report ID: LI5243
| Life Sciences & Healthcare
Cochlear Implant (CI) System Market By Type (Unilateral Cochlear Implants, Bilateral Cochlear Implants), By Components (Internal Device, External Device), By Technology (Electrical Stimulation, Acoustic Stimulation), By End-Use (Hospitals, ENT Clinics), and By Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Cochlear Implant (CI) System Market is expected to grow from USD 1.9 billion in 2023 at a CAGR of 10.8% to touch USD 4.0 billion by 2030. The Cochlear Implant (CI) System Market is dominated by key players such as, MED-EL Medical Electronics, Cochlear Limited, Nurotron Biotechnology Co., Ltd., Amplifon S.p.A., and Demant A/S.

Published: December, 2024
| Report ID: LI5241
| Life Sciences & Healthcare
Epidermal Growth Factors Market By Product Type (Recombinant Epidermal Growth Factors, Synthetic Epidermal Growth Factors, Natural Epidermal Growth Factors), By Application (Cancer Treatment, Wound Healing, Cosmetic Surgery, Hair Growth Treatment, Burns Treatment), By End-User Industry (Pharmaceutical Industry, Healthcare & Wellness, Cosmeceuticals, Biotechnology Industry, Research & Development), and By Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Epidermal Growth Factors Market is expected to grow from USD 2.1 billion in 2023 at a CAGR of 6.5% to touch USD 3.3 billion by 2030. The Epidermal Growth Factors Market is dominated by key players such as Amgen Inc., Merck & Co., Inc., Eli Lilly and Company, Johnson & Johnson, Pfizer Inc., Novartis AG, Sanofi S.A., Genentech, Inc., Regeneron Pharmaceuticals, Inc., GlaxoSmithKline PLC, Teva Pharmaceutical Industries Ltd., Bio-Rad Laboratories, Inc., Mylan N.V., Boehringer Ingelheim International GmbH, AbbVie Inc.

Published: December, 2024
| Report ID: LI5240
| Life Sciences & Healthcare
Autoinjectors Market by Type (Disposable Autoinjectors, Reusable Autoinjectors), by Therapeutic Area (Allergy & Anaphylaxis, Rheumatoid Arthritis, Multiple Sclerosis, Diabetes), by End-Use Industry (Hospitals, Homecare, Ambulatory Care Centers); Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Autoinjectors Market is expected to grow from USD 8.3 Billion in 2023 at a CAGR of 10.7% to touch USD 17.0 Billion by 2030. The Autoinjectors Market is dominated by key players such as AbbVie, Amgen, Antares Pharma, Bayer AG, Becton, Dickinson and Company (BD), Biogen, Johnson & Johnson, Merck & Co., Mylan (Viatris), Novartis, Regeneron Pharmaceuticals, Rochem and Teva Pharmaceutical Industries Ltd.

Published: December, 2024
| Report ID: LI5232
| Life Sciences & Healthcare
Cardiopulmonary Autotransfusion System Market By Type (Disposable, Reusable), By Application (Cardiac Surgery, Orthopedic Surgery, Trauma Surgery, Spinal Surgery), By Technology (Vacuum Assisted Systems, Centrifugal Assisted Systems, Continuous Flow Systems), By End-Use (Hospitals, Ambulatory Surgical Centers, Specialty Clinics, Blood Banks), and By Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Cardiopulmonary Autotransfusion System Market is expected to grow from USD 1.5 billion in 2023 at a CAGR of 10.0% to touch USD 3.0 billion by 2030. The Cardiopulmonary Autotransfusion System Market is dominated by key players such as, Terumo Corporation, Haemonetics Corporation, Medtronic, JUNKEN GmbH, and Baxter International Inc.

Published: December, 2024
| Report ID: LI5229
| Life Sciences & Healthcare
Artificial Intelligence (AI) in Ultrasound Imaging Market by Technology (Machine Learning, Deep Learning, Natural Language Processing, Computer Vision), by Application (Obstetrics and Gynecology, Cardiology, Musculoskeletal Imaging, Abdominal Imaging, Emergency Medicine), by End-Use Industry (Hospitals, Diagnostic Imaging Centers, Research Institutes); Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Artificial Intelligence (AI) In Ultrasound Imaging Market is expected to grow from USD 3.0 Billion in 2023 at a CAGR of 24.2% to touch USD 13.5 Billion by 2030. The Artificial Intelligence (AI) In Ultrasound Imaging Market is dominated by key players such as Blackford Analysis, Butterfly Network, Canon Medical Systems, EchoNous, Esaote, Fujifilm Holdings Corporation, Hologic, Medtronic, Mindray, Philips Healthcare, Samsung Medison, Siemens Healthineers and Zebra Medical Vision.

Published: December, 2024
| Report ID: LI5228
| Life Sciences & Healthcare
Artificial Intelligence (AI) in Oncology Market by Technology (Machine Learning, Deep Learning, Natural Language Processing, Computer Vision), by Deployment Mode (Cloud-Based, On-Premise), by Application (Cancer Diagnosis, Drug Discovery and Development, Personalized Medicine), by End-Use Industry (Hospitals, Diagnostic Centers); Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Artificial Intelligence (AI) In Oncology Market is expected to grow from USD 4.2 Billion in 2023 at a CAGR of 22.3% to touch USD 17.0 Billion by 2030. The Artificial Intelligence (AI) In Oncology Market is dominated by key players such as Aidoc, Cancer Research UK, Fujifilm Holdings, GE Healthcare, Google Health, IBM Watson Health, Microsoft, NVIDIA, PathAI, Philips Healthcare, Siemens Healthineers, Tempus and Zebra Medical Vision.

Published: December, 2024
| Report ID: LI5226
| Life Sciences & Healthcare
Artificial Intelligence (AI) in Inflammatory Bowel Disease Market by Technology (Machine Learning, Deep Learning, Natural Language Processing), by Application (Early Diagnosis of Inflammatory Bowel Disease, Disease Progression Monitoring), by End-Use (Hospitals, Diagnostic Centers, Research and Development Institutions); Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Artificial Intelligence (AI) In Inflammatory Bowel Disease Market is expected to grow from USD 1.3 billion in 2023 at a CAGR of 44.5% to touch USD 17.0 billion by 2030. The Artificial Intelligence (AI) In Inflammatory Bowel Disease Market is dominated by key players such as AbbVie, AiCure, Bristol-Myers Squibb, CureMetrix, Fujifilm Holdings, GE Healthcare, Horizon Therapeutics, IBM Watson Health, IntelliHealth, Medtronic, Novartis, Siemens Healthineers and Zebra Medical Vision.

Published: December, 2024
| Report ID: LI5225
| Life Sciences & Healthcare
Artificial Intelligence (AI) in Breast Imaging Market by Technology (Machine Learning, Deep Learning, Natural Language Processing), by Application (Early Diagnosis of Breast Cancer, Tumor Detection and Classification, Image Enhancement and Analysis), by End-Use (Hospitals, Diagnostic Centers, Research and Development Institutions); Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Artificial Intelligence (AI) In Breast Imaging Market is expected to grow from USD 2.3 Billion in 2023 at a CAGR of 33.0% to touch USD 17.0 Billion by 2030. The Artificial Intelligence (AI) In Breast Imaging Market is dominated by key players such as Aidoc, Butterfly Network, Canon Medical Systems, Fujifilm Holdings, GE Healthcare, Hologic, Lunit, Medtronic, Mirada Medical, Philips Healthcare, ScreenPoint Medical, Siemens Healthineers, Zebra Medical Vision.

Published: December, 2024
| Report ID: LI5222
| Life Sciences & Healthcare
Antibody Therapy Market by Antibody Type (Monoclonal Antibodies, Polyclonal Antibodies, Bispecific Antibodies, Conjugated Antibodies), by Therapy Type (Cancer Immunotherapy, Autoimmune Disease Therapy, Infectious Disease Treatment), by End-Use (Hospitals, Ambulatory Surgical Centers); Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Antibody Therapy Market is expected to grow from USD 83.5 Billion in 2023 at a CAGR of 11.3% to touch USD 176.3 Billion by 2030. The Antibody Therapy Market is dominated by key players such as AbbVie, Amgen, AstraZeneca, Bristol-Myers Squibb, Celltrion Healthcare, Eli Lilly and Company, GlaxoSmithKline, Johnson & Johnson, Merck & Co., Novartis, Pfizer, Regeneron Pharmaceuticals and Sanofi.

Published: December, 2024
| Report ID: LI5213
| Life Sciences & Healthcare
Antibody Production Market by Technology (Recombinant DNA Technology, Hybridoma Technology, Phage Display Technology, Transgenic Animal Technology), by Antibody Type (Monoclonal Antibodies, Polyclonal Antibodies, Bispecific Antibodies, Recombinant Antibodies), by Production System (Mammalian Cell Systems, E. coli-based Systems, Yeast-based Systems, Insect Cell Systems), by End-Use (Biopharmaceutical Companies, Contract Manufacturing Organizations); Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Antibody Production Market is expected to grow from USD 18.1 Billion in 2023 at a CAGR of 13.5% to touch USD 44.0 Billion by 2030. The Antibody Production Market is dominated by key players such as AbbVie, Amgen, Biogen Idec, Boehringer Ingelheim, Celltrion Healthcare, Eli Lilly and Company, Mabtech, Merck & Co., Novartis, Lonza Group, Regeneron Pharmaceuticals, Roche Diagnostics and WuXi AppTec.

Published: December, 2024
| Report ID: LI5190
| Life Sciences & Healthcare
Antibody Discovery Market by Technology (Phage Display Technology, Hybridoma Technology, Ribosome Display Technology, Transgenic Mice Technology), by Antibody Type (Monoclonal Antibodies, Polyclonal Antibodies, Bispecific Antibodies), by Application (Cancer Treatment, Autoimmune Diseases, Infectious Diseases, Inflammatory Diseases), by End-User (Pharmaceutical & Biotechnology Companies, Contract Research Organizations); Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Antibody Discovery Market is expected to grow from USD 4.9 Billion in 2023 at a CAGR of 19.4% to touch USD 17.0 Billion by 2030. The Antibody Discovery Market is dominated by key players such as Abcam, Adimab LLC, Amgen, Biogen Idec, Bristol Myers Squibb, Eli Lilly, Genmab, Lonza, MedImmune (AstraZeneca), Merck & Co., Novartis, Regeneron Pharmaceuticals and WuXi AppTec.

Published: December, 2024
| Report ID: LI5189
| Life Sciences & Healthcare
Anti-Biofilm Wound Dressing Market by Type of Dressing (Hydrocolloid Dressing, Hydrogel Dressing, Foam Dressing, Film Dressing), by Wound Type (Chronic Wounds, Acute Wounds), by Material (Natural Materials, Synthetic Materials), by End-User (Hospitals & Ambulatory Surgical Centers, Clinics); Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Anti-Biofilm Wound Dressing Market is expected to grow from USD 2.3 Billion in 2023 at a CAGR of 33.0% to touch USD 17.0 Billion by 2030. The Anti-Biofilm Wound Dressing Market is dominated by key players such as 3M Health Care, Acelity (KCI), Advanced Medical Solutions Group, B. Braun Melsungen AG, Coloplast, Convatec, Hollister Incorporated, Johnson & Johnson, Medtronic, Mölnlycke Health Care, Paul Hartmann AG, Smith & Nephew and Vygon.

Published: December, 2024
| Report ID: LI5188
| Life Sciences & Healthcare
Angioplasty Balloons Market by Type of Balloons (Drug-Eluting Angioplasty Balloons, Non-Drug Eluting Angioplasty Balloons, Cutting Balloons), by Application (Coronary Artery Disease, Peripheral Artery Disease, Renal Artery Disease), by End-User (Hospitals, Ambulatory Surgical Centers); Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Angioplasty Balloons Market is expected to grow from USD 3.4 Billion in 2023 at a CAGR of 10.9% to touch USD 7.1 Billion by 2030. The Angioplasty Balloons Market is dominated by key players such as Abbott Laboratories, B. Braun Melsungen AG, Boston Scientific Corporation, Cardinal Health, Inc., Cook Medical, Cordis Corporation (Johnson & Johnson), Medinol Ltd., Medtronic PLC, MicroPort Scientific Corporation, Raumedic AG, Smith & Nephew PLC, Surmodics, Inc. and Vascular Solutions.

Published: December, 2024
| Report ID: LI5185
| Life Sciences & Healthcare
Anesthesia Monitoring Devices Market by Type of Devices (Anesthesia Depth Monitoring Devices, Anesthesia Ventilation Monitoring Devices, Anesthesia Circulation Monitoring Devices), by Technology (Standalone Monitoring Devices, Integrated Monitoring Systems), by End-User (Hospitals, Ambulatory Surgical Centers); Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Anesthesia Monitoring Devices Market is expected to grow from USD 3.3 Billion in 2023 at a CAGR of 10.3% to touch USD 6.6 Billion by 2030. The Anesthesia Monitoring Devices Market is dominated by key players such as CAS Medical Systems, Inc., Drägerwerk AG & Co. KGaA, GE Healthcare, Masimo Corporation, Medtronic PLC, Mindray Medical International Limited, Nonin Medical, Inc., Osypka Medical, Philips Healthcare, Schiller AG, Siemens Healthineers and Smiths Medical.

Published: December, 2024
| Report ID: LI5184
| Life Sciences & Healthcare
Anesthesia Drugs Market by Drug Type (General Anesthetics, Local Anesthetics, Sedatives, Narcotics), by Route of Administration (Intravenous, Inhalation, Topical, Oral), by Application (Surgery, Pain Management, Diagnostic Procedures), by End-User (Hospitals, Ambulatory Surgical Centers, Clinics); Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Anesthesia Drugs Market is expected to grow from USD 9.7 Billion in 2023 at a CAGR of 6.1% to touch USD 14.7 Billion by 2030. The Anesthesia Drugs Market is dominated by key players such as AbbVie Inc., Baxter International Inc., Cardinal Health, Inc., Drägerwerk AG & Co. KGaA, F. Hoffmann-La Roche Ltd., Fresenius Kabi AG, Hikma Pharmaceuticals PLC, Johnson & Johnson Services, Inc., Medtronic PLC, Mylan N.V. (Viatris Inc.), Novartis AG, Sandoz (A Novartis Division) and Zydus Cadila.

Published: December, 2024
| Report ID: LI5183
| Life Sciences & Healthcare
Anesthesia and Respiratory Devices Market by Device Type (Anesthesia Machines, Anesthesia Vaporizers, Breathing Circuits, Respiratory Masks, Positive Airway Pressure Devices (PAP), Ventilators, Nebulizers), by Mode of Use (Invasive, Non-Invasive), by Application (Surgery, Intensive Care Units (ICU), Chronic Obstructive Pulmonary Disease (COPD), Sleep Apnea), by End-User (Hospitals, Ambulatory Surgical Centers); Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Anesthesia and Respiratory Devices Market is expected to grow from USD 19.9 Billion in 2023 at a CAGR of 7.4% to touch USD 32.9 Billion by 2030. The Anesthesia and Respiratory Devices Market is dominated by key players such as Air Liquide Medical Systems, Becton, Dickinson and Company (BD), Drägerwerk AG & Co. KGaA, F. Hoffmann-La Roche Ltd., Fisher & Paykel Healthcare Corporation, GE Healthcare, Masimo Corporation, Medtronic PLC, Mindray Medical International Limited, Omron Healthcare, Philips Healthcare, ResMed Inc. and Ventec Life Systems.

Published: December, 2024
| Report ID: LI5182
| Life Sciences & Healthcare
Anatomic Pathology Market by Product Type (Instruments, Reagents, Consumables), by Technology (Immunohistochemistry, In situ Hybridization, Polymerase Chain Reaction (PCR), Digital Pathology), by Application (Cancer Diagnosis, Infectious Disease Diagnosis, Neurological Disorders, Cardiovascular Disorders), by End-User (Hospitals, Diagnostic Laboratories, Research Institutes, Academic Institutes); Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Anatomic Pathology Market is expected to grow from USD 42.5 Billion in 2023 at a CAGR of 7.4% to touch USD 70.0 Billion by 2030. The Anatomic Pathology Market is dominated by key players such as Abbott Laboratories, Agilent Technologies, Inc., BD Biosciences, Bio-Rad Laboratories, Canon Medical Systems Corporation, Danaher Corporation, General Electric (GE) Healthcare, Hologic, Inc., Leica Biosystems, Merck & Co., Inc., PerkinElmer, Inc., Philips Healthcare and Thermo Fisher Scientific, Inc.

Published: December, 2024
| Report ID: LI5181
| Life Sciences & Healthcare
Anastomosis Devices Market by Device Type (Circular Staplers, Linear Staplers, Endoscopic Staplers, Stapler Reloads, Surgical Clamps), by Application (Gastrointestinal Surgeries, Cardiovascular Surgeries, Urological Surgeries, Thoracic Surgeries), by End-User (Hospitals, Ambulatory Surgical Centers, Specialty Clinics), by Procedure Type (Open Surgery, Minimally Invasive Surgery); Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Anastomosis Devices Market is expected to grow from USD 3.9 Billion in 2023 at a CAGR of 6.9% to touch USD 6.2 Billion by 2030. The Anastomosis Devices Market is dominated by key players such as 3M Company, B. Braun Melsungen AG, Conmed Corporation, Cook Medical, Endo International PLC, Intuitive Surgical Inc., Karl Storz SE & Co. KG, KLS Martin Group, Medtronic PLC, Smith & Nephew PLC, Stryker Corporation, Terumo Corporation and Zimmer Biomet.

Published: December, 2024
| Report ID: LI5180
| Life Sciences & Healthcare
Analgesics Market by Drug Type (Opioids, Non-Opioids, Combination Analgesics), by Route of Administration (Oral, Topical, Intravenous, Transdermal, Rectal), by Indication (Post-Surgical Pain, Cancer Pain, Neuropathic Pain, Chronic Back Pain, Migraine), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies); Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Analgesics Market is expected to grow from USD USD 48.4 Billion in 2023 at a CAGR of 4.4% to touch USD 65.3 Billion by 2030. The Analgesics Market is dominated by key players such as AbbVie Inc., AstraZeneca plc, Bayer AG, Boehringer Ingelheim GmbH, Eli Lilly and Company, Endo International plc, Hikma Pharmaceuticals PLC, Johnson & Johnson, Mylan N.V., Novartis AG, Pfizer Inc., Sanofi S.A. and Teva Pharmaceutical Industries Ltd.

Published: December, 2024
| Report ID: LI5179
| Life Sciences & Healthcare
Cardiac Arrhythmia Monitoring Devices Market By Product Type (Electrocardiogram (ECG) Monitors, Implantable Cardioverter Defibrillators (ICDs), Pacemakers, Event Monitors, Holter Monitors, Mobile Health (mHealth) Devices, Fetal and Neonatal Monitors), By Application (Atrial Fibrillation, Ventricular Arrhythmias, Bradycardia, Tachycardia), By End-User Industry (Hospitals, Diagnostic Centers, Ambulatory Surgical Centers, Home Healthcare, Cardiology Clinics), By Technology (Traditional Monitoring Devices, Wireless Monitoring Devices), and By Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Cardiac Arrhythmia Monitoring Devices Market is expected to grow from USD 5.6 billion in 2023 at a CAGR of 10.7% to touch USD 11.3 billion by 2030. The Cardiac Arrhythmia Monitoring Devices Market is dominated by key players such as Medtronic, Abbott Laboratories, GE Healthcare, Philips Healthcare, Siemens Healthineers, Boston Scientific Corporation, Biotronik, Honeywell Life Care Solutions, Zoll Medical Corporation, Hill-Rom, Johnson & Johnson, LifeWatch (Acquired by BioTelemetry), CardioComm Solutions, Inc., Vivalink, Nuvasive, Inc.

Published: December, 2024
| Report ID: LI5163
| Life Sciences & Healthcare
Anti-Obesity Drugs Market By Drug Class (Orlistat, GLP-1 Receptor Agonists, Phentermine & Topiramate Combination, Bupropion & Naltrexone Combination, Liraglutide, Other Drug Classes), By Mechanism of Action (Appetite Suppressants, Lipase Inhibitors, Thermogenesis Enhancers, Neurotransmitter Modulators), By Route of Administration (Oral, Injectable, Transdermal, Intranasal), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Specialty Clinics, Direct to Consumer), and By Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Anti-Obesity Drugs Market is expected to grow from USD 6.2 billion in 2023 at a CAGR of 28.5% to touch USD 35.9 billion by 2030. The Anti-Obesity Drugs Market is dominated by key players such as Novo Nordisk, Eli Lilly and Company, Bristol-Myers Squibb, GlaxoSmithKline, Pfizer Inc., Orexigen Therapeutics, Sanofi S.A., AstraZeneca, Roche, AbbVie, Johnson & Johnson, Amgen Inc., Bayer AG, Mylan N.V., Allergan

Published: December, 2024
| Report ID: LI5162
| Life Sciences & Healthcare
Industrial Microbiology Market By Product (Microbial Culture, Enzyme Products, Bioreactors), By Application (Food & Beverages, Pharmaceuticals, Environmental Testing), By End-User (Pharmaceutical Companies, Food & Beverage Companies, Biotechnology Companies, Environmental Agencies, Research Institutes), and By Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Industrial Microbiology Market is expected to grow from USD 4.7 billion in 2023 at a CAGR of 8.6% to touch USD 8.3 billion by 2030. The Industrial Microbiology Market is dominated by key players such as, Merck KGaA, Thermo Fisher Scientific, Lonza Group, Beckman Coulter (Danaher), and Eppendorf AG.

Published: December, 2024
| Report ID: LI5156
| Life Sciences & Healthcare
Prenatal Vitamin Ingredients Market By Type (Vitamins, Minerals, Omega-3 Fatty Acids, Amino Acids), By Application (Supplements, Functional Foods, Beverages), By End-Use Industry (Dietary Supplements, Pharmaceuticals, Food & Beverages), and By Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Prenatal Vitamin Ingredients Market is expected to grow from USD 1.2 billion in 2023 at a CAGR of 10.1% to touch USD 2.3 billion by 2030. The Prenatal Vitamin Ingredients Market is dominated by key players such as, DSM Nutritional Products, BASF SE, Nature’s Way Products LLC, FBC Industries, Inc., and Kemin Industries.

Published: December, 2024
| Report ID: LI5155
| Life Sciences & Healthcare
Amyotrophic Lateral Sclerosis Treatment Market by Drug Type (Riluzole, Edaravone), by Route of Administration (Oral, Intravenous, Subcutaneous), by End-User (Hospitals, Clinics); Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Amyotrophic Lateral Sclerosis Treatment Market is expected to grow from USD 4.0billion in 2023 at a CAGR of 10.7% to touch USD 8.1 billion by 2030. The Amyotrophic Lateral Sclerosis Treatment Market is dominated by key players such as AbbVie Inc., Alexion Pharmaceuticals (AstraZeneca), Amylyx Pharmaceuticals, Biogen Inc., F. Hoffmann-La Roche AG, Horizon Therapeutics, Mitsubishi Tanabe Pharma Corporation, Mylan N.V. (Viatris), Novartis AG, Regeneron Pharmaceuticals, Roche Holding AG, Sanofi S.A. and Vertex Pharmaceuticals.

Published: December, 2024
| Report ID: LI5143
| Life Sciences & Healthcare
Surgical Energy Instruments Market By Type (Electrosurgical Instruments, Laser Surgical Instruments, Ultrasound Surgical Instruments, Cryosurgical Instruments, Radiofrequency Surgical Instruments), By Application (General Surgery, Cardiac Surgery, Orthopedic Surgery, Neurological Surgery, ENT (Ear, Nose, Throat) Surgery, Urological Surgery, Gynecological Surgery), By End-Use Industry (Hospitals & Surgical Centers, Ambulatory Surgical Centers, Clinics), and By Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Surgical Energy Instruments Market is expected to grow from USD 6.9 billion in 2023 at a CAGR of 7.9% to touch USD 11.8 billion by 2030. The Surgical Energy Instruments Market is dominated by key players such as, Johnson & Johnson, Medtronic, B. Braun Melsungen AG, KLS Martin Group, and Conmed Corporation.

Published: December, 2024
| Report ID: LI5140
| Life Sciences & Healthcare
Warm Blood Perfusion System Market By Type (Heart Perfusion Systems, Lung Perfusion Systems, Kidney Perfusion Systems, Multi-organ Perfusion Systems), By Application (Organ Transplantation, Organ Preservation, Research & Development), By End-Use Industry (Hospitals & Medical Centers, Research Institutes, Organ Banks, Biopharmaceutical Industry), and By Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Warm Blood Perfusion System Market is expected to grow from USD 0.4 billion in 2023 at a CAGR of 11.0% to touch USD 0.8 billion by 2030. The Warm Blood Perfusion System Market is dominated by key players such as, TransMedics, Inc., Organ Recovery Systems, Inc., Roche Diagnostics, Charles River Laboratories, and LivaNova PLC.

Published: December, 2024
| Report ID: LI5136
| Life Sciences & Healthcare
Healthcare Information Exchange Market By Type (Health Information Exchange, Electronic Health Records (EHR), Patient Portals), By Technology (Cloud-based Solutions, Integration Platforms, Data Security & Privacy Technologies, Interoperability Standards, Blockchain in Healthcare), By Application (Patient Data Management, Clinical Data Exchange, Public Health Data Management, Revenue Cycle Management, Population Health Management), By End Use (Healthcare Providers, Hospitals & Clinics, Government Agencies, Insurance Providers, Pharmaceutical Companies), and By Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Healthcare Information Exchange Market is expected to grow from USD 1.8 billion in 2023 at a CAGR of 8.6% to touch USD 3.2 billion by 2030. The Healthcare Information Exchange Market is dominated by key players such as, Allscripts Healthcare Solutions, Inc., Cerner Corporation, IBM Watson Health, HealthFusion, and Oracle Corporation.

Published: December, 2024
| Report ID: LI5132
| Life Sciences & Healthcare
Biological Safety Testing Market by Product Type (Instruments, Kits & Reagents, Services), Test Type (Sterility Testing, Bioburden Testing, Endotoxin Testing, Residual Host Contaminant Detection, Cell Line Authentication & Characterization Tests, Adventitious Agent Detection Tests), Application (Vaccine Development, Blood and Plasma Product Testing, Gene Therapy and Cell Therapy, Biopharmaceutical Production), End-User (Pharmaceutical and Biotechnology Companies, Contract Research Organizations (CROs), Academic and Research Institutes), and Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Biological Safety Testing Market is expected to grow from USD 1.5 billion in 2023 at a CAGR of 20.9% to touch USD 5.6 billion by 2030. The Biological Safety Testing Market is dominated by key players such as Charles River Laboratories, Lonza Group AG, Merck KGaA, Sartorius AG, Thermo Fisher Scientific Inc., SGS S.A., Eurofins Scientific, WuXi AppTec, Bio-Rad Laboratories, Inc., Toxikon Corporation, Cytovance Biologics, Avance Biosciences Inc., Paragon Bioservices (Catalent), Pacific BioLabs, Nelson Labs.

Published: December, 2024
| Report ID: LI5131
| Life Sciences & Healthcare
Healthcare Analytical Testing Services Market By Service Type (Analytical Testing, Laboratory Testing, Outsourced Testing Services), By Technology (Chromatography, Mass Spectrometry, Next-Generation Sequencing (NGS)), By Application (Drug Development, Diagnostics & Personalized Medicine, Biotechnology & Biopharma), By End Use (Pharmaceutical Companies, Biotechnology Companies, Contract Research Organizations (CROs), Hospitals & Diagnostic Laboratories), and By Region; Global Insights & Forecast (2024 – 2030)

According According to Intent Market Research, the Healthcare Analytical Testing Services Market is expected to grow from USD 5.3 billion in 2023 at a CAGR of 11.1% to touch USD 11.1 billion by 2030. The Healthcare Analytical Testing Services Market is dominated by key players such as, Charles River Laboratories, Labcorp Drug Development, Medpace, Inc., BioAnalytix, and Covance (Labcorp).

Published: December, 2024
| Report ID: LI5123
| Life Sciences & Healthcare
Genotyping Assay Market By Product & Service (Reagents & Consumables, Instruments, Software & Services), By Technology (Polymerase Chain Reaction (PCR), Microarrays, Next-Generation Sequencing (NGS), Mass Spectrometry), By Application (Pharmacogenomics, Diagnostics & Personalized Medicine, Agricultural Biotechnology), By End Use (Pharmaceutical & Biotechnology Companies, Academic & Research Institutions, Diagnostic Laboratories), and By Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Genotyping Assay Market is expected to grow from USD 12.2 billion in 2023 at a CAGR of 8.3% to touch USD 21.3 billion by 2030. The Genotyping Assay Market is dominated by key players such as, Illumina, Inc., Thermo Fisher Scientific, Inc., Agilent Technologies, Inc., Becton, Dickinson and Company, and PerkinElmer, Inc.

Published: December, 2024
| Report ID: LI5120
| Life Sciences & Healthcare
Antimicrobial Hospital Textile Market By Product Type (Bed Linen, Pillow Covers, Curtains & Drapes, Surgical Gowns, Scrubs), By Material Type (Cotton, Polyester, Blends), By End Use (Hospitals, Specialty Clinics, Ambulatory Surgical Centers), and By Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Antimicrobial Hospital Textile Market is expected to grow from USD 1.1 billion in 2023 at a CAGR of 7.9% to touch USD 1.9 billion by 2030. The Antimicrobial Hospital Textile Market is dominated by key players such as, 3M Company, Medline Industries, Mölnlycke Health Care AB, Baxter International Inc., and Smith & Nephew.

Published: December, 2024
| Report ID: LI5118
| Life Sciences & Healthcare
Advanced Balloon Catheter Market By Product Type (Drug-Eluting Balloon Catheters, Non-Drug-Eluting Balloon Catheters, Cutting Balloon Catheters, Scoring Balloon Catheters), By Material (Polyurethane, Nylon, PVC, Silicone), By Application (Coronary Artery Disease Treatment, Peripheral Artery Disease Treatment, Urological Treatments, Gastrointestinal Disorders), By End-User (Hospitals, Ambulatory Surgical Centers, Clinics, Research Institutes), and By Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Advanced Balloon Catheter Market is expected to grow from USD 2.8 billion in 2023 at a CAGR of 10.7% to touch USD 5.7 billion by 2030. The Advanced Balloon Catheter Market is dominated by key players such as Boston Scientific Corporation, Medtronic PLC, Abbott Laboratories, Terumo Corporation, Cook Medical, Cordis (Johnson & Johnson), Smith & Nephew PLC, Teleflex Incorporated, B. Braun Melsungen AG, AngioDynamics, Inc., Endologix, Inc., Merit Medical Systems, Inc., Philips Healthcare, Cardinal Health, Inc., MicroPort Scientific Corporation.

Published: December, 2024
| Report ID: LI5117
| Life Sciences & Healthcare
Antiemetics Drugs Market By Drug Class (5-HT3 Receptor Antagonists, Dopamine Antagonists, Antihistamines, NK1 Receptor Antagonists, Cannabinoids, Steroids), By Application (Chemotherapy-Induced Nausea and Vomiting (CINV), Postoperative Nausea and Vomiting (PONV), Motion Sickness, Morning Sickness, Gastroenteritis), By Route of Administration (Oral, Injectable, Transdermal), By End-Use (Hospitals, Clinics, Homecare), and By Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Antiemetics Drugs Market is expected to grow from USD 4.0 billion in 2023 at a CAGR of 4.7% to touch USD 5.5 billion by 2030. The Antiemetics Drugs Market is dominated by key players such as, Merck & Co., Inc., GlaxoSmithKline Plc, Johnson & Johnson (Janssen Pharmaceuticals), Teva Pharmaceutical Industries Ltd., and Bristol-Myers Squibb.

Published: December, 2024
| Report ID: LI5116
| Life Sciences & Healthcare
Acute Migraine Treatment Market By Drug Class (Triptans, Ergot Alkaloids, NSAIDs, Antiemetics, Opioids), By Treatment Type (Oral Medications, Injectable Medications, Nasal Sprays, Transdermal Patches), By Route of Administration (Oral, Injectable, Intranasal, Topical), By End-User (Hospitals, Clinics, Homecare Settings, Ambulatory Surgical Centers); Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Acute Migraine Treatment Market is expected to grow from USD 1.9 billion in 2023 at a CAGR of 20.0% to touch USD 6.6 billion by 2030. The Acute Migraine Treatment Market is dominated by key players such as Amgen Inc., Eli Lilly and Co., GlaxoSmithKline PLC, Novartis AG, Pfizer Inc., Teva Pharmaceutical Industries Ltd., Alder BioPharmaceuticals, Supernus Pharmaceuticals Inc., Cipla Ltd., Lundbeck A/S, Johnson & Johnson, Merck & Co., Inc., Sanofi S.A., AbbVie Inc., Biohaven Pharmaceuticals Holding Company.

Published: December, 2024
| Report ID: LI5115
| Life Sciences & Healthcare
Antidote Market By Type (Chemical Antidotes, Biological Antidotes, Physical Antidotes), By Drug Class (Chelating Agents, Enzyme Inhibitors, Receptor Antagonists), By Application (Heavy Metal Poisoning, Paracetamol Overdose, Opioid Overdose, Pesticide Poisoning, Snake Bites, Alcohol Intoxication, Radiation Poisoning), By End-Use (Hospitals, Poison Control Centers, Specialty Clinics), and By Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Antidote Market is expected to grow from USD 2.1 billion in 2023 at a CAGR of 6.2% to touch USD 3.1 billion by 2030. The Antidote Market is dominated by key players such as Mylan N.V. (Viatris), Pfizer Inc., Novartis AG, GlaxoSmithKline Plc, F. Hoffmann-La Roche Ltd., Teva Pharmaceutical Industries Ltd., Fresenius SE & Co. KGaA, Johnson & Johnson (Janssen Pharmaceuticals), Boehringer Ingelheim International GmbH, Dr. Reddy’s Laboratories Ltd., Sun Pharmaceutical Industries Ltd., Hikma Pharmaceuticals PLC, Zydus Lifesciences (Cadila Healthcare), Mallinckrodt Pharmaceuticals, CSL Limited.

Published: December, 2024
| Report ID: LI5114
| Life Sciences & Healthcare
Acute Hospital Care Market By Type of Care (Emergency Care, Intensive Care, Critical Care, Trauma Care), By Specialty (Cardiology, Orthopedics, Neurology, Pulmonology, Oncology), By Service (Diagnostic Services, Therapeutic Services, Surgical Services, Emergency Services, Nursing Services), By End-User (Hospitals, Clinics, Ambulatory Surgical Centers, Homecare Settings, Rehabilitation Centers), and By Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Acute Hospital Care Market is expected to grow from USD 2,169.1 billion in 2023 at a CAGR of 6.9% to touch USD 3,456.2 billion by 2030. The Acute Hospital Care Market is dominated by key players such as HCA Healthcare, Tenet Healthcare, Mayo Clinic, Kaiser Permanente, Cleveland Clinic, Ascension Health, UPMC (University of Pittsburgh Medical Center), Universal Health Services, Catholic Health Initiatives, Community Health Systems, Fresenius Medical Care, Medtronic, GE Healthcare, Siemens Healthineers, Johnson & Johnson.

Published: December, 2024
| Report ID: LI5113
| Life Sciences & Healthcare
Transfection Technologies Market By Technology (Physical Methods, Chemical Methods, Viral Vectors), By Application (Gene Therapy, Drug Discovery, Vaccine Development, Cancer Research), By End-User (Pharmaceutical Companies, Biotech Companies, Research Institutes, Contract Research Organizations (CROs), Hospitals & Clinics), and By Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Transfection Technologies Market is expected to grow from USD 1.3 billion in 2023 at a CAGR of 10.3% to touch USD 2.6 billion by 2030. The Transfection Technologies Market is dominated by key players such as, Lonza Group, Thermo Fisher Scientific, MaxCyte, Inc., Promega Corporation, and InvivoGen.

Published: December, 2024
| Report ID: LI5112
| Life Sciences & Healthcare
Biotechnology Reagents and Kits Market By Product Type (Reagents, Kits, Consumables, Antibodies, Enzymes), By Application (PCR, Sequencing, Cell Culture, Western Blotting, Diagnostics, Protein Analysis), By End-User Industry (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Diagnostic Laboratories, Hospitals & Clinics), and By Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Biotechnology Reagents & Kits Market is expected to grow from USD 102.7 billion in 2023 at a CAGR of 15.1% to touch USD 274.1 billion by 2030. The Biotechnology Reagents & Kits Market is dominated by key players such as Thermo Fisher Scientific, Inc., Agilent Technologies, Inc., Merck KGaA, Bio-Rad Laboratories, Inc., PerkinElmer, Inc., Roche Diagnostics, Abbott Laboratories, QIAGEN N.V., Sigma-Aldrich Co. LLC, Illumina, Inc., GE Healthcare Life Sciences, Danaher Corporation, F. Hoffmann-La Roche AG, Bio-Techne Corporation, Eppendorf AG.

Published: December, 2024
| Report ID: LI5111
| Life Sciences & Healthcare
Biotechnology Instruments Market By Type (Chromatography Instruments, Electrophoresis Instruments, Spectrophotometers, Microscopes, Centrifuges, PCR Systems), By Application (Drug Discovery, Diagnostics, Research & Development, Proteomics, Genomics), By End-User Industry (Pharmaceuticals, Biotechnology, Hospitals & Diagnostic Laboratories, Academic & Research Institutes, Food & Beverage), and By Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Biotechnology Instruments Market is expected to grow from USD 80.5 billion in 2023 at a CAGR of 5.7% to touch USD 118.4 billion by 2030. The Biotechnology Instruments Market is dominated by key players such as Thermo Fisher Scientific Inc., Agilent Technologies Inc., Bio-Rad Laboratories, Inc., Illumina Inc., PerkinElmer Inc., Merck & Co. Inc., Waters Corporation, Sartorius AG, Abbott Laboratories, Danaher Corporation, GE Healthcare Life Sciences, Beckman Coulter, Inc., Eppendorf AG, Shimadzu Corporation, Hitachi High-Technologies Corporation.

Published: December, 2024
| Report ID: LI5110
| Life Sciences & Healthcare
Biosimilars Market By Product Type (Monoclonal Antibodies, Recombinant Proteins, Erythropoietin, Insulin, Growth Hormones, Granulocyte Colony-Stimulating Factor (G-CSF)), By Application (Oncology, Autoimmune Diseases, Diabetes, Growth Disorders, Hematology, Infectious Diseases), By End-User (Hospitals, Pharmaceutical Companies, Biotech Companies, Research Institutes), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and By Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Biosimilars Market is expected to grow from USD 22.2 billion in 2023 at a CAGR of 17.6% to touch USD 69.0 billion by 2030. The Biosimilars Market is dominated by key players such as Amgen Inc., Sandoz International GmbH, Pfizer Inc., Biocon Limited, Celltrion Inc., Samsung Bioepis, Mylan N.V. (Now Viatris), Eli Lilly and Co., Teva Pharmaceutical Industries Ltd., Novartis AG, AbbVie Inc., Merck & Co., Inc., Boehringer Ingelheim GmbH, Stada Arzneimittel AG, Fresenius Kabi AG.

Published: December, 2024
| Report ID: LI5107
| Life Sciences & Healthcare
Biopsy Needle Market By Product Type (Spring-Loaded Needle, Vacuum-Assisted Needle, Core Needle, Fine Needle Aspiration Needle (FNA), Others), By Material (Stainless Steel, Titanium, Plastic), By Application (Breast Biopsy, Lung Biopsy, Prostate Biopsy, Liver Biopsy, Skin Biopsy), By End-User (Hospitals, Diagnostic Laboratories, Clinics, Ambulatory Surgical Centers), and By Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Biopsy Needle Market is expected to grow from USD 0.9 billion in 2023 at a CAGR of 11.5% to touch USD 2.0 billion by 2030. The Biopsy Needle Market is dominated by key players such as BD (Becton, Dickinson and Company), Medtronic PLC, Smith & Nephew PLC, Boston Scientific Corporation, Cook Medical, Hologic Inc., Thermo Fisher Scientific, Johnson & Johnson, F. Hoffmann-La Roche AG, Stryker Corporation, Intuitive Surgical, Olympus Corporation, B. Braun Melsungen AG, Alcon Laboratories, Biopsy Sciences.

Published: December, 2024
| Report ID: LI5105
| Life Sciences & Healthcare
Biological Treatment Technologies Market By Technology Type (Biological Filtration, Bioreactors, Membrane Bioreactors, Aerobic & Anaerobic Treatment, Biological Nutrient Removal), By Application (Wastewater Treatment, Air Pollution Control, Soil Remediation, Industrial Waste Treatment), By End-User Industry (Water Treatment Industry, Food & Beverage, Oil & Gas, Pharmaceutical, Mining, Agriculture), and By Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Biological Treatment Technologies Market is expected to grow from USD 2.8 billion in 2023 at a CAGR of 7.9% to touch USD 4.7 billion by 2030. The Biological Treatment Technologies Market is dominated by key players such as Veolia Environment, SUEZ.

Published: December, 2024
| Report ID: LI5103
| Life Sciences & Healthcare
Bariatric Surgery Devices Market By Type of Device (Intragastric Balloon Systems, Bariatric Surgery Staples, Gastric Bands, Gastric Bypass Instruments), By Procedure (Sleeve Gastrectomy, Gastric Bypass, Gastric Banding, Duodenal Switch), By End-User (Hospitals, Clinics, Ambulatory Surgical Centers, Homecare Settings), and By Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Bariatric Surgery Devices Market is expected to grow from USD 2.3 billion in 2023 at a CAGR of 8.7% to touch USD 4.2 billion by 2030. The Bariatric Surgery Devices Market is dominated by key players such as Johnson & Johnson, Kimberly-Clark Corporation, Procter & Gamble, The Clorox Company, Reckitt Benckiser Group, Unicharm Corporation, Edgewell Personal Care, Medline Industries, SC Johnson Professional, AlcoPro, Alea Care, The Honest Company, VWR International, Ecolab, Gojo Industries.

Published: December, 2024
| Report ID: LI5101
| Life Sciences & Healthcare
Bacterial and Viral Specimen Collection Market By Type (Swabs, Specimen Collection Kits, Transport Media), By Type of Specimen (Blood, Nasal Swabs, Throat Swabs, Sputum, Urine), By Application (Diagnostics, Research & Development, Forensic), By End-User (Hospitals, Diagnostic Laboratories, Research Institutions, Home Care Settings), and By Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Bacterial and Viral Specimen Collection Market is expected to grow from USD 18.5 billion in 2023 at a CAGR of 13.3% to touch USD 44.4 billion by 2030. The Bacterial and Viral Specimen Collection Market is dominated by key players such as Thermo Fisher Scientific, Inc., BD (Becton, Dickinson and Company), Copan Diagnostics, Inc., Hologic, Inc., Merck & Co., Inc., BioMérieux S.A., Abbott Laboratories, Charles River Laboratories, VWR International, LLC, Qiagen N.V., LabCorp, F. Hoffmann-La Roche AG, Omega Diagnostics Group PLC, PerkinElmer Inc., Tecan Group Ltd.

Published: December, 2024
| Report ID: LI5086
| Life Sciences & Healthcare
Baby Skincare Market By Product Type (Baby Shampoo, Baby Lotion, Baby Cream, Baby Oil, Baby Powder), By Ingredient Type (Natural/Organic, Chemical-Based, Combination), By Age Group (Newborn, Infant, Toddler), By Distribution Channel (Online Stores, Supermarkets/Hypermarkets, Specialty Stores, Pharmacies/Drugstores), and By Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Baby Skincare Market is expected to grow from USD 13.0 billion in 2023 at a CAGR of 8.3% to touch USD 22.7 billion by 2030. The Baby Skincare Market is dominated by key players such as Johnson & Johnson, Procter & Gamble (P&G), Unilever, Nestlé (Gerber Baby), The Himalaya Drug Company, Beiersdorf AG, L'Oréal, Aveeno (Johnson & Johnson), Burt's Bees (Clorox), Pigeon Corporation, Carter's (OshKosh), Kimberly-Clark Corporation, Chicco (Artsana Group), Mustela (Laboratoires Expanscience), Earth Mama Organics.

Published: December, 2024
| Report ID: LI5085
| Life Sciences & Healthcare
Epilepsy Drug Market By Drug Type (Antiepileptic Drugs, Anti-seizure Medications, Brand-name Drugs, Generic Epilepsy Drugs), By Mechanism of Action (Sodium Channel Blockers, GABAergic Drugs, Glutamate Antagonists, Calcium Channel Blockers), By Administration Route (Oral Drugs, Injectable Drugs, Nasal Spray, Transdermal Patches), By Age Group (Pediatric, Adult, Geriatric), By End-User (Hospitals, Clinics, Homecare Settings, Research Institutes); Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Epilepsy Drug Market is expected to grow from USD 9.3 billion in 2023 at a CAGR of 5.2% to touch USD 13.2 billion by 2030. The Epilepsy Drug Market is dominated by key players such as Pfizer Inc., GlaxoSmithKline (GSK), Johnson & Johnson, Novartis AG, UCB Pharma, Eisai Co., Ltd., Abbott Laboratories, Sanofi, Merck & Co., Inc., Teva Pharmaceuticals, Sun Pharmaceutical Industries Ltd., Astellas Pharma Inc., Mylan N.V., Zogenix, Inc., LivaNova.

Published: December, 2024
| Report ID: LI5084
| Life Sciences & Healthcare
Epigenomics Market By Product Type (Reagents & Kits, Instruments, Enzymes, Services), By Technology (PCR-based Technologies, Sequencing Technologies, Chromatin Immunoprecipitation (ChIP), Microarray-based Technologies), By Application (Cancer Research, Drug Discovery, Agriculture & Animal Research, Diagnostics), By End-User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Diagnostic Laboratories, Hospitals & Clinics), and By Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Epigenomics Market is expected to grow from USD 13.0 billion in 2023 at a CAGR of 23.5% to touch USD 56.7 billion by 2030. The Epigenomics Market is dominated by key players such as Illumina, Inc., Thermo Fisher Scientific, Inc., Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., Qiagen N.V., Merck & Co., Inc., Roche Diagnostics, Oxford Nanopore Technologies, Pacific Biosciences of California, Inc., New England Biolabs, Inc., Promega Corporation, PerkinElmer, Inc., Bio-Techne Corporation, Zymo Research Corporation, Abcam PLC.

Published: December, 2024
| Report ID: LI5083
| Life Sciences & Healthcare
Epigenetics Market By Product Type (Reagents & Kits, Instruments, Enzymes, Services), By Technology (PCR-based Technologies, Sequencing Technologies, Chromatin Immunoprecipitation, Microarray-based Technologies), By Application (Cancer Research, Drug Discovery, Agriculture & Animal Research, Diagnostics), By End-User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Diagnostic Laboratories, Hospitals & Clinics); Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Epigenetics Market is expected to grow from USD 0.9 billion in 2023 at a CAGR of 24.0% to touch USD 4.2 billion by 2030. The Epigenetics Market is dominated by key players such as Thermo Fisher Scientific, Inc., Illumina, Inc., Qiagen N.V., Merck KGaA, Darmstadt, Germany, Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., New England Biolabs, Inc., Abcam plc, PerkinElmer, Inc., Zymo Research Corporation, Active Motif, Inc., EpigenDx, Inc., Cambridge Epigenetix Ltd., System Biosciences, Becton, Dickinson and Company.

Published: December, 2024
| Report ID: LI5082
| Life Sciences & Healthcare
Drug Delivery Devices Market By Product Type (Needle-Free Injectors, Insulin Pens, Inhalers, Microneedles, Gene Therapy Devices, Implantable Pumps, Smart Devices for Drug Delivery), By Application (Cancer Treatment, Diabetes Management, Neurological Disorders, Cardiovascular Diseases, Genetic Disorders, Autoimmune Diseases, Infectious Diseases), By End-User Industry (Hospitals, Ambulatory Surgical Centers, Homecare Settings, Clinics, Research Institutes), By Technology (Nanotechnology, Polymeric Drug Delivery, Liposome Drug Delivery, Hydrogels, Targeted Drug Delivery Systems, Gene Editing Technologies), and By Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Drug Delivery Devices Market is expected to grow from USD 194.3 billion in 2023 at a CAGR of 9.2% to touch USD 359.1 billion by 2030. The Drug Delivery Devices Market is dominated by key players such as Medtronic, Johnson & Johnson, Becton, Dickinson and Company (BD), Pfizer Inc., Roche, Novo Nordisk, Stryker Corporation, Sanofi S.A., AbbVie Inc., Mylan N.V., Eli Lilly and Co., Boehringer Ingelheim, GlaxoSmithKline (GSK), Novartis AG, Merck & Co.

Published: December, 2024
| Report ID: LI5081
| Life Sciences & Healthcare
Global Drug and Gene Delivery Devices Market By Product Type (Needle-Free Injectors, Insulin Pens, Inhalers, Microneedles, Gene Therapy Devices, Implantable Pumps, Smart Devices for Drug Delivery), By Application (Cancer, Diabetes, Neurological Disorders, Cardiovascular Diseases, Genetic Disorders, Autoimmune Diseases, Infectious Diseases), By End-User Industry (Hospitals, Ambulatory Surgical Centers, Homecare Settings, Clinics, Research Institutes), and By Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Drug and Gene Delivery Devices Market is expected to grow from USD 370.0 billion in 2023 at a CAGR of 10.7% to touch USD 756.0 billion by 2030. The Drug and Gene Delivery Devices Market is dominated by key players such as AbbVie Inc., BD (Becton, Dickinson and Company), Medtronic, Boston Scientific Corporation, Johnson & Johnson, Stryker Corporation, Novartis AG, Pfizer Inc., Roche Holding AG, Novo Nordisk, Mylan N.V., Siemens Healthineers, Merck & Co., Inc., AstraZeneca, Sanofi S.A.

Published: December, 2024
| Report ID: LI5080
| Life Sciences & Healthcare
DNA Microarray Market By Product Type (Consumables, Instruments, Software & Services), By Type (cDNA Microarrays, Oligonucleotide DNA Microarrays), By Application (Gene Expression Analysis, Genotyping, Cancer Diagnostics, Drug Discovery, Agricultural Biotechnology), By End-User (Academic and Research Institutes, Pharmaceutical and Biotechnology Companies, Diagnostic Laboratories, Contract Research Organizations), and By Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the DNA Microarray Market is expected to grow from USD 2.0 billion in 2023 at a CAGR of 9.2% to touch USD 3.8 billion by 2030. The DNA Microarray Market is dominated by key players such as Philips Healthcare, Medtronic PLC, GE Healthcare, Siemens Healthineers, Johnson & Johnson, Abbott Laboratories, Linde Group, Amedisys Inc., LHC Group, Inc., Fresenius Medical Care, Invacare Corporation, Baxter International Inc., ResMed Inc., Vivalto Santé, Kindred Healthcare.

Published: December, 2024
| Report ID: LI5079
| Life Sciences & Healthcare
DNA Forensics Market by Application (Criminal Investigation, Paternity Testing, Ancestry Testing, Missing Person Identification, Disaster Victim Identification), Type (Capillary Electrophoresis, Polymerase Chain Reaction, Next-Generation Sequencing, Microarrays), End-User (Law Enforcement Agencies, Forensic Laboratories, Academic and Research Institutes, Healthcare and Clinical Settings, Government and Legal Agencies), Sample Type (Blood, Hair, Saliva, Semen, Bone), and By Region; Global Insights & Forecast (2024–2030)

According to Intent Market Research, the DNA Forensics Market is expected to grow from USD 2.3 billion in 2023 at a CAGR of 7.3% to touch USD 3.8 billion by 2030. The DNA Forensics Market is dominated by key players such as Thermo Fisher Scientific, Promega Corporation, Qiagen, Illumina, Inc., Agilent Technologies, GE Healthcare, Bio-Rad Laboratories, F. Hoffmann-La Roche AG, Eurofins Scientific, LGC Limited, NEC Corporation, NMS Labs, Verogen, Inc., Labcorp, IntegenX.

Published: December, 2024
| Report ID: LI5078
| Life Sciences & Healthcare
Disposable Syringes Market By Product Type (Luer Lock Syringes, Luer Slip Syringes), By Material (Plastic Syringes, Glass Syringes), By Capacity (0.5-5 ml, 5.1-10 ml, 10.1-20 ml, Above 20 ml), By End-User (Hospitals, Clinics, Homecare Settings, Ambulatory Surgical Centers), By Application (Insulin Administration, Vaccination, Intravenous Administration); Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Disposable Syringes Market is expected to grow from USD 13.0 billion in 2023 at a CAGR of 7.0% to touch USD 20.8 billion by 2030. The Disposable Syringes Market is dominated by key players such as Becton, Dickinson and Company (BD), Terumo Corporation, Medtronic, Smiths Group, Fresenius Kabi AG, Nipro Corporation, Gerresheimer AG, Hindustan Syringes & Medical Devices Ltd., Schott AG, Steris Corporation, Embulife, Abbott Laboratories, Alcon, Syringe Supplies, B. Braun Melsungen.

Published: December, 2024
| Report ID: LI5077
| Life Sciences & Healthcare
Disposable Surgical Devices Market By Product Type (Surgical Gloves, Gowns, Drapes, Face Masks, Scalpels, Forceps, Syringes, Cannulas, Sutures, and Staplers), By Material (Polypropylene, Polyethylene, Non-Woven Fabrics, Latex), By End-User (Hospitals, Ambulatory Surgical Centers, Clinics, Diagnostic Centers, Homecare Settings), By Application (General Surgery, Orthopedic Surgery, Cardiovascular Surgery, Neurosurgery, Obstetrics and Gynecology Surgery, Urology Surgery), and By Distribution Channel (Direct Sales, Online Sales, Distributors and Wholesalers); Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Disposable Surgical Devices Market is expected to grow from USD 4.6 billion in 2023 at a CAGR of 12.3% to touch USD 10.4 billion by 2030. The Disposable Surgical Devices Market is dominated by key players such as Johnson & Johnson, 3M Company, Medtronic, Becton, Dickinson and Company, Cardinal Health, B. Braun Melsungen AG, Boston Scientific Corporation, Stryker Corporation, Baxter International Inc., Smith & Nephew, Mölnlycke Health Care AB, Owens & Minor, Inc., Ansell Limited, Halyard Health, Zimmer Biomet Holdings.

Published: December, 2024
| Report ID: LI5076
| Life Sciences & Healthcare
Disease Management Apps Market By Disease Type (Chronic Diseases, Respiratory Diseases, Cancer, Neurological Disorders, Infectious Diseases, Mental Health Disorders), By Platform (iOS, Android, Web-Based), By End-User (Patients, Healthcare Providers, Caregivers, Insurance Companies), By Deployment Type (Cloud-Based, On-Premise), and By Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Disease Management Apps Market is expected to grow from USD 8.3 billion in 2023 at a CAGR of 13.2% to touch USD 19.8 billion by 2030. The Disease Management Apps Market is dominated by key players such as Apple Inc., Fitbit (Owned by Google), Samsung Electronics, Medtronic, Philips Healthcare, Cerner Corporation, Allscripts Healthcare Solutions, HealthCatalyst, iHealth Labs, Livongo Health, Omron Healthcare, Dexcom, MySugr (Acquired by Roche), Healint, Pear Therapeutics.

Published: December, 2024
| Report ID: LI5074
| Life Sciences & Healthcare
Dental Imaging Equipment Market By Product Type (Intraoral X-ray Systems, Extraoral X-ray Systems, Cone Beam Computed Tomography (CBCT) Systems, Intraoral Sensors, Dental Lasers), By Technology (Digital Radiography, Analog Radiography, 3D Imaging, 2D Imaging), By Application (Diagnostic Imaging, Implantology, Orthodontics, Periodontics, Endodontics, Oral Surgery), By End-User Industry (Dental Clinics, Hospitals, Diagnostic Centers, Research Institutes), and By Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Dental Imaging Equipment Market is expected to grow from USD 2.8 billion in 2023 at a CAGR of 10.7% to touch USD 5.7 billion by 2030. The Dental Imaging Equipment Market is dominated by key players such as Sirona Dental Systems , Carestream Health, Planmeca Oy, GE Healthcare, Vatech Co., Ltd., Konica Minolta, Inc., Fujifilm Holdings Corporation, 3Shape, Ricoh Company, Ltd., Asahi Roentgen, Morita Mfg. Corp., Nobel Biocare, NewTom, Panasonic Corporation, Oraltronics.

Published: December, 2024
| Report ID: LI5071
| Life Sciences & Healthcare
Cardiac Rhythm Management Devices Market By Type (Pacemakers, Implantable Cardioverter Defibrillators (ICD), Cardiac Resynchronization Therapy Devices (CRT-D/CRT-P), External Defibrillators), By Technology (Bi-Ventricular Pacing, Subcutaneous ICD, Transvenous Pacing, Leadless Pacemaker), By Application (Heart Failure, Arrhythmias, Syncope, Bradycardia, Tachycardia), By End-User (Hospitals, Clinics, Homecare Settings, Ambulatory Surgical Centers), and By Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Cardiac Rhythm Management Devices Market is expected to grow from USD 17.6 billion in 2023 at a CAGR of 9.0% to touch USD 32.1 billion by 2030. The Cardiac Rhythm Management Devices Market is dominated by key players such as Medtronic, Boston Scientific Corporation, Abbott Laboratories, Biotronik SE & Co. KG, St. Jude Medical (Now part of Abbott), Philips Healthcare, Stryker Corporation, MicroPort Scientific Corporation, Hoya Corporation, Medico S.p.A., Biotronik, Cook Medical, Zoll Medical Corporation, LivaNova PLC, Edwards Lifesciences Corporation.

Published: December, 2024
| Report ID: LI5070
| Life Sciences & Healthcare
Cardiac Resynchronization Therapy Market By Product Type (Biventricular Pacemaker, CRT-D, CRT-P), By Application (Heart Failure, Arrhythmias), By End-User Industry (Hospitals, Clinics, Ambulatory Surgical Centers, Homecare Settings), and By Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Cardiac Resynchronization Therapy Market is expected to grow from USD 4.6 billion in 2023 at a CAGR of 10.7% to touch USD 9.5 billion by 2030. The Cardiac Resynchronization Therapy Market is dominated by key players such as Medtronic PLC, Abbott Laboratories, Boston Scientific Corporation, Biotronik SE & Co. KG, Philips Healthcare, St. Jude Medical, MicroPort Scientific Corporation, Zoll Medical Corporation, GE Healthcare, Siemens Healthineers, Biotronik, Vitatron, LivaNova PLC, SJM (St. Jude Medical), EBR Systems, Inc.

Published: December, 2024
| Report ID: LI5069
| Life Sciences & Healthcare
Cancer/Oncology Drugs Market By Drug Type (Chemotherapy Drugs, Targeted Therapy Drugs, Immunotherapy Drugs, Hormone Therapy Drugs, Stem Cell Therapy), By Cancer Type (Lung Cancer, Breast Cancer, Prostate Cancer, Colorectal Cancer, Skin Cancer, Leukemia, Lymphoma, Ovarian Cancer, Pancreatic Cancer, Head and Neck Cancer), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and By Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Cancer Drugs Market is expected to grow from USD 203.5 billion in 2023 at a CAGR of 13.1% to touch USD 482.0 billion by 2030. The Cancer Drugs Market is dominated by key players such as Roche Holding AG, Novartis International AG, Bristol Myers Squibb, Merck & Co., Inc., AstraZeneca PLC, Pfizer Inc., Eli Lilly and Co., Johnson & Johnson, Sanofi S.A., AbbVie Inc., GlaxoSmithKline PLC, Amgen Inc., Gilead Sciences, Inc., Boehringer Ingelheim GmbH, Bayer AG.

Published: December, 2024
| Report ID: LI5068
| Life Sciences & Healthcare
Uterine Fibroid Treatment Devices Market by Device Type (Uterine Fibroid Embolization (UFE) Devices, MRI-Guided Focused Ultrasound (MRgFUS) Devices, Laparoscopic Instruments, Hysteroscopic Instruments, Radiofrequency Ablation (RFA) Devices), By Procedure (Minimally Invasive Surgery, Surgical Procedures, Non-Invasive Procedures), By End-User (Hospitals, Ambulatory Surgical Centers, Specialty Clinics, Home Care), and By Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Uterine Fibroid Treatment Devices Market is expected to grow from USD 4.2 billion in 2023 at a CAGR of 6.6% to touch USD 6.6 billion by 2030. The Uterine Fibroid Treatment Devices Market is dominated by key players such as Medtronic, Johnson & Johnson, Boston Scientific Corporation, ConMed Corporation, Hologic, Inc., Cook Medical, AngioDynamics, Inc., EDAP TMS, Merit Medical Systems, Inc., GE Healthcare, Philips Healthcare, Siemens Healthineers, Theraclion, Biotronik, InSightec

Published: December, 2024
| Report ID: LI5046
| Life Sciences & Healthcare
Autologous Stem Cell & Non-Stem Cell Therapies Market By Therapy Type (Autologous Stem Cell Therapy, Non-Stem Cell Therapy), By Application (Cancer Treatment, Orthopedic Applications, Cardiovascular Diseases, Neurological Disorders, Autoimmune Disorders), By End-User (Hospitals, Clinics, Research & Academic Institutes, Stem Cell Banks), and By Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Autologous Stem Cell & Non-Stem Cell Therapies Market is expected to grow from USD 4.2 billion in 2023 at a CAGR of 26.2% to touch USD 21.3 billion by 2030. The Autologous Stem Cell & Non-Stem Cell Therapies Market is dominated by key players such as Novartis, Roche, Bristol-Myers Squibb, Gilead Sciences, Celltex Therapeutics, Mesoblast, Cytori Therapeutics, Medtronic, Biotime, Haplogen, Lonza Group, Vericel Corporation, Celyad, Kite Pharma, Bluebird Bio

Published: December, 2024
| Report ID: LI5028
| Life Sciences & Healthcare
Autoimmune Hemolytic Anemia Treatment Market By Treatment Type (Corticosteroids, Immunosuppressive Drugs, Intravenous Immunoglobulins (IVIG), Rituximab, Splenectomy, Blood Transfusion), By Disease Type (Warm Autoimmune Hemolytic Anemia (WAIHA), Cold Autoimmune Hemolytic Anemia (CAIHA), Mixed-Type Autoimmune Hemolytic Anemia), By End-User (Hospitals, Specialty Clinics, Research & Academic Institutes), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East & Africa); Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Autoimmune Hemolytic Anemia Treatment Market is expected to grow from USD 0.7 billion in 2023 at a CAGR of 5.9% to touch USD 1.0 billion by 2030. The Autoimmune Hemolytic Anemia Treatment Market is dominated by key players such as Pfizer Inc., F. Hoffmann-La Roche Ltd., GlaxoSmithKline plc, Sanofi S.A., Novartis AG, AstraZeneca plc, Amgen Inc., Eli Lilly and Company, Johnson & Johnson Services, Inc., Biogen Inc., Takeda Pharmaceutical Company Limited, Alexion Pharmaceuticals, Inc., Merck & Co., Inc., CSL Behring, BioMarin Pharmaceutical Inc.

Published: December, 2024
| Report ID: LI5023
| Life Sciences & Healthcare
Autoimmune Disease Diagnostics Market By Test Type (Autoantibody Tests, Antinuclear Antibody (ANA) Tests, Complete Blood Count (CBC) Tests, C-Reactive Protein (CRP) Tests, Erythrocyte Sedimentation Rate (ESR) Tests, Urinalysis, Imaging Tests), By Disease Type (Systemic Lupus Erythematosus (SLE), Rheumatoid Arthritis (RA), Type 1 Diabetes, Multiple Sclerosis (MS), Inflammatory Bowel Disease (IBD), Psoriasis, Hashimoto’s Thyroiditis), By End-User (Hospitals, Diagnostic Laboratories, Research Laboratories, Academic Institutes), and By Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Autoimmune Disease Diagnostics Market is expected to grow from USD 4.9 billion in 2023 at a CAGR of 6.8% to touch USD 7.7 billion by 2030. The Autoimmune Disease Diagnostics Market is dominated by key players such as Abbott Laboratories, Roche Diagnostics, Siemens Healthineers, Thermo Fisher Scientific, Bio-Rad Laboratories, Danaher Corporation, Beckman Coulter, Inc., Quest Diagnostics, EUROIMMUN (A PerkinElmer Company), Inova Diagnostics, Grifols, S.A., Myriad Genetics, Trinity Biotech, Hologic, Inc., Ortho Clinical Diagnostics

Published: December, 2024
| Report ID: LI5021
| Life Sciences & Healthcare
Artemisinin Antimalarial Drugs Market By Drug Type (Artemisinin, Artemether, Artesunate, Dihydroartemisinin), By Combination Therapy (Artemether-Lumefantrine, Artesunate-Mefloquine, Artesunate-Amodiaquine, Artesunate-Sulfadoxine-Pyrimethamine), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By End-User (Hospitals, Clinics, Research Institutes), and By Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Artemisinin Antimalarial Drugs Market is expected to grow from USD 0.6 billion in 2023 at a CAGR of 5.8% to touch USD 0.8 billion by 2030. The Artemisinin Antimalarial Drugs Market is dominated by key players such as Novartis AG, Sanofi, Cipla Inc., IPCA Laboratories, Guilin Pharmaceutical Co. Ltd., Strides Pharma Science Limited, KPC Pharmaceuticals, Inc., Mylan N.V. (now part of Viatris), F. Hoffmann-La Roche AG, Ranbaxy Laboratories (now part of Sun Pharma), Ajanta Pharma Ltd., GlaxoSmithKline (GSK), Pfizer Inc., Bayer AG, Jiangsu Shenhua Pharmaceutical Co. Ltd.

Published: December, 2024
| Report ID: LI5020
| Life Sciences & Healthcare
Anthrax Treatment Market By Treatment Type (Antibiotics, Antitoxins, Vaccines), By Route of Administration (Oral, Injectable), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By End-User (Hospitals, Clinics, Government & Defense Organizations), and By Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Anthrax Treatment Market is expected to grow from USD 210.7 million in 2023 at a CAGR of 8.6% to touch USD 376.6 million by 2030. The Anthrax Treatment Market is dominated by key players such as Emergent BioSolutions, GlaxoSmithKline (GSK), Pfizer Inc., Sanofi, Elusys Therapeutics, Bayer AG, Merck & Co., Inc., Teva Pharmaceutical Industries Ltd., Novartis AG, AstraZeneca, Johnson & Johnson, CSL Limited, Lonza Group, BioPort Corporation, Altimmune Inc.

Published: December, 2024
| Report ID: LI5019
| Life Sciences & Healthcare
Rapid Microbiology Testing Market By Product Type (Kits & Reagents, Instruments, Consumables), By Technology (PCR, Immunoassays, DNA Sequencing, Microbial Identification), By Application (Food & Beverage Testing, Pharmaceutical Testing, Environmental Testing, Clinical Testing, Cosmetic & Personal Care Testing), By End-User Industry (Healthcare & Pharmaceuticals, Food & Beverages, Agriculture & Environment, Cosmetics & Personal Care); Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Rapid Microbiology Testing Market is expected to grow from USD 4.7 billion in 2023 at a CAGR of 9.6% to touch USD 9.0 billion by 2030. The Rapid Microbiology Testing Market is dominated by key players such as Thermo Fisher Scientific, Abbott Laboratories, BioMérieux, Danaher Corporation, Becton, Dickinson and Company (BD), Cepheid, Merck KGaA, Agilent Technologies, Luminex Corporation, Eppendorf AG, Quidel Corporation, Roche Diagnostics, IDEXX Laboratories, F. Hoffmann-La Roche, Horiba Ltd.

Published: December, 2024
| Report ID: LI5011
| Life Sciences & Healthcare
Transitional Care Management Services Market By Service Type (Patient Assessment and Care Planning, Medication Management and Reconciliation, Health Monitoring and Education, Coordination and Follow-Up Care, Social Support and Counseling), By Mode of Delivery (In-Hospital, Telehealth and Remote Monitoring, Home-Based), By End-User (Hospitals, Clinics, Ambulatory Care Centers, Home Healthcare Providers), and By Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Transitional Care Management Services Market is expected to grow from USD 196.9 billion in 2023 at a CAGR of 16.8% to touch USD 584.8 billion by 2030. The Transitional Care Management Services Market is dominated by key players such as UnitedHealth Group, Aetna Inc. (a CVS Health Company), Humana Inc., Cigna Corporation, Centene Corporation, Anthem, Inc. (now Elevance Health), Optum, Inc., Kaiser Permanente, Fresenius Medical Care, AccentCare, Inc., Encompass Health Corporation, VITAS Healthcare, Brookdale Senior Living, LHC Group, Medtronic Care Management Services

Published: December, 2024
| Report ID: LI5008
| Life Sciences & Healthcare
Stroke Diagnostic and Therapeutics Market By Diagnostic Technology (CT Scans, MRI, Carotid Ultrasound, Electroencephalogram (EEG), Positron Emission Tomography (PET)) By Therapeutic Technology (Thrombectomy Devices, Thrombolytics, Anticoagulants, Neuroprotective Drugs, Rehabilitation Devices) By End-User (Hospitals, Clinics, Rehabilitation Centers, Home Care Settings) Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Stroke Diagnostic and Therapeutics Market is expected to grow from USD 33.9 billion in 2023 at a CAGR of 7.2% to touch USD 55.3 billion by 2030. The Stroke Diagnostic and Therapeutics Market is dominated by key players such as Medtronic, Abbott Laboratories, GE Healthcare, Siemens Healthineers, Philips Healthcare, Johnson & Johnson, Stryker Corporation, Boston Scientific, Penumbra, Inc., Biogen Inc., Boehringer Ingelheim, Bayer AG, Zimmer Biomet, Toshiba Medical Systems, NeuroPace, Inc.

Published: December, 2024
| Report ID: LI5003
| Life Sciences & Healthcare
Cognitive Behavioral Therapy Market By Therapy Type (In-Person CBT, Online/Telehealth CBT, Self-Help CBT, Group CBT), By Application (Anxiety Disorders, Depression, PTSD, OCD, Insomnia, Substance Use Disorder, Eating Disorders), By End-User (Healthcare Providers, Psychological and Counseling Centers, Private Practice Providers, Hospitals and Clinics, Academic Institutions), By Delivery Mode (Face-to-Face, Online Therapy, Blended Therapy), By Age Group (Adults, Children and Adolescents, Elderly); Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Cognitive Behavioral Therapy Market is expected to grow from USD 5.6 billion in 2023 at a CAGR of 20.8% to touch USD 20.8 billion by 2030. The Cognitive Behavioral Therapy Market is dominated by key players such as Pear Therapeutics, Talkspace, BetterHelp, Woebot Health, MindDoc, Lumos Diagnostics, SilverCloud Health, ReGain, Cerebral, TruReach, Therapist Aid, Cogito Health, Sanvello Health, Journify, Headspace Health.

Published: December, 2024
| Report ID: LI4994
| Life Sciences & Healthcare
Dental Flap Surgery Market by Type of Surgery (Simple Flap Surgery, Mucoperiosteal Flap Surgery, Advanced Flap Surgery, Split Thickness Flap Surgery), by Application (Periodontal Diseases, Dental Implants, Gum Recession Treatment, Bone Grafting, Oral Cancer Treatment), by End-User (Dental Clinics, Hospitals, Research Institutes, Academic & Training Centers), and by Technology (Laser-Assisted Flap Surgery, Traditional Surgical Methods, Robotic-Assisted Surgery); Global Insights & Forecast (2024–2030)

According to Intent Market Research, the Dental Flap Surgery Market is expected to grow from USD 4.6 billion in 2023 at a CAGR of 7.3% to touch USD 7.6 billion by 2030. The Dental Flap Surgery Market is dominated by key players such as Straumann Group, Nobel Biocare Services AG, Zimmer Biomet Holdings, Inc., Dentsply Sirona, Danaher Corporation, Biomet 3i, 3M, OSSTEM Implant Co., Ltd., Henry Schein, Inc., Patterson Companies, Inc., Kavo Kerr, Implant Direct, Bicon, LLC, Dentium Co., Ltd., Carestream Dental.

Published: December, 2024
| Report ID: LI4986
| Life Sciences & Healthcare
Voice Prosthesis Device Market By Product Type (Pneumatic Voice Prosthesis, Mechanical Voice Prosthesis, Electrical Voice Prosthesis), By End-User (Hospitals, Clinics, Home Care Settings), By Application (Cancer Treatment, Neurological Disorders, Vocal Cord Paralysis), By Technology (Traditional Voice Prosthesis, Advanced Voice Prosthesis), and By Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Voice Prosthesis Device Market is expected to grow from USD 211.9 million in 2023 at a CAGR of 4.7% to touch USD 292.1 million by 2030. The Voice Prosthesis Device Market is dominated by key players such as Atos Medical, Smith & Nephew, Medtronic, Boston Scientific, Medefil, SEKISUI Medical, Oculus Surgical, InHealth Technologies, Roche, Hollister Incorporated, B. Braun Melsungen AG, Teleflex, Vallis Surgical, Lupin Pharmaceuticals, Fisher & Paykel Healthcare

Published: December, 2024
| Report ID: LI4985
| Life Sciences & Healthcare
GLP-1 Analogues Market By Product (Ozempic, Trulicity, Mounjaro, Wegovy, Rybelsus, Saxenda, Victoza, Zepbound), By Application (Type 2 Diabetes Mellitus, Obesity), By Route of Administration (Subcutaneous Injection, Oral Route), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and By Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the GLP-1 Analogues Market is expected to grow from USD 49.5 billion in 2023 at a CAGR of 17.0% to touch USD 148.1 billion by 2030. The GLP-1 Analogues Market is dominated by key players such as Novo Nordisk, Eli Lilly and Company, Merck & Co., Inc., Sanofi, AstraZeneca, Bristol-Myers Squibb, Glenmark Pharmaceuticals, Hanmi Pharm. Co., Ltd., D&D Pharmatech, Lexicon Pharmaceuticals, Inc., Eccogen, Xeris Pharmaceuticals, Vir Biotechnology, Amgen Inc., Boehringer Ingelheim

Published: December, 2024
| Report ID: LI4982
| Life Sciences & Healthcare
Dental Extraction Forceps Market By Product Type (Universal Extraction Forceps, Upper Jaw Extraction Forceps, Lower Jaw Extraction Forceps, Surgical Extraction Forceps, Pedodontic Extraction Forceps), By End-User (Dental Clinics, Hospitals, Research Institutes, Academic & Training Centers, Others), By Material Type (Stainless Steel Forceps, Titanium Forceps), By Application (Tooth Extraction, Wisdom Tooth Removal, Root Stump Extraction, Surgical Extraction, Pedodontic Extraction), and By Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Dental Extraction Forceps Market is expected to grow from USD 87.9 million in 2023 at a CAGR of 8.1% to touch USD 151.2 million by 2030. The Dental Extraction Forceps Market is dominated by key players such as Hu-Friedy Mfg. Co., LLC, Dentsply Sirona Inc., Aseptico Inc., Kerr Corporation, Integra LifeSciences Corporation, 3M Health Care, Henry Schein, Inc., Medtronic PLC, Friedrich August Lücke GmbH & Co. KG, GPI International, Ritter Dental, Amann Girrbach AG, Everest Dental, Spencer Instruments Inc., Brasseler USA.

Published: December, 2024
| Report ID: LI4981
| Life Sciences & Healthcare
Clear Aligners Market By Type (In-office Clear Aligners, At-home Clear Aligners, Removable Clear Aligners), By End-User (Adult, Teenagers, Children), By Material Type (Polyurethane-based Aligners, Polyethylene-based Aligners), By Distribution Channel (Direct Sales, Retail Sales, Online Sales, Others), By Technology (3D Printing Technology, Digital Scanning Technology), and By Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Clear Aligners Market is expected to grow from USD 4.6 billion in 2023 at a CAGR of 30.2% to touch USD 29.3 billion by 2030. The Clear Aligners Market is dominated by key players such as Align Technology, Inc., 3M Company, Dentsply Sirona Inc., Henry Schein, Inc., ClearCorrect, Smilify, Straumann Group, OrthoClear, Inc., Angelalign Technology Inc., Dental Morell, Candid Care Co., SmileDirectClub, Inc., G&H Orthodontics, K Line Orthodontics, Ultradent Products.

Published: December, 2024
| Report ID: LI4979
| Life Sciences & Healthcare
Cleanroom Technology Market By Product Type (Cleanroom Systems, Cleanroom Furniture, Cleanroom Consumables, Cleanroom Apparels, Air Filtration Systems), By End-User Industry (Pharmaceuticals, Biotechnology, Healthcare, Electronics, Food & Beverages, Chemicals, Aerospace & Defense, Others), By Class of Cleanroom (Class 100 (ISO 5), Class 10,000 (ISO 7), Class 100,000 (ISO 8)), By Cleanroom Type (Modular Cleanrooms, Hardwall Cleanrooms, Softwall Cleanrooms, Fan Filter Units (FFUs)); Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Cleanroom Technology Market is expected to grow from USD 7.4 billion in 2023 at a CAGR of 7.5% to touch USD 12.3 billion by 2030. The Cleanroom Technology Market is dominated by key players such as DuPont, Kimberly-Clark Corporation, Mott Manufacturing Ltd., Clean Air Products, Terra Universal, AES Clean Technology, STEMCELL Technologies, Maclean-Fogg, Envirotech Cleanroom Solutions, Bertin Technologies, Modular Cleanrooms, Inc., Cleanroom World, U.S. Cleanrooms, Inc., Swantec Cleanroom Technology, VWR International.

Published: December, 2024
| Report ID: LI4976
| Life Sciences & Healthcare
Cell and Gene Therapy Manufacturing Market by Therapy Type (Gene Therapy, Cell Therapy, Combination Therapies), Technology (Viral Vector Manufacturing, Non-Viral Vector Manufacturing, Cell Expansion and Culturing Technologies), Application (Oncology, Genetic Disorders, Cardiovascular Diseases, Neurological Disorders), End-User (Biopharmaceutical Companies, CDMOs, Research Institutes), Process Type (Autologous Manufacturing, Allogeneic Manufacturing); Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Cell and Gene Therapy Manufacturing Market is expected to grow from USD 6.5 billion in 2023 at a CAGR of 26.7% to touch USD 34.0 billion by 2030. The Cell and Gene Therapy Manufacturing Market is dominated by key players such as Lonza Group, WuXi AppTec, Samsung Biologics, Gilead Sciences (Kite Pharma), Novartis (AveXis), Catalent, Sartorius AG, MilliporeSigma, Bayer AG, Boehringer Ingelheim, Regeneron Pharmaceuticals, Bristol-Myers Squibb, Vertex Pharmaceuticals, Cytiva (Danaher Corporation), Oxford Biomedica

Published: December, 2024
| Report ID: LI4974
| Life Sciences & Healthcare
Cell and Gene Therapy Clinical Trials Market by Therapy Type (Gene Therapy, Cell Therapy, Combination Therapies), by Application (Oncology, Genetic Disorders, Cardiovascular Diseases, Neurological Disorders, Infectious Diseases), by Phase of Development (Preclinical Trials, Phase I Trials, Phase II Trials, Phase III Trials, Phase IV Trials), by Indication (Cancer, Hematological Disorders, Rare Diseases, Autoimmune Diseases, Cardiovascular Diseases), by End-User (Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, CROs, Hospitals and Clinics), and by Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Cell and Gene Therapy Clinical Trials Market is expected to grow from USD 10.2 billion in 2023 at a CAGR of 15.8% to touch USD 28.4 billion by 2030. The Cell and Gene Therapy Clinical Trials Market is dominated by key players such as Novartis, Gilead Sciences, Kite Pharma (A Gilead Company), Bristol-Myers Squibb, Bluebird Bio, Regeneron Pharmaceuticals, CRISPR Therapeutics, Sarepta Therapeutics, Editas Medicine, Spark Therapeutics (A Roche Company), Gene Editing Institute, Cell and Gene Therapy Catapult, Orchard Therapeutics, Cellectis, Allogene Therapeutics.

Published: December, 2024
| Report ID: LI4971
| Life Sciences & Healthcare
Cardiac Monitoring Market By Product Type (Electrocardiogram (ECG) Monitors, Implantable Cardioverter Defibrillators (ICDs), Pacemakers, Holter Monitors, Event Monitors, Mobile Health (mHealth) Devices, Fetal and Neonatal Monitors), By Application (Atrial Fibrillation, Ventricular Arrhythmias, Bradycardia, Tachycardia), By End-User Industry (Hospitals, Diagnostic Centers, Home Healthcare, Cardiology Clinics, Ambulatory Surgical Centers), By Technology (Traditional Monitoring Devices, Wireless Monitoring Devices), and By Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Cardiac Monitoring Market is expected to grow from USD 19.4 billion in 2023 at a CAGR of 3.4% to touch USD 24.6 billion by 2030. The Cardiac Monitoring Market is dominated by key players such as Medtronic, Abbott Laboratories, Philips Healthcare, GE Healthcare, Boston Scientific Corporation, Siemens Healthineers, Biotronik, Johnson & Johnson, Zoll Medical Corporation, Hill-Rom, LifeWatch (Acquired by BioTelemetry), Vivalink, Nuvasive, Inc., CardioComm Solutions, Inc., BioTelemetry, Inc.

Published: December, 2024
| Report ID: LI4968
| Life Sciences & Healthcare
Cannabis Pharmaceuticals Market By Product Type (Cannabinoid-Based Drugs, Synthetic Cannabinoids, Herbal Cannabis Products), By Application (Pain Management, Neurological Disorders, Oncology, Sleep Disorders), By Distribution Channel (Hospitals, Retail Pharmacies, Online Pharmacies, Specialty Clinics), and By Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Cannabis Pharmaceuticals Market is expected to grow from USD 1.9 billion in 2023 at a CAGR of 49.1% to touch USD 30.2 billion by 2030. The Cannabis Pharmaceuticals Market is dominated by key players such as GW Pharmaceuticals (Jazz Pharmaceuticals), Tilray, Inc., Canopy Growth Corporation, Aurora Cannabis Inc., Cronos Group, Medical Marijuana, Inc., Insys Therapeutics, AbbVie Inc., MedReleaf Corp., Aphria Inc., Spectrum Therapeutics, Corbus Pharmaceuticals, Arena Pharmaceuticals, Kalytera Therapeutics, Zynerba Pharmaceuticals.

Published: December, 2024
| Report ID: LI4958
| Life Sciences & Healthcare
Amniocentesis Needle Market by Needle Type (Standard Amniocentesis Needles, Ultra-Needles), Product Length (100mm, 120mm, 150mm), Needle Material (Stainless Steel, Plastic-Coated Needles), Guided Technology (Ultrasound Guided, Non-Guided), Needle Size (18G, 20G, 22G), End-Use Application (Prenatal Genetic Diagnosis, Fetal Health Monitoring); Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Amniocentesis Needle Market is expected to grow from USD 3.0 billion in 2023 at a CAGR of 6.9% to touch USD 4.7 billion by 2030. The Amniocentesis Needle Market is dominated by key players such as Medtronic PLC, Smiths Medical, BD (Becton Dickinson and Company), Teleflex Incorporated, Cook Medical, Argon Medical Devices, Inc., Abbott Laboratories, Olympus Corporation, Hologic, Inc., Pernix Therapeutics, Stryker Corporation, Fresenius Medical Care AG and Biomet, Inc.

Published: December, 2024
| Report ID: LI4934
| Life Sciences & Healthcare
Wavefront Aberrometers Market By Product Type (Shack-Hartmann Aberrometer, Tscherning Aberrometer, Ray-Tracing Aberrometer, Retinal Plane Aberrometer), By Application (Ophthalmic Diagnostics, Vision Correction Procedures, Refractive Surgery Planning, Research & Development), By End-User Industry (Hospitals, Eye Clinics, Ambulatory Surgical Centers, Academic & Research Institutes), and By Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Wavefront Aberrometers Market is expected to grow from USD 146.2 million in 2023 at a CAGR of 3.6% to touch USD 187.1 million by 2030. The Wavefront Aberrometers Market is dominated by key players such as Alcon, Bausch + Lomb, Johnson & Johnson Vision Care, Carl Zeiss Meditec AG, Nidek Co., Ltd., Topcon Corporation, Essilor International, Luneau Technology, Optos Plc, Haag-Streit AG, Ziemer Ophthalmic Systems, AMICO Group, Oculus Optikgeräte GmbH, Canon Medical Systems, Tomey Corporation.

Published: December, 2024
| Report ID: LI4932
| Life Sciences & Healthcare
Aminophylline Market by Type (Injectable Aminophylline, Oral Aminophylline), Formulation (Tablet, Injectable, Oral Suspension), Application (Asthma and Chronic Obstructive Pulmonary Disease [COPD], Bronchospasm, Apnea), End-Use (Hospitals, Clinics, Home Care); Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Aminophylline Market is expected to grow from USD 1.2 billion in 2023 at a CAGR of 7.4% to touch USD 2.0 billion by 2030. The Aminophylline Market is dominated by key players such as Amgen Inc., AstraZeneca PLC, Bayer AG, Cipla Limited, Dr. Reddy’s Laboratories, Fresenius Kabi AG, Merck & Co., Mylan N.V., Novartis AG, Pfizer Inc., Sanofi S.A., Sun Pharmaceutical Industries Ltd. and Zydus Cadila.

Published: December, 2024
| Report ID: LI4925
| Life Sciences & Healthcare
Aminoglycosides Market by Type (Gentamicin, Tobramycin, Amikacin, Streptomycin, Neomycin), Formulation (Injectable, Oral, Topical), Application (Bacterial Infections, Tuberculosis, Respiratory Infections, Urinary Tract Infections), End-Use (Hospital, Home Healthcare, Clinics); Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Aminoglycosides Market is expected to grow from USD 4.0 billion in 2023 at a CAGR of 7.1% to touch USD 6.4 billion by 2030. The Aminoglycosides Market is dominated by key players such as AbbVie Inc., Aurobindo Pharma, Bayer AG, Bristol-Myers Squibb Company, Fresenius Kabi AG, GSK (GlaxoSmithKline plc), Lupin Pharmaceuticals, Inc., Merck & Co., Inc., Mylan N.V., Novartis AG, Pfizer Inc., Sanofi S.A. and Zydus Cadila.

Published: December, 2024
| Report ID: LI4922
| Life Sciences & Healthcare
Ambulatory Surgical Centers IT Services Market by Type (Hospital-Associated Ambulatory Surgery Centers, Freestanding Ambulatory Surgery Centers), Specialty (Gastroenterology, Ophthalmology, Orthopedics, Cardiovascular, Pain Management, Urology), Service (Diagnostic Services, Surgical Services, Preventive Care Services), End-Use (Hospitals, Clinics, Specialty Centers); Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Ambulatory Surgical Centers IT Services Market is expected to grow from USD 5.4 billion in 2023 at a CAGR of 11.7% to touch USD 11.6 billion by 2030. The Ambulatory Surgical Centers IT Services Market is dominated by key players such as, Cerner Corporation (Oracle Health), Allscripts Healthcare Solutions, NextGen Healthcare, Athenahealth, Inc., eClinicalWorks, GE Healthcare, Greenway Health, CareCloud, Inc., McKesson Corporation, Infor, Change Healthcare, Philips Healthcare and AdvancedMD, Inc.

Published: December, 2024
| Report ID: LI4921
| Life Sciences & Healthcare
Healthcare IT Outsourcing Market By Service Type (Application Outsourcing, Infrastructure Outsourcing, Business Process Outsourcing, Cloud Services Outsourcing, Database Management Outsourcing), By Deployment Mode (On-Premise, Cloud-Based), By End-User Industry (Healthcare Providers, Healthcare Payers, Pharmaceuticals & Biotech Companies), and By Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Healthcare IT Outsourcing Market is expected to grow from USD 63.9 billion in 2023 at a CAGR of 7.7% to touch USD 107.1 billion by 2030. The Healthcare IT Outsourcing Market is dominated by key players such as Accenture, IBM Corporation, Cognizant Technology Solutions, Tata Consultancy Services (TCS), Infosys Limited, Wipro Limited, DXC Technology, HCL Technologies, Atos SE, Tech Mahindra, Genpact Limited, Capgemini, Oracle Corporation, Cerner Corporation, NTT Data Corporation

Published: December, 2024
| Report ID: LI4917
| Life Sciences & Healthcare
Healthcare ERP Market By Deployment Type (On-Premise, Cloud-Based), By End-User Industry (Hospitals, Clinics, Ambulatory Surgery Centers, Long-Term Care Facilities, Pharmacies), By Application (Financial Management, Supply Chain Management, Human Resource Management, Customer Relationship Management), and By Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Healthcare ERP Market is expected to grow from USD 7.2 billion in 2023 at a CAGR of 6.7% to touch USD 11.3 billion by 2030. The Healthcare ERP Market is dominated by key players such as SAP SE, Oracle Corporation, Microsoft Corporation, Cerner Corporation, Infor, Inc., Epic Systems Corporation, McKesson Corporation, Allscripts Healthcare Solutions, Inc., Netsmart Technologies, Inc., Meditech, GE Healthcare, Ramco Systems, Sage Group, Syspro, Workday, Inc.

Published: December, 2024
| Report ID: LI4916
| Life Sciences & Healthcare
Health Intelligent Virtual Assistant Market By Technology (Natural Language Processing, Machine Learning, Speech Recognition, Text-to-Speech), By Application (Virtual Health Assistants, Appointment Scheduling & Reminders, Medication Management, Virtual Consultations, Health Monitoring), By End-User Industry (Healthcare Providers, Healthcare Payers, Pharmaceuticals & Biotech Companies, Patients & Consumers), By Deployment Mode (On-Premise, Cloud-Based); Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Health Intelligent Virtual Assistant Market is expected to grow from USD 368.8 million in 2023 at a CAGR of 25.1% to touch USD 1771.1 million by 2030. The Health Intelligent Virtual Assistant Market is dominated by key players such as Nuance Communications, Google Health, Microsoft Corporation, IBM Watson Health, Amazon Web Services (AWS), Xerox Corporation, Babylon Health, Sensely, CareSkore, Infermedica, HealthTap, CureMetrix, Livi, Ada Health, Your.MD

Published: December, 2024
| Report ID: LI4914
| Life Sciences & Healthcare
Ambulatory Surgical Center Market By Type (Single-Specialty Ambulatory Surgical Centers, Multi-Specialty Ambulatory Surgical Centers), By Procedure (Ophthalmic Surgery, Orthopedic Surgery, Gastrointestinal Surgery, Pain Management, Cosmetic Surgery, Urology Surgery), By End-User (Hospitals, Healthcare Providers, Ambulatory Surgical Centers, Clinics, Independent Healthcare Facilities), and By Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Ambulatory Surgical Center Market is expected to grow from USD 86.0 billion in 2023 at a CAGR of 6.9% to touch USD 137.0 billion by 2030. The Ambulatory Surgical Center Market is dominated by key players such as HCA Healthcare, Mednax, Surgery Partners, Tenet Healthcare, United Surgical Partners International (USPI), Ascension Health, Healthtronics, Orthopedic Centers of Colorado, Surgical Care Affiliates (SCA), Ambulatory Surgical Centers of America (ASCOA), Mercy Health, Physicians Surgery Centers, Regency Surgical Center, Surgery Center Network, American Surgical Centers.

Published: December, 2024
| Report ID: LI4912
| Life Sciences & Healthcare
Ambulatory EHR Market By Product Type (Integrated EHR, Standalone EHR), By Application (Clinical Workflow Management, Revenue Cycle Management, Population Health Management, e-Prescribing, Patient Portals), By End-User (Small & Medium-sized Practices, Large Healthcare Practices, Ambulatory Surgery Centers, Diagnostic Centers), By Deployment Mode (Cloud-Based Deployment, On-Premise Deployment); Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Ambulatory EHR Market is expected to grow from USD 5.6 billion in 2023 at a CAGR of 7.9% to touch USD 9.5 billion by 2030. The Ambulatory EHR Market is dominated by key players such as Epic Systems Corporation, Cerner Corporation, Allscripts Healthcare Solutions, Inc., McKesson Corporation, Athenahealth, Inc., NextGen Healthcare, MEDITECH, Greenway Health, LLC, eClinicalWorks, GE Healthcare, CureMD, Optum, Kareo, AdvancedMD, Practice Fusion.

Published: December, 2024
| Report ID: LI4911
| Life Sciences & Healthcare
Allogeneic Cell Therapy Devices Market By Device Type (Cell Culture Systems, Bioreactors, Cell Separation Systems, Cryopreservation Equipment, Cell Expansion Systems), By Application (Oncology, Cardiovascular Disorders, Neurological Disorders, Musculoskeletal Disorders, Autoimmune Diseases), By End-User (Academic & Research Institutes, Biopharmaceutical & Biotechnology Companies, Hospitals & Clinics, Contract Manufacturing Organizations), and By Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Allogeneic Cell Therapy Devices Market is expected to grow from USD 0.5 billion in 2023 at a CAGR of 22.3% to touch USD 1.9 billion by 2030. The Allogeneic Cell Therapy Devices Market is dominated by key players such as Thermo Fisher Scientific, Lonza Group, Merck KGaA, Sartorius AG, Corning Incorporated, Cytiva (Danaher Corporation), Terumo Corporation, Eppendorf AG, Bio-Techne Corporation, Miltenyi Biotec, STEMCELL Technologies, Fujifilm Irvine Scientific, CellGenix GmbH, Beckman Coulter (Danaher Corporation), Bluebird Bio, Inc.

Published: December, 2024
| Report ID: LI4909
| Life Sciences & Healthcare
Bioreactors Market By Product Type (Single-Use Bioreactors, Glass Bioreactors, Stainless Steel Bioreactors), By Capacity (< 5 Liters, 5–20 Liters, 20–200 Liters, 200–1500 Liters, > 1500 Liters), By End-User (Biopharmaceutical Companies, Contract Manufacturing Organizations (CMOs), Academic and Research Institutes), and By Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Bioreactors Market is expected to grow from USD 5.3 billion in 2023 at a CAGR of 7.3% to touch USD 8.6 billion by 2030. The Bioreactors Market is dominated by key players such as, Sartorius AG, Thermo Fisher Scientific Inc., GE Healthcare, Distek, Inc., and Applikon Biotechnology (Getinge AB).

Published: December, 2024
| Report ID: LI4905
| Life Sciences & Healthcare
Age-Related Macular Degeneration (AMD) Treatment Market by Treatment Type (Anti-VEGF Therapy, Photodynamic Therapy, Laser Therapy, Corticosteroid Treatment, Combination Therapy), Stage (Early AMD, Intermediate AMD, Late AMD), Distribution Channel (Hospitals & Clinics, Ambulatory Surgical Centers, Specialty Clinics, Retail Pharmacies, Online Pharmacies), and Region; Global Insights & Forecast (2024–2030)

According to Intent Market Research, the Age-Related Macular Degeneration Treatment Market is expected to grow from USD 11.1 billion in 2023 at a CAGR of 7.9% to touch USD 18.9 billion by 2030. The Age-Related Macular Degeneration Treatment Market is dominated by key players such as Regeneron Pharmaceuticals, Inc., Novartis AG, Bayer AG, Roche Holding AG, Pfizer Inc., Allergan (AbbVie), Kodiak Sciences Inc., Adverum Biotechnologies, Outlook Therapeutics, Inc., Ophthotech Corporation, Apellis Pharmaceuticals, Inc., Iveric Bio (formerly Ophthotech), Alimera Sciences, Graybug Vision, Inc., Biogen Inc.

Published: December, 2024
| Report ID: LI4904
| Life Sciences & Healthcare
Aesthetic Devices Market By Product Type (Laser Aesthetic Devices, Body Contouring Devices, Skin Aesthetic Devices, Hair Removal Devices, Facial Aesthetic Devices), By Application (Hair Removal, Anti-Aging Treatment, Body Contouring & Fat Reduction, Scar Treatment, Tattoo Removal, Skin Rejuvenation), By End-User (Beauty Clinics, Hospitals, Home Care Settings, Dermatology Centers, Spas & Wellness Centers), and By Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Aesthetic Devices Market is expected to grow from USD 12.0 billion in 2023 at a CAGR of 3.3% to touch USD 15.1 billion by 2030. The Aesthetic Devices Market is dominated by key players such as Allergan, Cynosure (Hologic, Inc.), Lumenis Ltd., Syneron Medical Ltd., Venus Concept, Cutera Inc., BTL Industries, Solta Medical (A division of Valeant Pharmaceuticals), Fotona, Alma Lasers, Lutronic, Hologic Inc., Merz Pharmaceuticals, Ellman International, Inc., Sciton, Inc.

Published: December, 2024
| Report ID: LI4903
| Life Sciences & Healthcare
Acne Treatment Market By Treatment Type (Topical Medications, Oral Medications, Procedural Treatments, Combination Therapies), By Acne Type (Inflammatory Acne, Non-Inflammatory Acne), By End-User (Hospitals, Dermatology Clinics, Pharmacies, Online Channels), and By Region; Global Insights & Forecast (2024–2030)

According to Intent Market Research, the Acne Treatment Market is expected to grow from USD 11.1 billion in 2023 at a CAGR of 7.9% to touch USD 18.9 billion by 2030. The Acne Treatment Market is dominated by key players such as Johnson & Johnson, Galderma Laboratories, AbbVie Inc., Pfizer Inc., Almirall S.A., Sun Pharmaceutical Industries Ltd., Bausch Health Companies Inc., Bayer AG, Teva Pharmaceutical Industries Ltd., GlaxoSmithKline plc, L’Oréal S.A., Reckitt Benckiser Group plc, Nestlé Skin Health, Hologic Inc., Candela Corporation.

Published: December, 2024
| Report ID: LI4900
| Life Sciences & Healthcare
3D Printing in Healthcare Market by Technology (Stereolithography (SLA), Fused Deposition Modeling (FDM), Selective Laser Sintering (SLS), Digital Light Processing (DLP), Binder Jetting), Component (3D Printers, Materials, Software, Services), Application (Implants & Prosthetics, Surgical Guides, Tissue & Organ Fabrication, Customized Medical Devices, Dental Applications), End-User (Hospitals & Clinics, Research Institutions, Diagnostic Centers, Academic Institutions), and By Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the 3D Printing in Healthcare Market is expected to grow from USD 0.9 billion in 2023 at a CAGR of 25.8% to touch USD 4.6 billion by 2030. The 3D Printing in Healthcare Market is dominated by key players such as Stratasys Ltd., 3D Systems Corporation, Materialise NV, EnvisionTEC GmbH, GE Additive, EOS GmbH, SLM Solutions Group AG, Formlabs, Inc., Carbon, Inc., Desktop Metal, Inc., Prodways Group, Renishaw plc, HP Inc., Autodesk, Inc., Organovo Holdings.

Published: December, 2024
| Report ID: LI4898
| Life Sciences & Healthcare
3D Printed Medical Devices Market By Type (Surgical Instruments, Implants, Prosthetics, Orthopedic Devices, Dental Devices, Hearing Aids, Bioprinted Medical Devices), By Technology (Stereolithography (SLA), Fused Deposition Modeling (FDM), Selective Laser Sintering (SLS), Digital Light Processing (DLP), PolyJet Printing, Electron Beam Melting (EBM)), By Component (Materials (Polymers, Metals, Ceramics, Biomaterials), 3D Printers, Software, Services), By End-User (Hospitals & Clinics, Academic & Research Institutions, Medical Device Companies, Contract Manufacturing Organizations (CMOs)), and By Region; Global Insights & Forecast (2024 – 2030).

According to Intent Market Research, the 3D Printed Medical Devices Market is expected to grow from USD 4.6 billion in 2023 at a CAGR of 18.4% to touch USD 15.1 billion by 2030. The 3D Printed Medical Devices Market is dominated by key players such as GE Additive, 3D Systems Corporation, Stratasys Ltd., Materialise NV, EnvisionTEC GmbH, Renishaw plc, EOS GmbH, Stryker Corporation, Zimmer Biomet Holdings, Inc., Medtronic plc, Johnson & Johnson Services, Inc., Smith & Nephew plc, Align Technology, Inc., Organovo Holdings, Inc., Proto Labs.

Published: December, 2024
| Report ID: LI4897
| Life Sciences & Healthcare
3D Printed Drugs Market by Technology (Fused Deposition Modeling, Inkjet Printing, Stereolithography, Selective Laser Sintering), Application (Oral Drugs, Injectable Drugs, Topical Drugs, Personalized Medicine), End-User Industry (Pharmaceutical Companies, Research Laboratories, Contract Manufacturers, Hospitals & Healthcare Providers), and Drug Type (Generic Drugs, Branded Drugs, Over-the-Counter Drugs); Global Insights & Forecast (2024–2030).

According to Intent Market Research, the 3D Printed Drugs Market is expected to grow from USD 92.5 million in 2023 at a CAGR of 26.2% to touch USD 472.5 million by 2030. The 3D Printed Drugs Market is dominated by key players such as GlaxoSmithKline (GSK), Merck & Co., 3D Systems Corporation, Aprecia Pharmaceuticals, BASF SE, Pfizer Inc., Stratasys Ltd., Materialise NV, Novartis AG, Trellisys Health, OrganoClick, Teva Pharmaceutical Industries Ltd., CAM Bioceramics B.V., Boehringer Ingelheim, Johnson & Johnson.

Published: December, 2024
| Report ID: LI4894
| Life Sciences & Healthcare
Anesthesia Needles and Syringes Market By Product Type (Spinal Needles, Epidural Needles, General Anesthesia Syringes, Regional Anesthesia Syringes, Disposable Needles and Syringes, Reusable Needles and Syringes), By Usage (Single-Use, Multiple-Use), By End-User (Hospitals, Ambulatory Surgical Centers, Clinics, Specialty Centers), By Distribution Channel (Direct Sales, Retail Pharmacies, Online Pharmacies), and By Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Anesthesia Needles and Syringes Market is expected to grow from USD 1.5 billion in 2023 at a CAGR of 6.9% to touch USD 2.4 billion by 2030. The Anesthesia Needles and Syringes Market is dominated by key players such as B. Braun Melsungen AG, Becton, Dickinson and Company (BD), Smiths Medical, Terumo Corporation, Medtronic plc, Teleflex Incorporated, Nipro Corporation, Cardinal Health, Inc., Merit Medical Systems, Vygon SA, Boston Scientific Corporation, Ambu A/S, Cook Medical, Halyard Health (Owens & Minor), C.R. Bard (Now part of BD)

Published: December, 2024
| Report ID: LI4879
| Life Sciences & Healthcare
Allogeneic Cell Therapy Market by Therapy Type (Stem Cell Therapies, Non-stem Cell Therapies), By Therapeutic Area (Hematological Disorders, Dermatological Disorders), and By Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Allogeneic Cell Therapy Market is expected to grow from USD 1.2 billion in 2023 at a CAGR of 19.6% to touch USD 4.2 billion by 2030. The Allogeneic Cell Therapy Market is dominated by key players such as, Cleveland Cord Blood Center, SSM Cardinal Glennon Children's Medical Center, Clinimmune Labs, University of Colorado Cord Blood Bank, Sumitomo Pharma Co., Ltd., and LifeSouth Community Blood Centers, Inc.

Published: December, 2024
| Report ID: LI4875
| Life Sciences & Healthcare
Ambulatory Surgery Centers Market by Type (Hospital-Associated Ambulatory Surgery Centers, Freestanding Ambulatory Surgery Centers), Specialty (Gastroenterology, Ophthalmology, Orthopedics, Cardiovascular, Pain Management, Urology), Service (Diagnostic Services, Surgical Services, Preventive Care Services), End-Use (Hospitals, Clinics, Specialty Centers); Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Ambulatory Surgery Centers Market is expected to grow from USD 85.4 billion in 2023 at a CAGR of 6.7% to touch USD 134.7 billion by 2030. The Ambulatory Surgery Centers Market is dominated by key players such as Ambulatory Surgery Center Association (ASCA), AMSURG Corp., Aspen Healthcare, Eifler Consulting Services, HCA Healthcare, Medical Facilities Corporation, Proliance Surgeons, Regent Surgical Health, SurgCenter Development, Surgery Partners, Inc., Surgical Care Affiliates, TeamHealth Holdings, Inc. and United Surgical Partners International.

Published: December, 2024
| Report ID: LI4874
| Life Sciences & Healthcare
Allergy Immunotherapy Market By Treatment Type (Subcutaneous Immunotherapy, Sublingual Immunotherapy), By Allergy Type (Allergic Rhinitis, Allergic Asthma), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), and By Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Allergy Immunotherapy Market is expected to grow from USD 2.5 billion in 2023 at a CAGR of 10.1% to touch USD 4.9 billion by 2030. The Allergy Immunotherapy Market is dominated by key players such as, Circassia, ASIT Biotech, Merck KGaA, HAL Allergy B.V., and Allergy Therapeutics.

Published: December, 2024
| Report ID: LI4873
| Life Sciences & Healthcare
Allergy Diagnostics and Therapeutics Market by Type (Diagnostics, Therapeutics), by Allergen Type (Food, Inhaled, Drug, Other Allergens), by Test Type (In vivo Test, In vitro Test), and by Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Allergy Diagnostics and Therapeutics Market is expected to grow from USD 4.7 billion in 2023 at a CAGR of 10.1% to touch USD 9.2 billion by 2030. The Allergy Diagnostics and Therapeutics Market is dominated by key players such as, Thermo Fisher Scientific, Inc., R-Biopharm AG, AESKU.GROUP GmbH, Minaris Medical America, Inc., and Siemens Healthcare GmbH.

Published: December, 2024
| Report ID: LI4872
| Life Sciences & Healthcare
Ambulatory Services Market By Service Type (Primary Care Services, Specialty Care Services, Surgical Services, Diagnostic Services, Rehabilitation Services, Emergency Care Services), By Facility Type (Hospital Outpatient Departments, Ambulatory Surgery Centers, Diagnostic Laboratories, Physician Offices, Urgent Care Centers), By Application (Ophthalmology, Gastroenterology, Orthopedics, Dermatology, Cardiology), and By Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Ambulatory Services Market is expected to grow from USD 4.3 billion in 2023 at a CAGR of 6.1% to touch USD 6.6 billion by 2030. The Ambulatory Services Market is dominated by key players such as Envision Healthcare, UnitedHealth Group, Tenet Healthcare, Surgery Partners, Fresenius Medical Care, DaVita Inc., HCA Healthcare, TeamHealth, MEDNAX, Inc., Aspen Dental Management, Inc., Terveystalo Healthcare, Sonic Healthcare, Quest Diagnostics, Laboratory Corporation of America (LabCorp), Apollo Hospitals

Published: December, 2024
| Report ID: LI4871
| Life Sciences & Healthcare
Ambulance Services Market By Service Type (Emergency Services, Non-Emergency Services), By Transport Type (Ground Ambulance, Air Ambulance, Water Ambulance), By Equipment (Basic Life Support [BLS], Advanced Life Support [ALS]), By End-User Industry (Healthcare, Industrial Manufacturing, Utilities, Oil & Gas), and By Region; Global Insights & Forecast (2024–2030)

According to Intent Market Research, the Ambulance Services Market is expected to grow from USD 38.9 billion in 2023 at a CAGR of 9.0% to touch USD 70.9 billion by 2030. The Ambulance Services Market is dominated by key players such as Hill-Rom, Medtronic, Philips Healthcare, Smiths Medical, Allied Healthcare Products, Inc., CHAD Therapeutics, Hollister Incorporated, Thermo Fisher Scientific, Vyaire Medical, Inc., Omron Healthcare, AeroCare Holdings, MediTech, Draeger Medical, Breas Medical, Löwenstein Medical.

Published: December, 2024
| Report ID: LI4869
| Life Sciences & Healthcare
Ambulance Equipment Market By Type (Emergency Medical Services (EMS) Equipment, Patient Monitoring Equipment, Transport Equipment, Defibrillators, Ventilators, First Aid Kits), By End-User (Hospitals, Ambulance Service Providers, Emergency Medical Response Units, Fire Departments), By Application (Pre-Hospital Care, Transporting Patients, Critical Care and Life Support, Emergency Medical Response, Disaster Management), and By Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Ambulance Equipment Market is expected to grow from USD 3.7 billion in 2023 at a CAGR of 8.7% to touch USD 6.6 billion by 2030. The Ambulance Equipment Market is dominated by key players such as Stryker Corporation, Medtronic, ZOLL Medical Corporation, Philips Healthcare, Johnson & Johnson, GE Healthcare, Becton Dickinson and Company, Smiths Medical, 3M Health Care, EMSAR, Ambulance Service Ltd., Ferno-Washington, Inc., Laerdal Medical, Bound Tree Medical, Acme Medical.

Published: December, 2024
| Report ID: LI4868
| Life Sciences & Healthcare
Alzheimer’s Therapeutics Market By Drug Class (Cholinesterase Inhibitors, Glutamate Regulators, Anti-Amyloid Antibodies, Anti-Tau Therapies), By Mechanism of Action (Neuroprotection, Symptomatic Treatment, Disease-Modifying Treatment), By Distribution Channel (Hospitals, Retail Pharmacies, Online Pharmacies), By Stage of Alzheimer’s (Early-stage Alzheimer’s, Mild Cognitive Impairment (MCI), Moderate to Severe Alzheimer’s), and By Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Alzheimer’s Therapeutics Market is expected to grow from USD 4.6 billion in 2023 at a CAGR of 10.7% to touch USD 9.5 billion by 2030. The Alzheimer’s Therapeutics Market is dominated by key players such as Eli Lilly and Co., Biogen Inc., Roche Holding AG, Johnson & Johnson, Novartis AG, Pfizer Inc., AstraZeneca, Merck & Co., Inc., Sanofi S.A., GlaxoSmithKline PLC, Amgen Inc., Mitsubishi Tanabe Pharma, AbbVie Inc., H. Lundbeck A/S, Takeda Pharmaceutical Company.

Published: December, 2024
| Report ID: LI4861
| Life Sciences & Healthcare
Alzheimer’s Disease Diagnostics Market By Test Type (Biomarker-based Tests, Neuroimaging, Genetic Tests, Cerebrospinal Fluid (CSF) Tests, Blood Tests), By End-User (Hospitals, Diagnostic Laboratories, Research Institutes, Home Care Settings), By Technology (Positron Emission Tomography (PET), Magnetic Resonance Imaging (MRI), Electroencephalogram (EEG), Computed Tomography (CT), Genomic Sequencing), By Disease Stage (Early-stage Alzheimer’s, Mild Cognitive Impairment (MCI), Advanced Alzheimer’s), and By Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Alzheimer’s Disease Diagnostics Market is expected to grow from USD 9.3 billion in 2023 at a CAGR of 8.0% to touch USD 15.9 billion by 2030. The Alzheimer’s Disease Diagnostics Market is dominated by key players such as Roche Holding AG, Eli Lilly and Co., Biogen Inc., Siemens Healthineers AG, GE Healthcare, Johnson & Johnson, AbbVie Inc., Novartis AG, Medtronic PLC, Philips Healthcare, AstraZeneca, Quanterix Corporation, Corteva Inc., Thermo Fisher Scientific, Mindset Inc.

Published: December, 2024
| Report ID: LI4860
| Life Sciences & Healthcare
Healthcare Transportation Services Market By Service Type (Non-Emergency Medical Transportation, Emergency Medical Transportation, Medical Courier Services, Ambulance Services, Patient Transport Services), By Mode of Transportation (Ground Transportation, Air Transportation, Water Transportation), By End-User (Hospitals, Clinics, Home Healthcare Providers, Ambulance Services, Pharmaceutical Companies), and By Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Healthcare Transportation Services Market is expected to grow from USD 88.1 billion in 2023 at a CAGR of 7.7% to touch USD 147.7 billion by 2030. The Healthcare Transportation Services Market is dominated by key players such as American Medical Response (AMR), MedTrans (Medline Industries), Falck A/S, Veyo, LogistiCare Solutions, STG Logistics, Acadian Ambulance Service, EMS Innovations, GMR (Global Medical Response), Medstar Ambulance, AmbuCare, Air Methods Corporation, Patient Transport Services, Lifeline Ambulance Service, Care Ambulance Services

Published: December, 2024
| Report ID: LI4853
| Life Sciences & Healthcare
Age-related Macular Degeneration Market by Treatment Type (Anti-VEGF Therapy, Photodynamic Therapy, Laser Therapy, Nutritional Therapy), Diagnosis Type (Ophthalmoscopy, Fluorescein Angiography), and End-User (Hospitals, Ambulatory Surgical Centers); Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Age-related Macular Degeneration Market is expected to grow from USD 8.4 billion in 2023 at a CAGR of 8.9% to touch USD 15.3 billion by 2030. The Age-related Macular Degeneration Market is dominated by key players such as AbbVie, Allergan (AbbVie), Apellis Pharmaceuticals, Bayer, Biogen, Genentech (Roche), Neovasc, Novartis, Ocular Therapeutix, Regeneron Pharmaceuticals, Roche, Senju Pharmaceutical and ThromboGenics.

Published: December, 2024
| Report ID: LI4801
| Life Sciences & Healthcare
Aesthetic Threads Market by Type of Threads (PDO Threads, PCL Threads, PLLA Threads), Application (Facial Contouring, Neck Lifting, Eyebrow Lifting, Skin Tightening), and End-Use (Dermatology Clinics, Hospitals); Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Aesthetic Threads Market is expected to grow from USD 1.2 billion in 2023 at a CAGR of 13.7% to touch USD 3.1 billion by 2030. The Aesthetic Threads Market is dominated by key players such as Aesthetic Works, Allergan (AbbVie Inc.), Candela Corporation, Derma Medical, Evolus, Inc., Hangzhou Aesthetic Medical Co., Ltd., Hugel Aesthetic, Hugel, Inc., Juvéderm, Lumenis Ltd., Medytox, Inc., Miracle Aesthetic and Sinclair Pharma.

Published: December, 2024
| Report ID: LI4799
| Life Sciences & Healthcare
Aesthetic Medicine Market by Procedure Type (Non-Surgical Procedures, Surgical Procedures), Product Type (Injectables, Implants, Energy-Based Devices, Topical Products), Application (Facial Aesthetics, Body Contouring, Skin Resurfacing, Hair Restoration), and End-Use (Hospitals, Dermatology Clinics, Ambulatory Surgical Centers); Global Insights & Forecast (2024–2030)

According to Intent Market Research, the Aesthetic Medicine Market is expected to grow from USD 67.1 billion in 2023 at a CAGR of 10.8% to touch USD 137.8 billion by 2030. The Aesthetic Medicine Market is dominated by key players such as Allergan, Alma Lasers Ltd., BioPlus Co., Ltd., Candela Corporation, Cutera, Inc., Cynosure, LLC, Evolus, Inc., Hugel, Inc., Ipsen, Lumenis Ltd., Medytox, Inc., Revance Therapeutics, Inc. and Teoxane SA.

Published: December, 2024
| Report ID: LI4798
| Life Sciences & Healthcare
Addiction Treatment Market By Treatment Type (Medication-Assisted Treatment, Behavioral Therapy, Detoxification), By Drug Type (Buprenorphine, Methadone, Naltrexone, Nicotine Replacement Therapy), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By End-User (Rehabilitation Centers, Hospitals, Clinics), and By Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Addiction Treatment Market is expected to grow from USD 18.6 billion in 2023 at a CAGR of 7.3% to touch USD 30.5 billion by 2030. The Addiction Treatment Market is dominated by key players such as, Alkermes plc, Indivior PLC, Cipla Limited, Dr. Reddy’s Laboratories, and Purdue Pharma L.P.

Published: December, 2024
| Report ID: LI4794
| Life Sciences & Healthcare
Acute Repetitive Seizures Market By Drug Type (Benzodiazepines, Non-Benzodiazepines), By Route of Administration (Intranasal, Rectal, Intramuscular), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By End-User (Hospitals, Clinics, Home Care), and By Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Acute Repetitive Seizures Market is expected to grow from USD 1.7 billion in 2023 at a CAGR of 9.8% to touch USD 3.2 billion by 2030. The Acute Repetitive Seizures Market is dominated by key players such as, Neurelis, Inc., UCB Pharma, Teva Pharmaceutical Industries Ltd., GlaxoSmithKline plc, and Lundbeck A/S.

Published: December, 2024
| Report ID: LI4791
| Life Sciences & Healthcare
Electronic Clinical Outcome Assessment (eCOA) Solutions Market by Type of Solution (Web-based eCOA Solutions, Mobile-based eCOA Solutions, Cloud-based eCOA Solutions, On-premise eCOA Solutions), By End-User (Pharmaceutical & Biotechnology Companies, Contract Research Organizations (CROs), Medical Device Companies, Healthcare Providers, Academic Research Institutes), By Application (Clinical Trials (Phases I-IV), Patient-Reported Outcomes (PROs), Cognitive and Behavioral Assessments, Drug Development & Approval, Post-market Surveillance), By Deployment Mode (Cloud-based, On-premise, Hybrid), and By Region: Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Electronic Clinical Outcome Assessment (eCOA) Solutions Market is expected to grow from USD 1.8 billion in 2023 at a CAGR of 12.0% to touch USD 3.9 billion by 2030. The electronic clinical outcome assessment solutions market is dominated by key players such as Medidata Solutions, Parexel International Corporation, Veeva Systems Inc., Pharmacare, eClinicalWorks, CRF Health (now part of Signant Health), PAREXEL International, BIO-Optronics, Oracle Corporation, Qualcomm Life, WCG Clinical, Clario, CRF Health, Xcellerate, Medrio

Published: December, 2024
| Report ID: LI4787
| Life Sciences & Healthcare
Aesthetic Surgery Procedures Market by Procedure Type (Surgical Aesthetic Procedures, Non-Surgical Aesthetic Procedures), Aesthetic Procedure (Liposuction, Breast Augmentation, Rhinoplasty, Facelifts, Blepharoplasty, Tummy Tuck, Chin Implants), Technology (Laser-Assisted Procedures, Ultrasound-Assisted Liposuction, Endoscopic Surgery, Robotic-Assisted Surgery, Traditional Surgical Procedures), and End-Use (Hospitals, Cosmetic Surgery Clinics); Global Insights & Forecast (2024–2030)

According to Intent Market Research, the Aesthetic Surgery Procedures Market is expected to grow from USD 22.6 billion in 2023 at a CAGR of 11.1% to touch USD 47.1 billion by 2030. The Aesthetic Surgery Procedures Market is dominated by key players such as Cutera, Inc., Cynosure, LLC, Hugel, Inc., InMode Ltd., Ipsen, KLS Martin Group, Lumenis Ltd., Medytox, Inc., Merz Pharmaceuticals, Revance Therapeutics, Inc., Sciton, Inc. and Surgical Innovations Group plc.

Published: November, 2024
| Report ID: LI4766
| Life Sciences & Healthcare
Aesthetic Injectable Market by Product Type (Botulinum Toxin, Dermal Fillers, Collagen, Hyaluronic Acid, Calcium Hydroxylapatite, Poly-L-Lactic Acid), Application (Facial Line Correction, Lip Augmentation, Wrinkle Reduction, Acne Scar Treatment), and End-Use (Hospitals, Dermatology Clinics, Medical Spas); Global Insights & Forecast (2024–2030)

According to Intent Market Research, the Aesthetic Injectable Market is expected to grow from USD 11.8 billion in 2023 at a CAGR of 10.7% to touch USD 24.2 billion by 2030. The Aesthetic Injectable Market is dominated by key players such as Allergan, BioPlus Co., Ltd., Bloomage Biotechnology Corporation Limited, Croma-Pharma GmbH, Daewoong Pharmaceutical Co., Ltd., Eris Lifesciences Limited, Hugel, Inc., Ipsen, Medytox, Inc., Revance Therapeutics, Inc., RevitaLash Cosmetics, Sinclair Pharma and Teoxane SA.

Published: November, 2024
| Report ID: LI4764
| Life Sciences & Healthcare
Aesthetic Fillers Market By Type (Hyaluronic Acid Fillers, Collagen Fillers, Calcium Hydroxylapatite Fillers, Poly-L-Lactic Acid Fillers, Polymethyl Methacrylate Fillers), By Application (Wrinkle Treatment, Lip Enhancement, Facial Contouring, Acne Scar Treatment, Nose Reshaping), By End-User (Dermatology Clinics, Plastic Surgery Clinics, Beauty & Spa Clinics, Hospitals, Homecare), By Distribution Channel (Direct Sales, Online Sales, Third-party Distribution), and By Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Aesthetic Fillers Market is expected to grow from USD 5.0 billion in 2023 at a CAGR of 7.8% to touch USD 8.5 billion by 2030. The Aesthetic Fillers Market is dominated by key players such as Allergan (AbbVie), Revance Therapeutics, Ipsen, Galderma, Merz Pharmaceuticals, Medytox, Syneron Candela, Hugel, ZO Skin Health, Algeness, Fillerina, Laboratoires Vivacy, TEOXANE, Suneva Medical, Luminera

Published: November, 2024
| Report ID: LI4763
| Life Sciences & Healthcare
Clinical Microbiology Market by Product Type (Instruments, Reagents & Kits, Consumables), Technology (PCR (Polymerase Chain Reaction), Immunoassays, Mass Spectrometry, Microbial Identification, Microscopy), Application (Infectious Disease Testing, Blood Culture Testing, Food & Beverage Testing, Environmental Testing, Clinical Diagnostic Testing), End-User (Hospitals, Diagnostic Laboratories, Research Institutes, Pharmaceutical & Biotechnology Companies), and Region; Global Insights & Forecast (2024–2030)

According to Intent Market Research, the Clinical Microbiology Market is expected to grow from USD 4.6 billion in 2023 at a CAGR of 6.3% to touch USD 7.1 billion by 2030. The Clinical Microbiology Market is dominated by key players such as Roche Diagnostics, Thermo Fisher Scientific, Siemens Healthineers, Abbott Laboratories, Becton, Dickinson and Company (BD), bioMérieux, QIAGEN, Hologic, Cepheid, Danaher Corporation, Beckman Coulter (A subsidiary of Danaher), Grifols, Merck KGaA, Bruker Corporation, PerkinElmer

Published: November, 2024
| Report ID: LI4750
| Life Sciences & Healthcare
Cell and Gene Supply Chain Services Market By Type of Service (Transportation and Logistics, Cold Chain Management, Warehousing and Distribution, Packaging and Labeling, Regulatory and Compliance Support), By End-User (Pharmaceutical and Biotechnology Companies, Research Institutions and Universities, Contract Research Organizations (CROs), Hospitals and Healthcare Providers, Cell and Gene Therapy Manufacturers), By Supply Chain Stage (Preclinical Stage, Clinical Trial Stage, Commercial Production Stage), By Mode of Transportation (Air Freight, Ground Freight, Sea Freight, Rail Freight), and By Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Cell and Gene Supply Chain Services Market is expected to grow from USD 1.4 billion in 2023 at a CAGR of 12.4% to touch USD 3.1 billion by 2030. The cell and gene supply chain services market is dominated by key players such as World Courier, UPS Healthcare, Kuehne + Nagel, DHL Supply Chain, FedEx, Ceva Logistics, Kerry Group, XPO Logistics, Cold Chain Technologies, Lineage Logistics, Marken, Panalpina, Air Canada Cargo, Biotec Services International, BioLife Solutions

Published: November, 2024
| Report ID: LI4749
| Life Sciences & Healthcare
Cardiac Pacemaker Market by Type (Single-Chamber Pacemaker, Dual-Chamber Pacemaker, Biventricular Pacemaker), Technology (Conventional Pacemaker, MRI-Compatible Pacemaker, Wireless Pacemaker), Application (Bradycardia Treatment, Tachycardia Treatment, Heart Failure Treatment), End-Use Industry (Hospitals, Ambulatory Surgical Centers, Home Healthcare): Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Cardiac Pacemaker Market is expected to grow from USD 5.1 billion in 2023 at a CAGR of 6.7% to touch USD 8.0 billion by 2030. The Cardiac Pacemaker Market is dominated by key players such as Abbott Laboratories, Biotronik SE & Co. KG, Boston Scientific Corporation, Cook Medical Inc., GE Healthcare, LivaNova PLC, Medtronic PLC, MicroPort Scientific Corporation, Oscor Inc., Pacetronix, Philips Healthcare and Zoll Medical Corporation.

Published: November, 2024
| Report ID: LI4748
| Life Sciences & Healthcare
Alpha-Lipoic Acid Market By Type (R-Lipoic Acid, S-Lipoic Acid, Mixed Lipoic Acid), By Application (Dietary Supplements, Pharmaceuticals, Cosmetics & Personal Care, Food & Beverages), By End-User Industry (Healthcare, Food Industry, Cosmetics Industry, Pharmaceutical Industry), and By Distribution Channel (Online Retail, Offline Retail, B2B, Pharmacies & Clinics); Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Alpha-lipoic Acid Market is expected to grow from USD 0.7 billion in 2023 at a CAGR of 8.7% to touch USD 1.3 billion by 2030. The Alpha-lipoic Acid Market is dominated by key players such as BASF SE, Thorne Research, Inc., Mitsubishi Chemical Corporation, Roche Diagnostics, NutraScience Labs, Sigma-Aldrich Co. LLC, Jiangsu Kanion Pharmaceutical Co. Ltd., LACTONIC Pharma, Cayman Chemical Company, Kemin Industries, Natural Factors Inc., Solgar Inc., Nutraceutical International Corporation, DSM Nutritional Products, Herbalife Nutrition Ltd.

Published: November, 2024
| Report ID: LI4731
| Life Sciences & Healthcare
Alpha-Glucosidase Inhibitors Market By Product Type (Acarbose, Miglitol, Voglibose), By Application (Diabetes Mellitus Type 2 Treatment, Obesity Management, Polyglucosan Diseases Treatment), By End-User Industry (Pharmaceuticals, Healthcare, Research Institutions), and By Distribution Channel (Online Retail, Hospitals/Clinics, Pharmacies, B2B); Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Alpha-glucosidase Inhibitors Market is expected to grow from USD 3.7 billion in 2023 at a CAGR of 6.3% to touch USD 5.7 billion by 2030. The Alpha-glucosidase Inhibitors Market is dominated by key players such as Merck & Co., Inc., Boehringer Ingelheim International GmbH, Sanofi S.A., Eli Lilly and Co., Novo Nordisk, Bristol Myers Squibb, Teva Pharmaceuticals, Takeda Pharmaceutical Company Limited, Mylan N.V. (now part of Viatris Inc.), Zydus Cadila, Astellas Pharma Inc., AbbVie Inc., Pfizer Inc., Amgen Inc., Hikma Pharmaceuticals.

Published: November, 2024
| Report ID: LI4730
| Life Sciences & Healthcare
Alpha Emitter Market By Type (Actinium-227, Radium-223, Thorium-227), By Application (Cancer Treatment, Medical Diagnostics, Research & Development, Industrial Applications), By End-User Industry (Healthcare, Nuclear Industry, Research Institutions, Pharmaceuticals), and By Distribution Channel (Direct Sales, Online Sales, Distributors); Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Alpha Emitter Market is expected to grow from USD 536.5 million in 2023 at a CAGR of 13.8% to touch USD 1,323.0 million by 2030. The Alpha Emitter Market is dominated by key players such as Alpha Therapeutics, Bayer AG, AstraZeneca PLC, Eli Lilly and Co., General Electric (GE) Healthcare, Canberra Industries, Inc., Thermo Fisher Scientific, Inc., Actinium Pharmaceuticals, Curium Pharma, Lantheus Holdings, Inc., Eckert & Ziegler AG, Novartis AG, Siemens Healthineers, PharmaLogic, Ion Beam Applications.

Published: November, 2024
| Report ID: LI4728
| Life Sciences & Healthcare
Alopecia Market By Type (Androgenic Alopecia, Alopecia Areata, Telogen Effluvium, Traction Alopecia, Scarring Alopecia), By Treatment (Drugs, Oral Medications, Topical Medications, Hair Transplantation, Platelet-Rich Plasma (PRP) Therapy, Laser Therapy, Wigs & Hairpieces), By Age Group (Pediatric, Adult, Geriatric), By End-User (Hospitals, Hair Clinics, Dermatology Clinics, Homecare), By Distribution Channel (Online Retail, Offline Retail, Hospitals & Clinics); Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Alopecia Market is expected to grow from USD 7.4 billion in 2023 at a CAGR of 9.7% to touch USD 14.2 billion by 2030. The Alopecia Market is dominated by key players such as Regenera Activa, Johnson & Johnson, L’Oréal S.A., Procter & Gamble, GlaxoSmithKline, Bayer AG, Rogaine, Viviscal, Aclaris Therapeutics, Hairmax, Medtronic, FOLIGAIN, Revivogen, Bosley, Mercury Pharmaceuticals.

Published: November, 2024
| Report ID: LI4726
| Life Sciences & Healthcare
Aloe Vera Extract Market By Type (Aloe Vera Gel Extract, Aloe Vera Whole Leaf Extract, Aloe Vera Powder Extract, Decolorized Aloe Vera Extract), By Form (Liquid, Powder, Capsules), By Application (Food & Beverages, Pharmaceuticals, Cosmetics & Personal Care, Dietary Supplements), By End-User Industry (Food & Beverage Industry, Pharmaceutical Industry, Cosmetic & Personal Care Industry, Nutraceutical Industry), By Distribution Channel (Online Retail, Supermarkets/Hypermarkets, Specialty Stores, B2B), and By Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Aloe Vera Extract Market is expected to grow from USD 2.8 billion in 2023 at a CAGR of 7.9% to touch USD 4.7 billion by 2030. The Aloe Vera Extract Market is dominated by key players such as Aloe Laboratories, Inc., Forever Living Products, Terry Laboratories, Lily of the Desert Organic Aloeceuticals, Foodchem International Corporation, Aloecorp, Inc., Herbalife Nutrition, Aloecorp (IASC), Pharmachem Laboratories, Inc., Aloe Vera Australia, Aloe Farms, Inc., Sarvliving, Natural Aloe Costa Rica, Patanjali Ayurved Limited, Fruit of the Earth, Inc.

Published: November, 2024
| Report ID: LI4725
| Life Sciences & Healthcare
Alginate Dressing Market by Product Type (Non-Woven Alginate Dressing, Woven Alginate Dressing, Alginate Gel Dressings, Alginate Fiber Dressings), Formulation (Calcium Alginate, Sodium Alginate, Hybrid Alginate), Application (Chronic Wounds, Acute Wounds, Ulcers), End-User (Hospitals, Ambulatory Surgical Centers): Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Alginate Dressing Market is expected to grow from USD 2.3 billion in 2023 at a CAGR of 10.1% to touch USD 4.5 billion by 2030. The Alginate Dressing Market is dominated by key players such as 3M Health Care, Acelity (Now part of 3M), B. Braun Melsungen AG, Cardinal Health, Coloplast A/S, ConvaTec Group, Hollister Incorporated, KCI Medical, Medline Industries, Inc., Medtronic PLC, Mölnlycke Health Care and Systagenix Wound Management.

Published: November, 2024
| Report ID: LI4719
| Life Sciences & Healthcare
Diabetes Care Devices Market by Product Type (Blood Glucose Monitoring Devices, Insulin Delivery Devices, Continuous Glucose Monitoring Devices, Insulin Pumps, Smart Diabetes Management Devices, Lancets and Lancing Devices, Glucometers), By End-User Industry (Hospitals and Clinics, Homecare Settings, Diagnostic Centers, Diabetes Care Centers), By Technology (Wearable Devices, Non-invasive Devices, Smart Glucose Monitors, Connected Diabetes Devices), and By Distribution Channel (Online Sales, Retail Pharmacies, Hospitals and Clinics, Diabetes Care Centers); Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Diabetes Care Devices Market is expected to grow from USD 41.6 billion in 2023 at a CAGR of 11.2% to touch USD 87.4 billion by 2030. The Diabetes Care Devices Market is dominated by key players such as Medtronic, Abbott Laboratories, Roche Diagnostics, Dexcom, Becton, Dickinson and Company, Insulet Corporation, Johnson & Johnson, Novo Nordisk, Sanofi, Terumo Corporation, F. Hoffmann-La Roche Ltd, Tandem Diabetes Care, Bayer AG, Eli Lilly and Company, GlaxoSmithKline (GSK).

Published: November, 2024
| Report ID: LI4715
| Life Sciences & Healthcare
Alexipharmic Drugs Market by Drug Type (Antidotes for Heavy Metal Poisoning, Antivenoms, Chemical Antidotes, Biological Antidotes), Route of Administration (Oral, Intravenous, Intramuscular, Subcutaneous), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and End-User (Hospitals, Specialty Clinics, Poison Control Centers): Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Alexipharmic Drugs Market is expected to grow from USD 1.5 billion in 2023 at a CAGR of 6.9% to touch USD 2.4 billion by 2030. The Alexipharmic Drugs Market is dominated by key players such as AbbVie Inc., AstraZeneca, Bayer AG, Boehringer Ingelheim International GmbH, Dr. Reddy’s Laboratories Ltd., Eisai Co., Ltd., GlaxoSmithKline plc, Johnson & Johnson, Merck & Co., Inc., Mylan N.V., Novartis AG, Pfizer Inc. and Takeda Pharmaceutical Company Limited.

Published: November, 2024
| Report ID: LI4707
| Life Sciences & Healthcare
Contact Lenses Market By Product Type (Soft Contact Lenses, Rigid Gas Permeable (RGP) Lenses, Hybrid Lenses, Scleral Lenses), By Design Type (Spherical Contact Lenses, Toric Contact Lenses, Multifocal Contact Lenses), By Usage (Disposable Contact Lenses, Reusable Contact Lenses), By Distribution Channel (Online Retail, Offline Retail, Eye Care Professionals), By End-User (Individual Consumers, Healthcare Professionals); Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Contact Lenses Market is expected to grow from USD 16.7 billion in 2023 at a CAGR of 8.9% to touch USD 30.2 billion by 2030. The Contact Lenses Market is dominated by key players such as Johnson & Johnson Vision Care, Inc., Alcon Inc., Bausch + Lomb, CooperVision, Inc., EssilorLuxottica Group, Carl Zeiss Vision, Hoya Corporation, Menicon Co., Ltd., Ciba Vision, The Sight Company, Contamac Ltd., Acuvue (Johnson & Johnson Vision Care), Vision Care Optical, UltraVision CLPL, X-Cel Specialty Contacts.

Published: November, 2024
| Report ID: LI4705
| Life Sciences & Healthcare
Alcohol Wipes Market By Type (Soft Sanitizing Wipes, Sensitive Skin Wipes), By Fabric Material (Synthetic, Natural), By Distribution Channel (Online Retail, Supermarkets/Hypermarkets, Pharmacies), By End-User Industry (Healthcare, Personal Care, Household, Industrial & Commercial); Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Alcohol Wipes Market is expected to grow from USD 604.5 million in 2023 at a CAGR of 6.4% to touch USD 930.8 million by 2030. The Alcohol Wipes Market is dominated by key players such as Johnson & Johnson, Kimberly-Clark Corporation, Procter & Gamble, The Clorox Company, Reckitt Benckiser Group, Unicharm Corporation, Edgewell Personal Care, Medline Industries, SC Johnson Professional, AlcoPro, Alea Care, The Honest Company, VWR International, Ecolab, Gojo Industries.

Published: November, 2024
| Report ID: LI4701
| Life Sciences & Healthcare
Albumin Market By Product Type (Human Albumin, Bovine Serum Albumin (BSA), Recombinant Albumin), By Application (Therapeutic Uses, Diagnostic Applications, Research and Laboratory Uses, Industrial Uses), By End-User Industry (Hospitals and Clinics, Diagnostic Laboratories, Research Institutes, Pharmaceutical Companies, Biopharmaceutical Companies), and By Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Albumin Market is expected to grow from USD 5.6 billion in 2023 at a CAGR of 7.9% to touch USD 9.5 billion by 2030. The Albumin Market is dominated by key players such as Grifols, CSL Behring, Shire (Takeda Pharmaceutical Company), Octapharma, Biotest AG, Sichuan Yuanda Shuyang Pharmaceutical, Eli Lilly and Company, Fresenius Kabi, Baxter International Inc., Sanofi, AbbVie, Emergent BioSolutions, Shanghai RAAS Blood Products Co. Ltd., Jiangsu Kanion Pharmaceutical Co. Ltd., Hualan Biological Engineering.

Published: November, 2024
| Report ID: LI4694
| Life Sciences & Healthcare
Airway Clearance Systems Market By Product Type (Positive Expiratory Pressure (PEP) Devices, High-Frequency Chest Wall Oscillation (HFCWO) Devices, Insufflation-Exsufflation Devices, Positive Airway Pressure (PAP) Devices, Mechanical Insufflation-Exsufflation Devices), By Application (Chronic Obstructive Pulmonary Disease (COPD), Cystic Fibrosis, Bronchiectasis, Asthma, Acute Respiratory Distress Syndrome (ARDS)), By End-User Industry (Hospitals and Clinics, Home Care Settings, Ambulatory Surgical Centers, Research Institutes), and By Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Airway Clearance Systems Market is expected to grow from USD 0.6 billion in 2023 at a CAGR of 10.7% to touch USD 1.1 billion by 2030. The Airway Clearance Systems Market is dominated by key players such as Hill-Rom, Medtronic, Philips Healthcare, Smiths Medical, Allied Healthcare Products, Inc., CHAD Therapeutics, Hollister Incorporated, Thermo Fisher Scientific, Vyaire Medical, Inc., Omron Healthcare, AeroCare Holdings, MediTech, Draeger Medical, Breas Medical, Löwenstein Medical.

Published: November, 2024
| Report ID: LI4693
| Life Sciences & Healthcare
Advanced Drug Delivery Market By Technology (Liposomal Drug Delivery, Nanoparticle Drug Delivery, Microneedles, Targeted Drug Delivery, Oral Drug Delivery), By Application (Oncology, Cardiovascular Diseases, Infectious Diseases, Central Nervous System Disorders, Autoimmune Diseases), By End-User (Pharmaceutical Companies, Biotechnology Companies, Research Institutes, Contract Research Organizations, Hospitals and Clinics), By Route of Administration (Oral Drug Delivery, Parenteral Drug Delivery, Topical Drug Delivery, Pulmonary Drug Delivery, Implantable Drug Delivery); Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Advanced Drug Delivery Market is expected to grow from USD 239.4 billion in 2023 at a CAGR of 5.8% to touch USD 354.9 billion by 2030. The Advanced Drug Delivery Market is dominated by key players such as Johnson & Johnson, Pfizer Inc., Roche Holding AG, Novartis AG, Merck & Co., Inc., Sanofi S.A., GlaxoSmithKline plc, AbbVie Inc., Amgen Inc., Bristol-Myers Squibb Company, Eli Lilly and Company, Baxter International Inc., Teva Pharmaceutical Industries Ltd., Medtronic PLC, Mylan N.V.

Published: November, 2024
| Report ID: LI4686
| Life Sciences & Healthcare
5G in Healthcare Market By Component (Hardware, Software, Services), By End-User Industry (Hospitals, Clinics, Diagnostic Centers, Research & Academic Institutes), By Application (Telemedicine, Remote Patient Monitoring, Smart Hospitals, Emergency Services), and By Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the 5G in Healthcare Market is expected to grow from USD 47.0 billion in 2023 at a CAGR of 32.6% to touch USD 338.1 billion by 2030. The 5G in Healthcare Market is dominated by key players such as Verizon Communications, AT&T Inc., Huawei Technologies Co., Ltd., Ericsson AB, Qualcomm Technologies, Inc., Samsung Electronics Co., Ltd., Vodafone Group Plc, Siemens Healthineers AG, GE Healthcare, Philips Healthcare, Intel Corporation, T-Mobile US, BT Group, ZTE Corporation, Ciena Corporation

Published: November, 2024
| Report ID: LI4680
| Life Sciences & Healthcare
AI in Pharmaceutical Market By Technology (Machine Learning (ML), Deep Learning, Natural Language Processing (NLP), Robotics), By Application (Drug Discovery, Drug Development, Precision Medicine, Healthcare Data Management), By End-Use Industry (Pharmaceutical Companies, Research Organizations, Contract Research Organizations (CROs)), and By Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the AI in Pharmaceutical Market is expected to grow from USD 2.7 billion in 2023 at a CAGR of 13.9% to touch USD 6.8 billion by 2030. The AI in Pharmaceutical Market is dominated by key players such as, Google LLC (Alphabet Inc.), IBM Corporation, NVIDIA Corporation, BenevolentAI, and Atomwise, Inc.

Published: November, 2024
| Report ID: LI4676
| Life Sciences & Healthcare
AI in Medical Writing Market By Technology (Natural Language Processing, Machine Learning, Deep Learning, Text Analytics), By Application (Clinical Trials Documentation, Regulatory Writing, Scientific Research & Publications, Medical Communication & Marketing), By End-Use Industry (Pharmaceutical Companies, Biotech Companies, Contract Research Organizations), and By Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the AI in Medical Writing Market is expected to grow from USD 1.2 billion in 2023 at a CAGR of 24.4% to touch USD 5.7 billion by 2030. The AI in Medical Writing Market is dominated by key players such as Accenture, Cerner Corporation, Cognizant Technology Solutions, Elsevier, IBM Watson Health, IQVIA, Medtronic, Nuance Communications, Parexel International, Veeva Systems, Veristat and Wiley.

Published: November, 2024
| Report ID: LI4674
| Life Sciences & Healthcare
AI in Genomics Market By Technology (Machine Learning, Deep Learning, Natural Language Processing), By Application (Drug Discovery, Genomic Sequencing, Genetic Research & Personalized Medicine, Biomarker Discovery), By End-Use Industry (Healthcare Providers, Pharmaceutical & Biotech Companies, Contract Research Organizations), and By Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the AI in Genomics Market is expected to grow from USD 3.2 billion in 2023 at a CAGR of 22.0% to touch USD 13.0 billion by 2030. The AI in Genomics Market is dominated by key players such as Agilent Technologies, BenevolentAI, Bristol-Myers Squibb, Deep Genomics, IBM Watson Health, Illumina, Insilico Medicine, Qiagen, Tempus, Thermo Fisher Scientific, and XtalPi.

Published: November, 2024
| Report ID: LI4668
| Life Sciences & Healthcare
AI in Epidemiology Market By Application (Disease Surveillance, Epidemic Forecasting, Risk Assessment, Outbreak Detection and Monitoring, Drug & Vaccine Development), By End-Use Industry (Healthcare Organizations, Research Institutions, Government & Public Health Agencies, Pharmaceutical & Biotechnology Firms), and By Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the AI in Epidemiology Market is expected to grow from USD 431.7 million in 2023 at a CAGR of 15.2% to touch USD 1,162.1 million by 2030. The AI in Epidemiology Market is dominated by key players such as, Google LLC (Alphabet Inc.), IBM Corporation, Accenture plc, Tempus Labs, and BlueDot.

Published: November, 2024
| Report ID: LI4666
| Life Sciences & Healthcare
AI in Biotechnology Market By Technology (Natural Language Processing, Machine Learning, Deep Learning, Predictive Analytics, Robotic Process Automation), By Application (Drug Discovery, Disease Diagnosis, Gene Editing & Therapy, Precision Medicine, Clinical Research & Trials), By End-Use Industry (Pharmaceutical Companies, Biotechnology Firms, Contract Research Organizations), and By Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the AI in Biotechnology Market is expected to grow from USD 5.2 billion in 2023 at a CAGR of 22.2% to touch USD 21.1 billion by 2030. The AI in Biotechnology Market is dominated by key players such as Atomwise, BASF SE, Bayer AG, Exscientia, Google Health (Alphabet Inc.), IBM Watson Health, Intel Corporation, Microsoft Corporation, NVIDIA Corporation, Schrödinger Inc., and SRI International.

Published: November, 2024
| Report ID: LI4655
| Life Sciences & Healthcare
AI in Biopharmaceutical Market By Technology (Machine Learning (ML), Deep Learning, Natural Language Processing (NLP), Robotics), By Application (Drug Discovery, Bioprocessing, Personalized Medicine, Healthcare Data Management, Diagnostics), By End-Use Industry (Biopharmaceutical Companies, Academics & Research Organizations, Contract Research Organizations (CROs)), and By Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the AI in Biopharmaceutical Market is expected to grow from USD 1.2 billion in 2023 at a CAGR of 17.2% to touch USD 3.7 billion by 2030. The AI in Biopharmaceutical Market is dominated by key players such as, Google LLC (Alphabet Inc.), IBM Corporation, Accenture plc, Tempus Labs, and Insilico Medicine.

Published: November, 2024
| Report ID: LI4652
| Life Sciences & Healthcare
AI in Revenue Cycle Management Market By Technology (Natural Language Processing, Machine Learning, Robotic Process Automation), By Application (Claims Management, Billing & Coding, Patient Payment & Collections), By End-Use Industry (Healthcare Providers, Insurance Providers, Billing & Coding Service Providers), and By Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the AI in Revenue Cycle Management Market is expected to grow from USD 6.3 billion in 2023 at a CAGR of 14.8% to touch USD 16.5 billion by 2030. The AI in Revenue Cycle Management Market is dominated by key players such as 3M Health Information Systems, Allscripts Healthcare Solutions, Cerner Corporation, Change Healthcare, Cognizant Technology Solutions, Epic Systems Corporation, GeBBS Healthcare Solutions, McKesson Corporation, NaviNet (a part of NantHealth), Nextech Systems, NextGen Healthcare and Optum (UnitedHealth Group).

Published: November, 2024
| Report ID: LI4648
| Life Sciences & Healthcare
AI in Precision Medicine Market By Technology (Machine Learning, Natural Language Processing, Computer Vision, Deep Learning), By Application (Cancer Treatment, Genetic Disorders, Cardiovascular Diseases, Neurological Disorders, Rare Diseases), By End-User Industry (Hospitals & Clinics, Pharmaceutical Companies, Biotechnology Companies), and By Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the AI in Precision Medicine Market is expected to grow from USD 5.6 billion in 2023 at a CAGR of 16.6% to touch USD 16.5 billion by 2030. The AI in Precision Medicine Market is dominated by key players such as Butterfly Network, Inc., Cerner Corporation, GE Healthcare, Health Catalyst, IBM Corporation, Illumina, Inc., Medtronic, Microsoft Corporation, NVIDIA Corporation, PathAI, Philips Healthcare, and Siemens Healthineers.

Published: November, 2024
| Report ID: LI4644
| Life Sciences & Healthcare
Healthcare Finance Solutions Market Healthcare Finance Solutions Market By Solution Type (Revenue Cycle Management), By Deployment Mode (Cloud-Based, On-Premise), By End User Industry (Healthcare Providers, Insurance Providers, Government Healthcare Organizations), and By Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Healthcare Finance Solutions Market is expected to grow from USD 134.6 billion in 2023 at a CAGR of 5.3% to touch USD 193.2 billion by 2030. The Healthcare Finance Solutions Market is dominated by key players such as, McKesson Corporation, Cerner Corporation, Athenahealth, Inc., Siemens Healthineers, and Meditech.

Published: November, 2024
| Report ID: LI4641
| Life Sciences & Healthcare
Healthcare Cybersecurity Market By Solution Type (Endpoint Security, Network Security, Application Security), By Deployment Type (On-Premises, Cloud-based, Hybrid), By End User Industry (Hospitals and Healthcare Providers, Pharmaceuticals and Biotech, Medical Device Manufacturers, Health Insurance Companies), and By Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Healthcare Cybersecurity Market is expected to grow from USD 17.5 billion in 2023 at a CAGR of 13.2% to touch USD 41.6 billion by 2030. The Healthcare Cybersecurity Market is dominated by key players such as, Fortinet, Inc., Cisco Systems, Inc., Check Point Software Technologies Ltd., CyberArk Software Ltd., and Trend Micro Incorporated.

Published: November, 2024
| Report ID: LI4640
| Life Sciences & Healthcare
Healthcare Asset Management Market by Asset Type (Medical Equipment, IT Equipment, Non-Medical Equipment, Consumables & Supplies), Deployment Mode (On-Premises, Cloud-Based), Technology (RFID, IoT, Artificial Intelligence), Application (Equipment Tracking and Management, Inventory Management, Predictive Maintenance, Asset Lifecycle Management, Regulatory Compliance Management), End-User (Hospitals & Healthcare Providers, Diagnostic Laboratories, Research Institutions), and Region: Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Healthcare Asset Management Market is expected to grow from USD 8.8 billion in 2023 at a CAGR of 12.7% to touch USD 20.3 billion by 2030. The Healthcare Asset Management Market is dominated by key players such as Ascom Holding AG, AssetWorks LLC, AT&T Inc., Cognizant Technology Solutions, GE Healthcare, Honeywell International Inc., Medtronic, Oracle Corporation, Philips Healthcare, Siemens Healthineers, Stanley Healthcare, Stryker Corporation and Zebra Technologies Corporation.

Published: November, 2024
| Report ID: LI4629
| Life Sciences & Healthcare
Vendor Neutral Archive (VNA) and PACS Market by Component (Software, Hardware, Services), Delivery Mode (On-Premises, Cloud-Based, Hybrid), Imaging Modality (X-Ray, Computed Tomography (CT), Magnetic Resonance Imaging (MRI), Ultrasound, Nuclear Medicine), End-User (Hospitals, Diagnostic Imaging Centers, Ambulatory Surgical Centers, Specialty Clinics), and By Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Vendor Neutral Archive (VNA) & PACS Market is expected to grow from USD 4.3 billion in 2023 at a CAGR of 8.2% to touch USD 7.4 billion by 2030. The Vendor Neutral Archive (VNA) & PACS Market is dominated by key players such as Agfa HealthCare, Carestream Health, Change Healthcare, Dell Technologies, Fujifilm Holdings Corporation, GE Healthcare, Hyland Software, IBM Watson Health, Intelerad Medical Systems, Mach7 Technologies, Merge Healthcare (an IBM Company), Novarad Corporation, Philips Healthcare, Sectra AB, Siemens Healthineers.

Published: November, 2024
| Report ID: LI4621
| Life Sciences & Healthcare
Surgical Robot Accessories Market By Product Type (Surgical Arms, End Effectors, Robot Control Consoles), By Technology (Mechanical Systems, Electromechanical Systems), By End User (Hospitals and Clinics, Surgical Centers, Research and Training Institutes), and By Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Surgical Robot Accessories Market is expected to grow from USD 3.7 billion in 2023 at a CAGR of 22.7% to touch USD 15.6 billion by 2030. The Surgical Robot Accessories Market is dominated by key players such as, Stryker Corporation, Intuitive Surgical, Inc., Johnson & Johnson, Mazor Robotics, and Smith & Nephew.

Published: November, 2024
| Report ID: LI4610
| Life Sciences & Healthcare
Vascular Ulcers Treatment Market By Treatment Type (Topical Agents, Wound Dressings, Surgical Treatment, Compression Therapy), By Ulcer Type (Venous Ulcers, Arterial Ulcers, Diabetic Foot Ulcers, Mixed Ulcers), By End-User (Hospitals, Clinics, Home Care Settings), and By Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Vascular Ulcers Treatment Market is expected to grow from USD 4.1 billion in 2023 at a CAGR of 8.9% to touch USD 7.4 billion by 2030. The Vascular Ulcers Treatment Market is dominated by key players such as 3M Health Care, Acelity, Acelity, B. Braun Melsungen AG, Cardinal Health, Coloplast, Convatec Group, DermaRite Industries, LLC, Hollister Incorporated, Johnson & Johnson, Medline Industries, Inc., Medtronic, Molnlycke Health Care, Mölnlycke Health Care, Smith & Nephew.

Published: November, 2024
| Report ID: LI4609
| Life Sciences & Healthcare
Micropump Market by Product Type (Mechanical Micropump, Non-Mechanical Micropump), Application (Drug Delivery, In-Vitro Diagnostics, Medical Devices), End-User (Biotechnology & Pharmaceutical Companies, Hospitals & Diagnostic Centres, Academic & Research Institutes), and Region: Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Micropump Market is expected to grow from USD 2.2 billion in 2023 at a CAGR of 13.8% to touch USD 5.5 billion by 2030. The Micropump Market is dominated by key players such as Bartels Mikrotechnik GmbH, Bürkert Fluid Control Systems, Dolomite Microfluidics, IDEX Corporation, KNF Group, Micropump, Takako Industries, Inc., The Lee Company, TTP Ventus Ltd, Xiamen AJK Technology Co., Ltd.

Published: November, 2024
| Report ID: LI4608
| Life Sciences & Healthcare
Vaccine Contract Manufacturing Market By Service Type (Fill & Finish Services, Drug Substance Manufacturing, Packaging Services), By Product Type (Recombinant Vaccines, Viral Vaccines, Bacterial Vaccines, Conjugate Vaccines), By End-User (Biopharmaceutical Companies, Government Agencies, Non-profit Organizations), By Application (Infectious Diseases, Oncology Vaccines, Autoimmune Vaccines), and By Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Vaccine Contract Manufacturing Market is expected to grow from USD 1.9 billion in 2023 at a CAGR of 8.8% to touch USD 3.5 billion by 2030. The Vaccine Contract Manufacturing Market is dominated by key players such as Bausch Health, Boehringer Ingelheim, Catalent, Inc., CordenPharma, Emergent BioSolutions, GlaxoSmithKline, Lonza Group AG, Recipharm AB, Samsung Biologics, Sanofi Pasteur, Serum Institute of India, Takeda Pharmaceutical Company, Vaccines Manufacturing, Inc. (VMI), Vetter Pharma International, WuXi AppTec.

Published: November, 2024
| Report ID: LI4605
| Life Sciences & Healthcare
Medical Device Cybersecurity Solutions Market By Solution Type (Endpoint Security, Network Security, Application Security), By Deployment Type (On-Premises, Cloud-based, Hybrid), By End User Industry (Medical Device Manufacturers, Hospitals and Healthcare Providers, Pharmaceuticals and Biotech, Government and Regulatory Bodies), and By Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Medical Device Cybersecurity Solutions Market is expected to grow from USD 7.2 billion in 2023 at a CAGR of 15.2% to touch USD 19.3 billion by 2030. The Medical Device Cybersecurity Solutions Market is dominated by key players such as, Johnson & Johnson, Medtronic PLC, GE Healthcare, Check Point Software Technologies, and CrowdStrike.

Published: November, 2024
| Report ID: LI4604
| Life Sciences & Healthcare
Advanced Wound Dressing Market By Product Type (Hydrocolloid Dressings, Foam Dressings, Alginate Dressings, Hydrogel Dressings, Film Dressings, Collagen Dressings), By Wound Type (Chronic Wounds, Acute Wounds), By End-User Industry (Hospitals & Clinics, Ambulatory Surgical Centers, Home Healthcare), and By Distribution Channel (Hospitals Pharmacies, Retail Pharmacies, Online Pharmacies, Direct Sales); Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Advanced Wound Dressing Market is expected to grow from USD 10.3 billion in 2023 at a CAGR of 9.6% to touch USD 19.6 billion by 2030. The Advanced Wound Dressing Market is dominated by key players such as Smith & Nephew PLC, Johnson & Johnson, 3M Health Care, Molnlycke Health Care, Coloplast A/S, ConvaTec Group PLC, BSN Medical, Hollister Incorporated, MediWound Ltd., KCI (Acelity), Derma Sciences (Integra LifeSciences), Systagenix Wound Management, Hartmann Group, Fresenius Kabi, Advanced Medical Solutions Group.

Published: November, 2024
| Report ID: LI4603
| Life Sciences & Healthcare
Advanced Therapy Medicinal Products (ATMP) CDMO Market By Therapy Type (Gene Therapy, Cell Therapy, Tissue Engineering), By Service Type (Process Development, Manufacturing, Regulatory Services, Analytical Services), By End-User Industry (Pharmaceutical & Biotechnology, Contract Manufacturing Organizations, Research Institutions, Hospitals & Clinics), By Application (Oncology, Cardiovascular Disorders, Genetic Disorders, Orthopedic Disorders, Neurological Disorders); Global Insights & Forecast (2024–2030)

According to Intent Market Research, the Advanced Therapy Medicinal Products CDMO Market is expected to grow from USD 5.2 billion in 2023 at a CAGR of 21.6% to touch USD 20.4 billion by 2030. The Advanced Therapy Medicinal Products CDMO Market is dominated by key players such as Lonza Group, Samsung Biologics, WuXi AppTec, Boehringer Ingelheim, Catalent, Kite Pharma (Gilead Sciences), Novartis (Kymriah), Sartorius Stedim Biotech, Regeneron Pharmaceuticals, VWR International, Cell and Gene Therapy Catapult, WuXi Advanced Therapies, AbbVie, Baxter International, Merck Group.

Published: November, 2024
| Report ID: LI4596
| Life Sciences & Healthcare
Advanced Ophthalmology Technology Market By Product Type (Surgical Instruments, Diagnostic Equipment, Therapeutic Devices), By Technology (Laser Surgery, Optical Coherence Tomography [OCT], Retinal Implants, Artificial Intelligence [AI] for Diagnosis), By End-User Industry (Hospitals, Ambulatory Surgical Centers, Ophthalmic Clinics), By Application (Cataract Surgery, Glaucoma Treatment, Retina Surgery, Refractive Surgery), and By Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Advanced Ophthalmology Technology Market is expected to grow from USD 7.7 billion in 2023 at a CAGR of 7.1% to touch USD 12.4 billion by 2030. The Advanced Ophthalmology Technology Market is dominated by key players such as Alcon, Johnson & Johnson Vision, Carl Zeiss Meditec AG, Bausch + Lomb, AbbVie (Allergan), Santen Pharmaceutical Co., Ltd., Hoya Corporation, Novartis AG, TearLab Corporation, Topcon Corporation, Rayner Intraocular Lenses Ltd., Nidek Co., Ltd., Medtronic, Olympus Corporation, Lumenis Ltd.

Published: November, 2024
| Report ID: LI4591
| Life Sciences & Healthcare
Advanced Bipolar Direct Energy Devices Market By Product Type (High-Power Bipolar Devices, Low-Power Bipolar Devices), By Application (Medical Devices, Industrial Equipment, Automotive Systems, Telecommunications), By End-User Industry (Healthcare, Automotive, Electronics & Semiconductor, Industrial Manufacturing), and By Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Advanced Bipolar Direct Energy Devices Market is expected to grow from USD 3.0 billion in 2023 at a CAGR of 11.5% to touch USD 6.3 billion by 2030. The Advanced Bipolar Direct Energy Devices Market is dominated by key players such as Analog Devices, Inc., Broadcom Inc., Cree, Inc., Infineon Technologies, Maxim Integrated, Microchip Technology Inc., NXP Semiconductors N.V., ON Semiconductor, Qualcomm Technologies, Inc., Renesas Electronics Corporation, Semtech Corporation, STMicroelectronics, Texas Instruments Inc., Toshiba Corporation, Vishay Intertechnology, Inc.

Published: November, 2024
| Report ID: LI4578
| Life Sciences & Healthcare
Advance Care Planning Solutions Market By Solution Type (Software Solutions, Consulting Services, Document Management Solutions), By End-User (Healthcare Providers, Patients and Families, Government and Regulatory Bodies, Payers), By Application (End-of-Life Care, Chronic Disease Management, Geriatric Care, Pediatric Care), and By Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Advance Care Planning Solutions Market is expected to grow from USD 93.9 billion in 2023 at a CAGR of 13.8% to touch USD 232.2 billion by 2030. The Advance Care Planning Solutions Market is dominated by key players such as Advance Care Planning Australia, Amedisys, CareSimple, Delmarva Foundation for Medical Care, ePOLST, HealthCare Interactive, Honoring Choices, LifeBio, MyDirectives, Palliative Care Center, Pathways Health.

Published: November, 2024
| Report ID: LI4574
| Life Sciences & Healthcare
Adult Vitamin Gummies Market By Product Type (Multivitamins, Single Vitamin), By Distribution Channel (Supermarkets/Hypermarkets, Pharmacies, Online Retail, Specialty Stores), By End-User (General Adults, Seniors, Specific Needs), And By Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Adult Vitamin Gummies Market is expected to grow from USD 4.3 billion in 2023 at a CAGR of 7.2% to touch USD 7.1 billion by 2030. The Adult Vitamin Gummies Market is dominated by key players such as Amway, Bayer, Church & Dwight Co., DSM, General Nutrition Centers Inc. (GNC), Hero Nutritionals, Jamieson, Nature’s Bounty Inc., Nature’s Way, Pfizer Inc., Pharmavite, Puritan's Pride, Sanofi, Smarty Pants Vitamins, Webber Naturals.

Published: November, 2024
| Report ID: LI4573
| Life Sciences & Healthcare
Cytotoxic Drugs Market By Drug Class (Alkylating Agents, Antimetabolites, Plant Alkaloids, Antitumor Antibiotics), By Mechanism of Action (DNA Intercalating Agents, DNA Alkylating Agents, Microtubule Inhibitors, Topoisomerase Inhibitors, Antimetabolites), By Application (Cancer Treatment, Autoimmune Disorders, Organ Transplantation), By End-User (Hospitals, Cancer Treatment Centers, Homecare Settings, Clinics), and By Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Cytotoxic Drugs Market is expected to grow from USD 14.1 billion in 2023 at a CAGR of 10.4% to touch USD 28.2 billion by 2030. The Cytotoxic Drugs Market is dominated by key players such as AbbVie Inc., Amgen Inc., AstraZeneca plc, Baxter International Inc., Bayer AG, Bristol Myers Squibb Company, Eli Lilly and Company, GlaxoSmithKline plc, Johnson & Johnson and Merck & Co., Inc.

Published: November, 2024
| Report ID: LI4559
| Life Sciences & Healthcare
Breast Shells Market By Usage (Reusable, Disposable), By Material (Plastic, Silicone), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Stores), and By Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Breast Shells Market is expected to grow from USD 341.6 million in 2023 at a CAGR of 10.5% to touch USD 685.7 million by 2030. The Breast Shells Market is dominated by key players such as, Ardo Medical Ltd., Ameda Inc., Medela AG, Lacticups, and Newell Brands.

Published: November, 2024
| Report ID: LI4555
| Life Sciences & Healthcare
Breast Cancer Liquid Biopsy Market By Circulating Biomarkers (Circulating Tumor Cells (CTCs), Circulating Cell-free DNA (cfDNA), Extracellular Vesicles (EVs)), By Application (Early Detection/Screening, Diagnosis, Treatment Selection, Monitoring), and By Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Breast Cancer Liquid Biopsy Market is expected to grow from USD 1.1 billion in 2023 at a CAGR of 14.7% to touch USD 2.9 billion by 2030. The Breast Cancer Liquid Biopsy Market is dominated by key players such as, NeoGenomics Laboratories, The Menarini Group, Thermo Fisher Scientific, Inc., Epic Sciences, Inc., and Biocept, Inc.

Published: November, 2024
| Report ID: LI4554
| Life Sciences & Healthcare
Bovine Tuberculosis Diagnosis Market By Test (Serological Tests, Molecular Diagnostic Tests, Traditional Tests), and By Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Bovine Tuberculosis Diagnosis Market is expected to grow from USD 585.4 million in 2023 at a CAGR of 5.8% to touch USD 871.3 million by 2030. The Bovine Tuberculosis Diagnosis Market is dominated by key players such as, PBD Biotech Ltd, IDEXX Laboratories, Inc., Thermo Fisher Scientific Inc., Bionote USA Inc., and AsureQuality Australia Pty Ltd.

Published: November, 2024
| Report ID: LI4552
| Life Sciences & Healthcare
Bone Morphogenetic Protein Market By Type (rhBMP-2, rhBMP-7), By Application (Spinal Fusion, Trauma, Reconstruction, Oral Maxillofacial), and By Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Bone Morphogenetic Protein Market is expected to grow from USD 472.2 million in 2023 at a CAGR of 6.6% to touch USD 738.7 million by 2030. The Bone Morphogenetic Protein Market is dominated by key players such as, Cellumed Co., Ltd., Medtronic plc, Prospec-Tany Technogene Ltd., Proteintech Group, Inc., and Bio-Techne.

Published: November, 2024
| Report ID: LI4551
| Life Sciences & Healthcare
Bone Grafts and Substitutes Market By Material Type (Allograft, Synthetic, Composites, Polymers, Bone Morphogenic Proteins (BMP)), By Application (Craniomaxillofacial, Dental, Foot & Ankle, Joint Reconstruction, Long Bone, Spinal Fusion), and By Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Bone Grafts and Substitutes Market is expected to grow from USD 5.7 billion in 2023 at a CAGR of 11.7% to touch USD 12.3 billion by 2030. The Bone Grafts And Substitutes Market is dominated by key players such as, DePuy Synthes (Johnson & Johnson), AlloSource, Smith + Nephew, Zimmer Biomet, and Orthofix Medical, Inc..

Published: November, 2024
| Report ID: LI4550
| Life Sciences & Healthcare
Artificial Disc Replacement Market By Disc Type (Cervical Artificial Discs, Lumbar Artificial Discs), By Material Type (Metal-on-Metal Discs, Metal-on-Biopolymer Discs), By Surgical Approach (Anterior Approach, Lateral Approach), By End-User (Hospitals, Ambulatory Surgical Centers, Specialty Clinics), and By Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Artificial Disc Replacement Market is expected to grow from USD 1.0 billion in 2023 at a CAGR of 11.5% to touch USD 2.2 billion by 2030. The Artificial Disc Replacement Market is dominated by key players such as Aesculap Implant Systems, LLC, AxioMed LLC, B. Braun Melsungen AG, Centinel Spine, LLC, DePuy Synthes (Johnson & Johnson), Globus Medical, Inc., LDR Holding Corporation, Medtronic PLC and NuVasive, Inc.

Published: November, 2024
| Report ID: LI4538
| Life Sciences & Healthcare
Aquatic Ecotoxicological Studies Market By Study Type (Acute Toxicity Studies, Chronic Toxicity Studies, Bioaccumulation Studies, Sediment Toxicity Studies, Multi-Species Interaction Studies), By Testing Method (In Vivo Testing, In Vitro Testing, Computational Models), By Organism Type (Fish, Amphibians, Aquatic Invertebrates, Algae), By End-Use Application (Industrial Effluent Testing, Pharmaceutical Testing, Pesticide and Fertilizer Testing, Chemicals and Materials Industry, Government and Regulatory Agencies), and By Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Aquatic Ecotoxicological Studies Market is expected to grow from USD 444.6 million in 2023 at a CAGR of 7.8% to touch USD 751.5 million by 2030. The Aquatic Ecotoxicological Studies Market is dominated by key players such as ALS Limited, Bioresearch Center (BRC), Burleson Research Technologies, Charles River Laboratories, EAG Laboratories, Envigo and Eurofins Scientific.

Published: November, 2024
| Report ID: LI4537
| Life Sciences & Healthcare
AI-Based Surgical Robots Market By Product Type (Robotic Systems, Instruments and Accessories, Services), By Application (General Surgery, Orthopedic Surgery, Neurosurgery, Cardiovascular Surgery, Gynecological Surgery), By End User (Hospitals, Ambulatory Surgical Centers, Specialty Clinics), and By Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the AI-Based Surgical Robots Market is expected to grow from USD 7.5 billion in 2023 at a CAGR of 22.8% to touch USD 31.3 billion by 2030. The AI-Based Surgical Robots Market is dominated by key players such as, Stryker Corporation, Intuitive Surgical Inc., Zimmer Biomet Holdings Inc., Vicarious Surgical Inc., and Asensus Surgical Inc.

Published: November, 2024
| Report ID: LI4536
| Life Sciences & Healthcare
Bone Allografts Market By Type (Cortical Bone Allografts, Cancellous Bone Allografts, Corticocancellous Bone Allografts, Demineralized Bone Matrix), By Application (Dental, Spine, Reconstruction & Traumatology), By End Use (Hospitals, Orthopedic & Trauma Centers), and By Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Bone Allografts Market is expected to grow from USD 2.7 billion in 2023 at a CAGR of 10.3% to touch USD 5.3 billion by 2030. The Bone Allografts Market is dominated by key players such as, Medtronic, Zimmer Biomet, Lynch Biologics, LLC., Baxter, and Johnson & Johnson Services, Inc.

Published: November, 2024
| Report ID: LI4535
| Life Sciences & Healthcare
AI In Patient Engagement Solutions Market By Component (Software, Services), By Deployment Mode (Cloud-Based, On-Premise), By Application (Patient Communication, Appointment Scheduling, Medication Adherence, Post-Treatment Care, Chronic Disease Management), By End User (Hospitals, Clinics, Ambulatory Surgical Centers, Insurance Providers), and By Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the AI In Patient Engagement Solutions Market is expected to grow from USD 5.7 billion in 2023 at a CAGR of 21.7% to touch USD 22.6 billion by 2030. The AI In Patient Engagement Solutions Market is dominated by key players such as, Cerner Corporation, Philips Healthcare, IBM Watson Health, Allscripts Healthcare Solutions, and Qualcomm Life.q

Published: November, 2024
| Report ID: LI4534
| Life Sciences & Healthcare
AI in Medical Imaging Market By Technology (Deep Learning, Machine Learning, Computer Vision, Natural Language Processing (NLP)), By Application (Radiology, Cardiology, Neurology, Oncology, Orthopedics), By End User (Hospitals and Diagnostic Centers, Research and Academic Institutes, Imaging Centers, Clinics), and By Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the AI in Medical Imaging Market is expected to grow from USD 2.7 billion in 2023 at a CAGR of 17.8% to touch USD 8.5 billion by 2030. The AI in Medical Imaging Market is dominated by key players such as, GE Healthcare, Siemens Healthineers, Canon Medical Systems Corporation, Zebra Medical Vision, and NVIDIA Corporation.

Published: November, 2024
| Report ID: LI4531
| Life Sciences & Healthcare
AI in Medical Coding Market By Component (Software, Services), By Deployment Mode (Cloud-Based, On-Premise), By Application (Diagnosis Coding, Procedure Coding), By End User (Hospitals, Clinics, Insurance Providers), and By Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the AI in Medical Coding Market is expected to grow from USD 2.5 billion in 2023 at a CAGR of 14.1% to touch USD 6.4 billion by 2030. The AI in Medical Coding Market is dominated by key players such as, Optum Inc., 3M Health Information Systems, Ciox Health, Cerner Corporation, and nThrive Inc.

Published: November, 2024
| Report ID: LI4530
| Life Sciences & Healthcare
Blood Processing Devices & Consumables Market By Product (Devices, Consumables), By End-use (Hospitals and Clinics, Diagnostic Laboratories), and By Region; Global Insights & Forecast (2024 – 2030)

Blood Processing Devices & Consumables Market By Product (Devices, Consumables), By End-use (Hospitals and Clinics, Diagnostic Laboratories), and By Region; Global Insights & Forecast (2024 – 2030)

Published: November, 2024
| Report ID: LI4529
| Life Sciences & Healthcare
Adipose Derived Stem Cell Therapy Market by Product Type (Cell-Based Therapy, Conditioned Media-Based Therapy, Exosome-Based Therapy), by Application (Regenerative Medicine, Orthopedic & Musculoskeletal Disorders, Dermatology & Wound Healing, Cardiovascular Diseases, Neurological Diseases, Autoimmune Diseases), by End-User (Hospitals & Clinics, Research Institutes, Stem Cell Banks), and by Technique (Adipose Tissue Harvesting, Cell Isolation, Cell Culture & Expansion); Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Adipose Derived Stem Cell Therapy Market is expected to grow from USD 12.3 billion in 2023 at a CAGR of 11.7% to touch USD 26.6 billion by 2030. The Adipose Derived Stem Cell Therapy Market is dominated by key players such as Anterogen Co., Ltd., Athersys, Inc., Celltex Therapeutics Corporation, ExCellThera, Inc., Haplogen GmbH, IsuAbxis and Mesoblast Ltd.

Published: November, 2024
| Report ID: LI4507
| Life Sciences & Healthcare
Behavioral Rehabilitation Market By Type (Cognitive Behavioral Therapy, Physical Rehabilitation, Speech and Language Therapy, Occupational Therapy), By Application (Substance Abuse Rehabilitation, Autism Spectrum Disorder Rehabilitation, Neurological Rehabilitation, Mental Health Rehabilitation, Geriatric Rehabilitation, Post-Traumatic Stress Disorder (PTSD)), By End-User (Hospitals, Rehabilitation Centers, Nursing Homes, Outpatient Clinics, Homecare Settings), and By Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Behavioral Rehabilitation Market is expected to grow from USD 228.4 billion in 2023 at a CAGR of 3.4% to touch USD 289.0 billion by 2030. The Behavioral Rehabilitation Market is dominated by key players such as AbbVie Inc., Amedisys, Inc., Boston Scientific Corporation, Cerner Corporation, Cigna Corporation, Cognizant Technology Solutions, HCA Healthcare, Inc. and Huntington Ingalls Industries.

Published: November, 2024
| Report ID: LI4499
| Life Sciences & Healthcare
Baby Oral Care Market By Product Type (Toothpaste, Toothbrushes, Mouthwash, Oral Gel), By Age Group (0-6 Months, 6-12 Months, 12-24 Months, 2+ Years), By Distribution Channel (Online Retail, Supermarkets/Hypermarkets, Drugstores/Pharmacies, Specialty Stores), By Formulation (Gel-based, Paste-based, Foam-based, Liquid-based); Global Insights & Forecast (2024-2030)

According to Intent Market Research, the Baby Oral Care Market is expected to grow from USD 1.5 billion in 2023 at a CAGR of 4.3% to touch USD 2.0 billion by 2030. The Baby Oral Care Market is dominated by key players such as Babyganics (Evergreen Innovation Group), Church & Dwight Co., Inc., Colgate-Palmolive Company, GlaxoSmithKline, Hain Celestial Group, Inc., Himalaya Drug Company, Johnson & Johnson, Kimberly-Clark Corporation and Lion Corporation.

Published: November, 2024
| Report ID: LI4485
| Life Sciences & Healthcare
Amniotic Membrane Market By Product Type (Cryopreserved Amniotic Membranes, Dehydrated Amniotic Membranes, Fresh Amniotic Membranes), By Application (Wound Care, Ophthalmology, Orthopedics, Dental Care), By End-User (Hospitals, Clinics, Ambulatory Surgical Centers, Research and Academic Institutes), and By Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Amniotic Membrane Market is expected to grow from USD 3.6 billion in 2023 at a CAGR of 14.1% to touch USD 9.1 billion by 2030. The Amniotic Membrane Market is dominated by key players such as Amniox Medical, Inc., Applied Biologics, Athersys, Inc., Celgene Corporation, Human Regenerative Therapy, Inc., Integra LifeSciences and Kerecis.

Published: November, 2024
| Report ID: LI4484
| Life Sciences & Healthcare
Amines Market By Type (Aliphatic Amines, Aromatic Amines, Heterocyclic Amines), By Application (Agriculture, Chemicals, Pharmaceuticals, Personal Care & Cosmetics, Textiles & Leather), By End-User Industry (Agriculture, Chemicals, Pharmaceuticals, Personal Care & Cosmetics, Textiles & Leather), and By Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Amines Market is expected to grow from USD 21.1 billion in 2023 at a CAGR of 5.8% to touch USD 31.3 billion by 2030. The Amines Market is dominated by key players such as BASF SE, Air Products and Chemicals, Inc., AkzoNobel N.V., China National Petroleum Corporation (CNPC), Dow Chemical Company, Eastman Chemical Company, Huntsman Corporation, Indo Amines Limited and Kraton Polymers.

Published: November, 2024
| Report ID: LI4480
| Life Sciences & Healthcare
Autotransfusion Devices Market By Product Type (Blood Collection Devices, Blood Processing Devices, Blood Storage Devices), By Application (Cardiac Surgery, Orthopedic Surgery, Trauma & Emergency Care, Obstetrics and Gynecology), By End-User (Hospitals, Ambulatory Surgical Centers, Blood Banks), and By Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Autotransfusion Devices Market is expected to grow from USD 504.7 million in 2023 at a CAGR of 7.6% to touch USD 841.7 million by 2030. The Autotransfusion Devices Market is dominated by key players such as Baxter International Inc., Biomet, Fresenius Medical Care, Grifols S.A., Haemonetics Corporation, LivaNova PLC, Macopharma and Medtronic.

Published: November, 2024
| Report ID: LI4477
| Life Sciences & Healthcare
Genetic Analysis Services Market By Service Type (DNA Sequencing Services, PCR Services, Genetic Counseling Services, Genotyping Services), By Technology (Next-Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Microarray, Fluorescent In Situ Hybridization (FISH)), By Application (Disease Diagnosis, Personalized Medicine, Drug Discovery and Development, Genetic Research), By End-User (Hospitals, Diagnostic Laboratories, Pharmaceutical & Biotechnology Companies, Academic & Research Institutes), and By Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Genetic Analysis Services Market is expected to grow from USD 3.1 billion in 2023 at a CAGR of 19.3% to touch USD 10.5 billion by 2030. The Genetic Analysis Services Market is dominated by key players such as 23andMe, Inc., Agilent Technologies, Inc., BGI Group, Bio-Rad Laboratories, Inc., Cepheid, Eurofins Scientific, Illumina, Inc., LabCorp (Covance), MedGenome Labs, Oxford Nanopore Technologies, Pacific Biosciences of California, Inc., PerkinElmer, Inc., QIAGEN N.V., Roche Holding AG, Thermo Fisher Scientific.

Published: November, 2024
| Report ID: LI4465
| Life Sciences & Healthcare
Amyloidosis Treatment Market By Treatment (Chemotherapy, Immunosuppressive Drugs, Transplantation, Supportive Care, Surgery), By End-use (Hospitals & Clinics, Ambulatory Surgical Centers, Home Care Settings), and By Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Amyloidosis Treatment Market is expected to grow from USD 3.3 billion in 2023 at a CAGR of 8.1% to touch USD 5.6 billion by 2030. The Amyloidosis Treatment Market is dominated by key players such as, Johnson & Johnson Services, Inc., Pfizer Inc., Amgen Inc., F. Hoffmann-La Roche Ltd, and Novartis AG.

Published: November, 2024
| Report ID: LI4463
| Life Sciences & Healthcare
Diabetic Foot Ulcer Treatment Market By Treatment Type (Wound Care Dressings, Biologics, Wound Care Devices), By Ulcer Type (Neuropathic Ulcers, Ischemic Ulcers, Neuroischemic Ulcers), By End-User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Home Care Settings), and By Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Diabetic Foot Ulcer Treatment Market is expected to grow from USD 4.4 billion in 2023 at a CAGR of 7.3% to touch USD 7.1 billion by 2030. The Diabetic Foot Ulcer Treatment Market is dominated by key players such as, B. Braun Melsungen, 3M, ConvaTec, Smith & Nephew, and Integra LifeSciences.

Published: November, 2024
| Report ID: LI4460
| Life Sciences & Healthcare
Oligonucleotide Synthesis Market By Type (DNA Oligonucleotides, RNA Oligonucleotides), By Application (Gene Synthesis, PCR, DNA Sequencing, RNA Interference, Diagnostics, Therapeutic), By Product (Custom Oligonucleotides), By End-User (Pharmaceutical & Biotechnology Companies, Research & Academic Institutions, Diagnostic Laboratories, Contract Research Organizations), and By Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Oligonucleotide Synthesis Market is expected to grow from USD 8.1 billion in 2023 at a CAGR of 12.9% to touch USD 19.0 billion by 2030. The Oligonucleotide Synthesis Market is dominated by key players such as Agilent Technologies, Inc., Beckman Coulter, Inc., Bioneer Corporation, Biosearch Technologies, Inc., DNA Script, Eurofins Genomics, GE Healthcare Life Sciences, Illumina, Inc. and Integrated DNA Technologies, Inc.

Published: November, 2024
| Report ID: LI4451
| Life Sciences & Healthcare
DNA Sequencing Market By Technology (Sanger Sequencing, Next-Generation Sequencing (NGS), Third-Generation Sequencing), By Application (Diagnostics, Drug Discovery & Development, Personalized Medicine, Agriculture & Animal Research, Forensic Science), By Product (Consumables, Instruments, Services), By End-User (Hospitals & Clinics, Research & Academic Institutions, Pharmaceutical & Biotechnology Companies, Diagnostic Laboratories), and By Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the DNA Sequencing Market is expected to grow from USD 13.7 billion in 2023 at a CAGR of 26.3% to touch USD 70.0 billion by 2030. The DNA Sequencing Market is dominated by key players such as Abbott Laboratories, ACGT Corporation, Agilent Technologies, Inc., BGI Genomics Co., Ltd., Bio-Rad Laboratories, Inc., Danaher Corporation, Genomic Health, Inc., Illumina, Inc. and Oxford Nanopore Technologies Ltd.

Published: November, 2024
| Report ID: LI4450
| Life Sciences & Healthcare
Acromegaly Treatment Market By Drug Class (Somatostatin Analogs, Growth Hormone Receptor Antagonists, Dopamine Agonists), By Route of Administration (Injectable, Oral), By Treatment Type (Medical Treatment, Surgical Treatment, Radiotherapy), By End-User Industry (Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Home Care), and By Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Acromegaly Treatment Market is expected to grow from USD 1.5 billion in 2023 at a CAGR of 10.2% to touch USD 2.9 billion by 2030. The Acromegaly Treatment Market is dominated by key players such as Alexion Pharmaceuticals (AstraZeneca), Amgen Inc., Chugai Pharmaceutical Co., Ltd., Eli Lilly and Company, Merck & Co., Inc., Novartis International AG, and Pfizer Inc.

Published: November, 2024
| Report ID: LI4449
| Life Sciences & Healthcare
Antiarrhythmic Drugs Market By Drug Class (Sodium Channel Blockers, Beta Blockers, Potassium Channel Blockers, Calcium Channel Blockers, Other), By Route of Administration (Oral, Parenteral, Other), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Other), and By Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Antiarrhythmic Drugs Market is expected to grow from USD 1.7 billion in 2023 at a CAGR of 8.3% to touch USD 2.9 billion by 2030. The Antiarrhythmic Drugs Market is dominated by key players such as, Novartis, Pfizer, Sanofi, Upsher-Smith Laboratories, and Mayne Pharma.

Published: November, 2024
| Report ID: LI4445
| Life Sciences & Healthcare
Ambient Assisted Living Market By Product (Medical Assistance Products, Safety and Security, Communication Devices, Telemonitoring, Mobility, Compensatory Impairments), and By Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Ambient Assisted Living Market is expected to grow from USD 9.6 billion in 2023 at a CAGR of 11.6% to touch USD 20.7 billion by 2030. The Ambient Assisted Living Market is dominated by key players such as, Assisted Living Technologies, Inc., 2PCS Solutions GmbH, Bay Alarm Medical, Legrand Group España, S.L., and ADT.

Published: November, 2024
| Report ID: LI4436
| Life Sciences & Healthcare
AI in Patient Engagement Market by Technology (Machine Learning, Natural Language Processing, Computer Vision, Speech Recognition), by Component (Solutions, Services, Managed Services, Professional Services), by Application (Screening & Diagnosis, Therapy Assistance, Patient Monitoring, Behavior & Mood Tracking, Risk Assessment & Predictive Analytics), by End User (Hospitals & Clinics, Research & Academic Institutes, Mental Health Centers, Individual Users), by Deployment Mode (Cloud-Based, On-Premises), and by Region; Global Insights & Forecast (2024–2030)

According to Intent Market Research, the AI In Patient Engagement Market is expected to grow from USD 5.9 billion in 2023 at a CAGR of 20.5% to touch USD 21.8 billion by 2030. The AI In Patient Engagement Market is dominated by key players such as Allscripts Healthcare Solutions, Amazon Web Services (AWS), Cerner Corporation, Cognizant Healthcare Solutions, Epic Systems Corporation, GE Healthcare, Google Health and IBM Watson Health.

Published: November, 2024
| Report ID: LI4428
| Life Sciences & Healthcare
AI in Mental Health Market By Technology (Machine Learning, NLP, Computer Vision, Speech Recognition), By Component (Solutions, Services, Managed Services, Professional Services), By Application (Screening & Diagnosis, Therapy Assistance, Patient Monitoring, Behavior & Mood Tracking, Risk Assessment & Predictive Analytics), By End User (Hospitals & Clinics, Research & Academic Institutes, Mental Health Centers, Individual Users), and By Deployment Mode (Cloud-Based, On-Premises); Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the AI In Mental Health Market is expected to grow from USD 1.1 billion in 2023 at a CAGR of 36.9% to touch USD 10.0 billion by 2030. The AI In Mental Health Market is dominated by key players such as Ada Health, Bark Technologies, BetterHelp. Big Health, Ginger, Happify Health, Lyra Health and Meru Health.

Published: November, 2024
| Report ID: LI4423
| Life Sciences & Healthcare
Airway Management Devices Market By Product (Supraglottic Devices, Infraglottic Devices, Resuscitators, Laryngoscopes), By Application (Anaesthesia, Emergency Medicine), By End-use (Hospitals, Homecare), and By Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Airway Management Devices Market is expected to grow from USD 3.1 billion in 2023 at a CAGR of 8.1% to touch USD 5.4 billion by 2030. The Airway Management Devices Market is dominated by key players such as, Teleflex Incorporated, Medtronic, BD, ICU Medical (Smiths Medical, Inc.), and Armstrong Medical Ltd.

Published: November, 2024
| Report ID: LI4421
| Life Sciences & Healthcare
Advanced Wound Care Market by Product Type (Moist, Antimicrobial, Active, Wound Cleanser Products, Compression Bandages), by Application (Chronic Wounds, Acute Wounds), by End-Use (Hospitals, Outpatient Facilities, Home Care), and by Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Advanced Wound Care Market is expected to grow from USD 10.3 billion in 2023 at a CAGR of 6.2% to touch USD 15.6 billion by 2030. The Advanced Wound Care Market is dominated by key players such as Mölnlycke Health Care AB, 3M, Smith & Nephew, Baxter International, Cardinal Health, Medline Industries, Inc., ConvaTec Inc. and Johnson & Johnson Services, Inc.

Published: November, 2024
| Report ID: LI4414
| Life Sciences & Healthcare
Adult Stem Cells Market by Type (Autologous Adult Stem Cells, Allogeneic Adult Stem Cells), by Product & Services (Kits, Media & Reagents, Hematopoietic, Mesenchymal, Neural, Epithelial/Skin Cells), by Indication (Bone & Cartilage Repair, Cardiovascular Diseases, Inflammatory & Immunological Diseases, Cancer, GvHD), by Application (Therapeutics, Disease Modeling, Drug Development & Discovery, Toxicology Studies, Biobanking, Tissue Engineering), and by End Use (Biopharmaceutical Companies, Research Institutes, Hospitals & Clinics); Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Adult Stem Cells Market is expected to grow from USD 11.4 billion in 2023 at a CAGR of 13.7% to touch USD 27.9 billion by 2030. The Adult Stem Cells Market is dominated by key players such as Thermo Fisher Scientific, Inc., STEMCELL Technologies, Osiris Therapeutics, Vericel Corporation, ZenBio, Inc., and Stempeutics Research.

Published: November, 2024
| Report ID: LI4412
| Life Sciences & Healthcare
Cancer Biomarkers Market By Type (Genomic Biomarkers, Proteomic Biomarkers, Metabolomic Biomarkers), By Technology (PCR, Next-Generation Sequencing (NGS), Immunoassays), By Application (Diagnostics, Prognosis, Treatment Decisions), and By Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Cancer Biomarkers Market is expected to grow from USD 19.7 billion in 2023 at a CAGR of 6.8% to touch USD 31.2 billion by 2030. The Cancer Biomarkers Market is dominated by key players such as, Agilent Technologies, Inc., Abbott Laboratories, Genomic Health, Inc., QIAGEN N.V., and Hologic, Inc.

Published: November, 2024
| Report ID: LI4392
| Life Sciences & Healthcare
Acute Ischemic Stroke Therapeutics Market By Type (Thrombolytics, Antiplatelet Agents, Anticoagulants, Neuroprotective Agents), By Route of Administration (Intravenous, Oral, Intra-arterial), By End-User (Hospitals, Specialty Clinics, Home Care Settings), and By Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Acute Ischemic Stroke Therapeutics Market is expected to grow from USD 8.6 billion in 2023 at a CAGR of 5.9% to touch USD 12.8 billion by 2030. The Acute Ischemic Stroke Therapeutics Market is dominated by key players such as, Amgen Inc., AbbVie Inc., Boehringer Ingelheim GmbH, Novo Nordisk A/S, and Eli Lilly and Company.

Published: November, 2024
| Report ID: LI4390
| Life Sciences & Healthcare
Antiseptic Bathing Products Market By Product (CHG Bath Towels and Wipes, CHG Solutions, Antiseptics Bathing Solutions, Antiseptics Wipes), By Application (Intensive Care Units, Surgical Wards, Medical Wards), and By Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Antiseptic Bathing Products Market is expected to grow from USD 19.5 billion in 2023 at a CAGR of 4.9% to touch USD 27.1 billion by 2030. The Antiseptic Bathing Products Market is dominated by key players such as, BD (Becton, Dickinson and Company), Ecolab, Medline Industries, LP, and Perrigo Company plc.

Published: November, 2024
| Report ID: LI4380
| Life Sciences & Healthcare
AI in Cardiology Market By Application (Cardiovascular Disease Diagnosis, Cardiovascular Imaging, Personalized Medicine, Clinical Decision Support Systems), By End-Use Industry (Healthcare Providers, Hospitals & Cardiology Clinics, Research Institutions, Medical Device Manufacturers), and By Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the AI in Cardiology Market is expected to grow from USD 1.7 billion in 2023 at a CAGR of 15.6% to touch USD 4.6 billion by 2030. The AI in Cardiology Market is dominated by key players such as, Google Health (Alphabet Inc.), IBM Corporation, Philips Healthcare, Cardiogram, and Medtronic plc.

Published: November, 2024
| Report ID: LI4365
| Life Sciences & Healthcare
Antimicrobial Resistance Diagnostics Market By Technology (Microbiology Culture, Immunoassay, PCR, NGS, Mass Spectrometry, Rapid & Point of Care), By Pathogen (Drug-resistant Streptococcus Pneumoniae (DRSP), Drug Resistant Campylobacter (DRC), Clostridium Difficile (CD), Methicillin Resistant Staphylococcus Aureus (MRSA), Drug Resistant Neisseria Gonorrhoeae (DRNG), Drug Resistant Salmonella (DRNTS)), By End Use (Hospitals, Diagnostic Laboratories, Pharmaceutical & Biotechnology Companies), and By Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Antimicrobial Resistance Diagnostics Market is expected to grow from USD 3.2 billion in 2023 at a CAGR of 10.3% to touch USD 6.3 billion by 2030. The Antimicrobial Resistance Diagnostics Market is dominated by key players such as, F. Hoffmann-La Roche Ltd., bioMerieux, BD, Molsid, and Accelerate Diagnostics, Inc..

Published: November, 2024
| Report ID: LI4362
| Life Sciences & Healthcare
Biological Sample Collection Kits Market By Product Type (Blood Collection Kits, Urine Collection Kits, Saliva Collection Kits, Tissue Collection Kits), By Sample Type (Blood Samples, Saliva Samples, Tissue Samples), By End-Use Industry (Hospitals, Diagnostic Laboratories, Pharmaceutical Companies), and By Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Biological Sample Collection Kits Market is expected to grow from USD 7.9 billion in 2023 at a CAGR of 7.6% to touch USD 13.1 billion by 2030. The Biological Sample Collection Kits Market is dominated by key players such as Becton, Dickinson and Company (BD), Merck KGaA, Qiagen N.V., Roche Diagnostics, Hologic, Inc., Cardinal Health, Inc., Medtronic plc, and Bio-Rad Laboratories, Inc.

Published: November, 2024
| Report ID: LI4360
| Life Sciences & Healthcare
Artificial Tendons and Ligaments Market By Application (Knee Injuries, Shoulder Injuries, Foot and Ankle Injuries), By End Use (Hospitals, Outpatient Facilities), and By Region; Global Insights & Forecast (2024 – 2030)

As per Intent Market Research, the Artificial Tendons and Ligaments Market was valued at USD 158.7 million in 2023 and will surpass USD 591.5 million by 2030; growing at a CAGR of 20.7% during 2024 - 2030.

Published: November, 2024
| Report ID: LI4357
| Life Sciences & Healthcare
Robotic Prosthetics Market By Product Type (Upper Limb Prosthetics, Lower Limb Prosthetics, Hybrid Prosthetics), By Technology (Body-Controlled, Myoelectric Control, Neural-Controlled), By End-User (Hospitals, Rehabilitation Centers, Home Care Settings), and By Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Robotic Prosthetics Market is expected to grow from USD 2.1 billion in 2023 at a CAGR of 8.8% to touch USD 3.8 billion by 2030. The Robotic Prosthetics Market is dominated by key players such as, Bionik Laboratories Corp., Amedica Corporation, EKSO Bionics Holdings, Inc., Rex Bionics, and InnoMotion GmbH.

Published: November, 2024
| Report ID: LI4352
| Life Sciences & Healthcare
Adeno Associated Virus Vector Manufacturing Market By Scale of Operations (Clinical, Preclinical, Commercial), By Method (In Vitro, In Vivo), By Therapeutic Area (Hematological Diseases, Infectious Diseases, Genetic Disorders, Neurological Disorders, Ophthalmic Disorders), By Application (Cell Therapy, Gene Therapy, Vaccine), and By Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Adeno Associated Virus Vector Manufacturing Market is expected to grow from USD 1.1 billion in 2023 at a CAGR of 18.3% to touch USD 3.6 billion by 2030. The Adeno Associated Virus Vector Manufacturing Market is dominated by key players such as, Wuxi AppTec, Lonza Group, Pharmaron, Regenxbio, and Oxford Biomedica.

Published: November, 2024
| Report ID: LI4351
| Life Sciences & Healthcare
Vital Signs Monitoring Market By Product Type (Blood Pressure Monitors, Pulse Oximeters, Temperature Monitoring Devices), By Technology (Digital Monitors, Analog Monitors, Wearable Technology), By Application (Hospitals, Home Care, Ambulatory Care, Emergency Care), and By Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Vital Signs Monitoring Market is expected to grow from USD 9.5 billion in 2023 at a CAGR of 5.5% to touch USD 13.8 billion by 2030. The Vital Signs Monitoring Market is dominated by key players such as, Cura Medical, Cardinal Health, Honeywell, Siemens Healthineers, and Medtronic.

Published: November, 2024
| Report ID: LI4350
| Life Sciences & Healthcare
ADME Toxicology Testing Market By Technology (Cell Culture Tech, High Throughput Tech, Molecular Imaging Tech, OMICS Technology), By Method Provider (Cellular Assay, Biochemical Assay, In-Silica, Ex-vivo), By Application (Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity), and By Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the ADME Toxicology Testing Market is expected to grow from USD 5.5 billion in 2023 at a CAGR of 8.7% to touch USD 9.8 billion by 2030. The ADME Toxicology Testing Market is dominated by key players such as, Charles River Laboratories, F. Hoffmann-La Roche Ltd, Yposkesi, Inc., Creative Biogene, and Pfizer Inc.

Published: November, 2024
| Report ID: LI4349
| Life Sciences & Healthcare
Osteoarthritis Therapeutics Market By Drug Class (Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Corticosteroids, Disease-Modifying Osteoarthritis Drugs (DMOADs), Analgesics, Biologics), By Route of Administration (Oral, Injectable, Topical), By End-User (Hospitals, Clinics, Home Healthcare), and By Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Osteoarthritis Therapeutics Market is expected to grow from USD 7.9 billion in 2023 at a CAGR of 6.9% to touch USD 12.6 billion by 2030. The Osteoarthritis Therapeutics Market is dominated by key players such as, Amgen Inc., AbbVie Inc., Eli Lilly and Company, Regeneron Pharmaceuticals, Inc., and Horizon Therapeutics plc

Published: November, 2024
| Report ID: LI4341
| Life Sciences & Healthcare
Sterility Indicators Market by Product Type (Biological Indicators, Chemical Indicators), Sterilization Process (Steam Sterilization, Ethylene Oxide, Dry Heat, Hydrogen Peroxide), Method Type (Self-Contained Indicators, Conventional Indicators), and End-Use (Hospitals, Pharmaceutical Companies, Medical Device Manufacturers, Research Laboratories, Food and Beverage) and By Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Sterility Indicators Market is expected to grow from USD 0.9 billion in 2023 at a CAGR of 11.2% to touch USD 2.0 billion by 2030. The Sterility Indicators Market is dominated by key players such as 3M Company, Becton, Dickinson and Company (BD), Thermo Fisher Scientific Inc., Merck KGaA, Cantel Medical Corp., Ecolab Inc., SteriPack, Biomérieux SA, and Halyard Health, Inc.

Published: November, 2024
| Report ID: LI4337
| Life Sciences & Healthcare
Continuous Bioprocessing Market by Product Type (Chromatography Systems and Consumables, Filtration Systems and Devices, Bioreactors, Cell Culture Media, Cell Lines, Buffers and Reagents), by Process Type (Upstream, Downstream), Application (Monoclonal Antibodies, Vaccines, Cell and Gene Therapy), by End-Use (Pharmaceutical & Biotechnology Companies, Contract Research Organizations & Contract Manufacturing Organizations, Academic & Research Institutes) and By Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Continuous Bioprocessing Market is expected to grow from USD 201.7 million in 2023 at a CAGR of 16.9% to touch USD 602.9 million by 2030. The Continuous Bioprocessing Market is dominated by key players such as 3M, Bionet, Corning Incorporated, Danaher, Fujifilm, Meissner, Merck and Repligen.

Published: November, 2024
| Report ID: LI4336
| Life Sciences & Healthcare
Biologics CDMO Market by Services (Development Services, Manufacturing Services, Packaging & Labeling Services, Quality Control and Assurance Services), Biologic Type (Monoclonal Antibodies, Recombinant Proteins, Vaccines, Cell and Gene Therapies, Blood and Blood Components), Operations (Preclinical, Clinical, Commercial), and End-User (Pharmaceutical Companies, Biotechnology Companies, Academic and Research Institutions, Contract Research Organizations) and By Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Biologics CDMO Market is expected to grow from USD 19.4 billion in 2023 at a CAGR of 18.9% to touch USD 65.2 billion by 2030. The Biologics CDMO Market is dominated by key players such as Lonza Group, Samsung Biologics, WuXi Biologics, Catalent, Inc., Fujifilm Diosynth Biotechnologies, Thermo Fisher Scientific (Patheon), AbbVie Contract Manufacturing, AGC Biologics, Rentschler Biopharma SE

Published: November, 2024
| Report ID: LI4330
| Life Sciences & Healthcare
AI in Life Science Analytics Market By Component (Software, Services), By Application (Clinical Trials and Research, Drug Discovery and Development, Patient Care and Management, Epidemiology and Disease Surveillance, Market Access and Commercialization), By End-User (Pharmaceutical Companies, Biotechnology Companies, Healthcare Providers, Research Organizations), and By Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the AI in Life Science Analytics Market is expected to grow from USD 2.8 billion in 2023 at a CAGR of 12.3% to touch USD 6.3 billion by 2030. The AI in Life Science Analytics Market is dominated by key players such as, BioSymetrics, Alphabet Inc., Deep Genomics, Roche, and IBM.

Published: November, 2024
| Report ID: LI4325
| Life Sciences & Healthcare
Acinetobacter Pneumonia Therapeutics Market By Drug Type (Antibiotics, Combination Therapies, Monoclonal Antibodies), By Route of Administration (Intravenous (IV), Oral), By Distribution Channel (Hospitals, Pharmacies), and By Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Acinetobacter Pneumonia Therapeutics Market is expected to grow from USD 421.6 million in 2023 at a CAGR of 7.8% to touch USD 715.3 million by 2030. The Acinetobacter Pneumonia Therapeutics Market is dominated by key players such as, AstraZeneca, AbbVie Inc., GlaxoSmithKline plc, Eli Lilly and Company, and Novartis International AG.

Published: November, 2024
| Report ID: LI4320
| Life Sciences & Healthcare
Absorbable Nasal Implant Devices Market By Product Type (Septal Implants, Turbinate Implants), By Material Type (Polycaprolactone, Polylactic Acid), By End-User (Hospitals, Outpatient Surgical Centers, Specialty Clinics), and By Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Absorbable Nasal Implant Devices Market is expected to grow from USD 417.4 million in 2023 at a CAGR of 11.8% to touch USD 912.4 million by 2030. The Absorbable Nasal Implant Devices Market is dominated by key players such as, Acelity L.P. Inc., Acclarent, Inc., EpiBone, Entellus Medical, Inc. (part of Stryker), and Genzyme Corporation (part of Sanofi).

Published: November, 2024
| Report ID: LI4317
| Life Sciences & Healthcare
Ablation Technology Market By Product Type (Energy-based Ablation Devices:, Ultrasound Ablation Devices, Electroporation Ablation Devices, Accessories and Consumables), By Application (Cardiovascular Applications, Oncology Applications, Gastroenterology Applications, Pulmonology Applications, Orthopedic Applications), By End-User (Hospitals, Ambulatory Surgical Centers (ASCs), Specialty Clinics), and By Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Ablation Technology Market is expected to grow from USD 7.3 billion in 2023 at a CAGR of 8.8% to touch USD 13.2 billion by 2030. The Ablation Technology Market is dominated by key players such as, AngioDynamics, Abbott Laboratories, Boston Scientific, Olympus Corporation, and Halyard Health.

Published: November, 2024
| Report ID: LI4316
| Life Sciences & Healthcare
3D Ultrasound Market By Product Type (3D Ultrasound Systems, Software Solutions, Accessories), By Application (Obstetrics and Gynecology, Cardiology, Musculoskeletal Imaging, Abdominal Imaging), By End-User (Hospitals, Diagnostic Imaging Centers, Research Institutions), and By Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the 3D Ultrasound Market is expected to grow from USD 2.8 billion in 2023 at a CAGR of 7.9% to touch USD 4.7 billion by 2030. The 3D Ultrasound Market is dominated by key players such as, Bracco Imaging S.p.A., Alpinion Medical Systems Co., Ltd., EchoNous, Inc., Philips Healthcare, and Fujifilm Holdings Corporation.

Published: November, 2024
| Report ID: LI4314
| Life Sciences & Healthcare
Spinal Implants and Devices Market By Product Type (Spinal Fusion Devices, Motion Preservation Devices, Vertebral Compression Fracture Devices, Spinal Bone Stimulators), By Surgery Type (Open Spine Surgery, Minimally Invasive Spine Surgery), By End-User (Hospitals, Ambulatory Surgical Centers, Specialty Clinics), and By Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Spinal Implants and Devices Market is expected to grow from USD 12.2 billion in 2023 at a CAGR of 6.3% to touch USD 18.6 billion by 2030. The Spinal Implants and Devices Market is dominated by key players such as, Alphatec Holdings, Inc., Aesculap Implant Systems, LLC, Globus Medical, Inc., SeaSpine Holdings Corporation, and K2M Group Holdings, Inc.

Published: November, 2024
| Report ID: LI4312
| Life Sciences & Healthcare
Acute Invasive Aspergillosis Treatment Market By Drug Class (Azoles, Amphotericin B, Echinocandins), By Route of Administration (Oral, Intravenous), By End-User (Hospitals, Specialty Clinics, Homecare), and By Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Acute Invasive Aspergillosis Treatment Market is expected to grow from USD 2.1 billion in 2023 at a CAGR of 5.7% to touch USD 3.1 billion by 2030. The Acute Invasive Aspergillosis Treatment Market is dominated by key players such as, Astellas Pharma Inc., Amphastar Pharmaceuticals, Inc., Cipla Inc., Novartis AG, and F. Hoffmann-La Roche Ltd.

Published: November, 2024
| Report ID: LI4308
| Life Sciences & Healthcare
Acetazolamide Market By Product Type (Tablets, Capsules, Injectable), By Application (Glaucoma, Epilepsy, Edema, Acute Mountain Sickness), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and By Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Acetazolamide Market is expected to grow from USD 346.2 million in 2023 at a CAGR of 6.5% to touch USD 539.3 million by 2030. The Acetazolamide Market is dominated by key players such as, Alvogen, Inc., Alembic Pharmaceuticals Ltd., Cipla Ltd., Sun Pharmaceutical Industries Ltd., and Hikma Pharmaceuticals PLC.

Published: November, 2024
| Report ID: LI4307
| Life Sciences & Healthcare
Radiofrequency Ablation Device Market By Product Type (Systems, Disposables, Consumables), By Application (Oncology, Cardiology, Pain Management, Dermatology), By End-User (Hospitals, Ambulatory Surgical Centers, Specialty Clinics), and By Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Radiofrequency Ablation Device Market is expected to grow from USD 4.3 billion in 2023 at a CAGR of 9.0% to touch USD 7.9 billion by 2030. The Radiofrequency Ablation Device Market is dominated by key players such as, Boston Scientific Corporation, Medtronic PLC, AngioDynamics, Inc., Smith & Nephew PLC, and Merit Medical Systems, Inc.

Published: November, 2024
| Report ID: LI4306
| Life Sciences & Healthcare
Active Implantable Medical Devices Market By Device Type (Implantable Cardioverter Defibrillators (ICDs), Pacemakers, Cochlear Implants, Neurostimulators, Implantable Infusion Pumps, Ventricular Assist Devices (VADs)), By Application (Cardiology, Neurology, Hearing Impairment, Pain Management, Diabetes Management), By End-User (Hospitals, Ambulatory Surgical Centers, Specialty Clinics, Home Care Settings), and By Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Active Implantable Medical Devices Market is expected to grow from USD 21.6 billion in 2023 at a CAGR of 6.8% to touch USD 34.3 billion by 2030. The Active Implantable Medical Devices Market is dominated by key players such as, Biotronik SE & Co. KG, Abbott Laboratories, LivaNova PLC, William Demant Holding A/S, and Medtronic plc.

Published: November, 2024
| Report ID: LI4291
| Life Sciences & Healthcare
Abdominal Pads Market By Type (Sterile, Non-Sterile, Super Absorbent), By Application (Surgical Wounds, Trauma Cases, Burn Wounds, Chronic Wounds), By End-User (Hospitals, Clinics, Ambulatory Surgical Centers, Home Care Settings), and By Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Abdominal Pads Market is expected to grow from USD 674.2 million in 2023 at a CAGR of 8.9% to touch USD 1,227.4 million by 2030. The Abdominal Pads Market is dominated by key players such as, B. Braun Melsungen AG, 3M Company, Derma Sciences, Inc., Coloplast Corporation, and Johnson & Johnson.

Published: November, 2024
| Report ID: LI4274
| Life Sciences & Healthcare
3D Printed Wearable Market By Product Type (3D Printed Footwear, 3D Printed Glasses, 3D Printed Watches, 3D Printed Jewelry), By Material Type (Polymers, Metals, Ceramics, Composites), By End-User (Healthcare, Consumer Electronics, Fashion & Jewelry, Sports & Fitness), and By Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the 3D Printed Wearable Market is expected to grow from USD 3.4 billion in 2023 at a CAGR of 9.6% to touch USD 6.4 billion by 2030. The 3D Printed Wearable Market is dominated by key players such as, Adidas AG, 3D Systems Corporation, EOS GmbH, Shapeways, Inc., and Hewlett-Packard (HP) Inc..

Published: November, 2024
| Report ID: LI4273
| Life Sciences & Healthcare
3D Printed Prosthetics Market By Type (Arm Prosthetics, Leg Prosthetics, Hand Prosthetics, Finger Prosthetics), By Technology (Fused Deposition Modeling (FDM), Stereolithography (SLA), Selective Laser Sintering (SLS), Electron Beam Melting (EBM)), By End-User (Hospitals, Clinics, Prosthetics Centers, Home Care Settings), and By Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the 3D Printed Prosthetics Market is expected to grow from USD 1.3 billion in 2023 at a CAGR of 15.1% to touch USD 3.5 billion by 2030. The 3D Printed Prosthetics Market is dominated by key players such as, BioDigital Prosthetics, 3D Systems Corporation, Enabling the Future, ProsFit Technologies, and Limbitless Solutions, Inc.

Published: November, 2024
| Report ID: LI4272
| Life Sciences & Healthcare
Cell and Gene Therapy Bioanalytical Testing Services Market By Type (Analytical Testing, Bioassay Development [Cell-Based Assays, In Vivo Assays], Release Testing), By Service Provider (Contract Research Organizations, Academic Research Institutions, Pharmaceutical Companies), By End-User (Biotechnology Companies, Research Institutions, Pharmaceutical Companies); and By Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Outsourced Semiconductor Assembly and Test Services Market is expected to grow from USD 35.7 billion in 2023 at a CAGR of 6.5% to touch USD 55.6 billion by 2030. The Outsourced Semiconductor Assembly and Test Services (OSAT) Market is dominated by key players such as Amkor Technology, ASE Technology Holding, ChipMOS Technologies Inc., HANA Mircon Corporation Business, Shenzhen CPET Electronics Co., Ltd., and UTAC Holdings Ltd.

Published: November, 2024
| Report ID: LI4271
| Life Sciences & Healthcare
Healthcare Workforce Management System Market By Component (Software [Time & Attendance Management, Staff Scheduling, Payroll Management, Analytics & Reporting], Services [Implementation & Integration, Support & Maintenance, Consulting Services]), By Deployment Mode (On-Premise, Cloud-Based [Public Cloud, Private Cloud, Hybrid Cloud]), By End-User (Hospitals & Clinics, Long-Term Care Facilities, Ambulatory Surgical Centers), By Functionality (Workforce Scheduling, Time & Attendance Management, Payroll & Benefits Administration, Talent Acquisition, Performance Management) and By Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Healthcare Workforce Management System Market is expected to grow from USD 1.5 billion in 2023 at a CAGR of 9.0% to touch USD 2.8 billion by 2030. The Healthcare Workforce Management System Market is dominated by key players such as Kronos Incorporated, Infor, Inc., Oracle Corporation, ADP, LLC, SAP SE, IBM Corporation, McKesson Corporation, Cerner Corporation, and GE Healthcare.

Published: November, 2024
| Report ID: LI4265
| Life Sciences & Healthcare
Brucellosis Vaccines Market By Type (Live Attenuated Vaccines, Inactivated Vaccines, Subunit Vaccines), By Target Animal (Cattle, Sheep, Goats), By Distribution Channel (Veterinary Clinics, Online), and By Region; Global Insights & Forecast (2024 - 2030)

According to Intent Market Research, the Brucellosis Vaccines Market is expected to grow from USD 226.6 million in 2023 at a CAGR of 4.2% to touch USD 303.1 million by 2030. The Brucellosis Vaccines Market is dominated by key players such as Merck Animal Health, Zoetis Inc., Elanco Animal Health, Bayer AG, Vetoquinol S.A., Ceva Santé Animale, HIPRA, S.A., Biogenesis Bago S.A, Novartis Animal Health and Indian Immunologicals Ltd.

Published: November, 2024
| Report ID: LI4264
| Life Sciences & Healthcare
Electron Microscopy Market By Type (Transmission Electron Microscopes (TEM), Scanning Electron Microscopes (SEM), Scanning Transmission Electron Microscopes (STEM)), By Application (Material Sciences, Life Sciences, Nanotechnology, Semiconductors & Electronics, Forensics), By End-User (Academic & Research Institutions, Pharmaceutical & Biotechnology Companies, Industrial & Manufacturing, Government Organizations), and By Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Electron Microscopy Market is expected to grow from USD 3.4 billion in 2023 at a CAGR of 8.1% to touch USD 5.9 billion by 2030. The Electron Microscopy Market is dominated by key players such as, Bruker Corporation, Advantest Corporation, Hitachi High-Tech Corporation, Olympus Corporation, and JEOL Ltd.

Published: November, 2024
| Report ID: LI4257
| Life Sciences & Healthcare
Direct-To-Consumer Laboratory Testing Market By Type (Genetic Testing, Infectious Disease Testing, Cholesterol Testing, Diabetes Testing, Thyroid Testing), By Sample Type (Blood, Urine, Saliva), By End-User (Individuals, Healthcare Providers, Employers, Insurance Companies), and By Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Direct-To-Consumer Laboratory Testing Market is expected to grow from USD 3.8 billion in 2023 at a CAGR of 17.3% to touch USD 11.6 billion by 2030. The Direct-To-Consumer Laboratory Testing Market is dominated by key players such as, CircleDNA, 23andMe, Everlywell, Orig3n, and Home Access Health Corporation.

Published: November, 2024
| Report ID: LI4256
| Life Sciences & Healthcare
Intrauterine Devices Market by Product Type (Hormonal IUDs, Non-Hormonal (Copper) IUDs), by Age Group (20 to 24 Years, 25 to 34 Years, 35 to 44 Years, Above 44 Years), by End Use (Hospitals, Gynecology Clinics, Community Healthcare Centers), and by Region; Global Insights & Forecast (2024 - 2030)

According to Intent Market Research, the Intrauterine Devices Market is expected to grow from USD 3.9 billion in 2023 at a CAGR of 9.0% to touch USD 7.1 billion by 2030. The Intrauterine Devices Market is dominated by key players such as Bayer, CooperSurgical, AbbVie Inc. (Allergan Plc), Pregna International Limited, DKT International, Medisafe Distribution, HLL Lifecare Limited, and Eurosurgical Ltd.

Published: October, 2024
| Report ID: LI4228
| Life Sciences & Healthcare
Ambulance Stretchers Market Size, Share & Trends Analysis Report By Product (Emergency, Transport), By Technology (Manual, Electric Powered, Pneumatic), By Equipment, By Region, And Segment Forecast (2024 – 2030)

This report on the global ambulance stretchers market provides a comprehensive analysis of the market's dynamics, including product types, technologies, equipment applications, and regional market assessments.

Published: October, 2024
| Report ID: LI4226
| Life Sciences & Healthcare
Accountable Care Solutions Market By Component (Solution, Services), By Delivery Mode (Web-Based & Cloud-Based, On-Premise), By End-User (Healthcare Providers, Healthcare Payers), and By Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Accountable Care Solutions Market is expected to grow from USD 21.3 billion in 2023 at a CAGR of 8.2% to touch USD 37.1 billion by 2030. The Accountable Care Solutions Market is dominated by key players such as, Athenahealth, Allscripts, Cerner Corporation, McKesson, and Epic Systems.

Published: October, 2024
| Report ID: LI4204
| Life Sciences & Healthcare
Medical Health Screening Market By Test Type (Routine Tests, Non-Routine Tests, Cancer Screening Tests, Specialty Tests) By Screening Method (Blood Tests, Imaging Tests, Biopsy) By End-User (Hospitals & Clinics, Diagnostic Laboratories) and By Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Medical Health Screening Market is expected to grow from USD 12.0 billion in 2023 at a CAGR of 7.2% to touch USD 19.6 billion by 2030. The Medical Health Screening Market is dominated by key players such as Abbott, Eurofins Scientific, F. Hoffmann-La Roche Ltd, GE Healthcare, Laboratory Corporation of America Holdings and Lifelabs.

Published: October, 2024
| Report ID: LI4201
| Life Sciences & Healthcare
Biometrics as a Service in Healthcare Market By Type of Biometric (Fingerprint Recognition, Facial Recognition, Iris Recognition, Voice Recognition, Palm Recognition) By Deployment Mode (Cloud-Based, On-Premises) By Application (Patient Identification and Verification, Access Control, Data Security and Privacy, Telehealth Services, Health Information Exchange, Fraud Prevention) By End-User (Hospitals, Clinics, Laboratories, Health Insurance Providers, Pharmacies) and By Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Biometrics as a Service in Healthcare Market is expected to grow from USD 0.6 billion in 2023 at a CAGR of 17.9% to touch USD 1.9 billion by 2030. The Biometrics as a Service in Healthcare Market is dominated by key players such as Bio-Key International, Crossmatch Technologies (HID Global), Fingerprint Cards AB, Gemalto (Thales Group), IBM, IDEMIA and M2SYS Technology.

Published: October, 2024
| Report ID: LI4199
| Life Sciences & Healthcare
Achondroplasia Treatment Market By Treatment Type (Pharmaceuticals, Surgical Interventions, Gene Therapy), By Route of Administration (Oral, Injectable, Topical), By Age Group (Pediatric Patients, Adult Patients), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By End-User (Hospitals, Specialty Clinics, Research Institutions) and By Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Achondroplasia Treatment Market is expected to grow from USD 0.03 million in 2023 at a CAGR of 59.8% to touch USD 0.8 million by 2030. The Achondroplasia Treatment Market is dominated by key players such as BioMarin Pharmaceutical, Eli Lilly and Company, Genetics Pharmaceuticals, Pfizer Inc., Novartis AG and Swedish Orphan Biovitrum.

Published: October, 2024
| Report ID: LI4195
| Life Sciences & Healthcare
3D Bioprinting Market By Technology (Inkjet Bioprinting, Extrusion Bioprinting, Laser-Assisted Bioprinting, Stereolithography) By Material (Bioinks, Biomaterials) By Application (Tissue Engineering, Organ Printing, Drug Development and Testing, Regenerative Medicine, Cosmetic Testing) By End-User (Academic Research Institutions, Pharmaceutical Companies, Biotechnology Companies, Healthcare Organizations) and By Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the 3D Bioprinting Market is expected to grow from USD 1.4 billion in 2023 at a CAGR of 12.0% to touch USD 3.1 billion by 2030. The 3D Bioprinting Market is dominated by key players such as Organovo Holdings, Inc., 3D Systems Corporation, Aspect Biosystems Ltd., Allevi, Inc., EnvisionTEC (Now part of Desktop Metal), Allevi, Inc. and Cellink AB.

Published: October, 2024
| Report ID: LI4193
| Life Sciences & Healthcare
Radiopharmaceuticals Market By Type (Diagnostic Radiopharmaceuticals, Therapeutic Radiopharmaceuticals), By Radioisotope (Technetium-99m, Iodine-131, Lutetium-177, Gallium-68, Yttrium-90, Fluorine-18), By Application (Oncology, Cardiology, Neurology), By End-User (Hospitals, Diagnostic Centers, Research Institutes), and By Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Radiopharmaceuticals Market is expected to grow from USD 6.1 billion in 2023 at a CAGR of 7.6% to touch USD 10.2 billion by 2030. The Radiopharmaceuticals Market is dominated by key players such as, Eckert & Ziegler, Bayer, GE Healthcare, Siemens, and Lantheus.

Published: October, 2024
| Report ID: LI4191
| Life Sciences & Healthcare
Radiology Services Market By Service Type (Diagnostic Imaging Services, Interventional Radiology Services, Radiation Oncology), By Modality (Digital Radiology, Analog Radiology), By Application (Cardiovascular Imaging, Neurology Imaging, Oncology Imaging, Abdominal Imaging, Musculoskeletal Imaging), By Organization (Hospitals, Diagnostic Centers, Ambulatory Surgical Centers, Clinics), and By Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Radiology Services Market is expected to grow from USD 18.4 billion in 2023 at a CAGR of 6.6% to touch USD 28.7 billion by 2030. The Radiology Services Market is dominated by key players such as, Alliance HealthCare, Agfa HealthCare, Healthscope, Teleradiology Solutions, and Nuffield Health.

Published: October, 2024
| Report ID: LI4184
| Life Sciences & Healthcare
DNA Repair Drugs Market By Drug Type (PARP Inhibitors, ATM Kinase Inhibitors, ATR Inhibitors, DNA-PK Inhibitors, BER Inhibitors, NER Inhibitors), By Application (Oncology, Genetic Disorders, Neurological Disorders), By End-User (Hospitals, Clinics) and By Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the DNA Repair Drugs Market is expected to grow from USD 7.9 billion in 2023 at a CAGR of 14.4% to touch USD 20.2 billion by 2030. The DNA Repair Drugs Market is dominated by key players such as Amgen Inc., AstraZeneca, Bristol-Myers Squibb Company, Eli Lilly and Company, Gilead Sciences, Inc. and Merck KGaA.

Published: October, 2024
| Report ID: LI4179
| Life Sciences & Healthcare
DNA Diagnostics Market By Product Type (Reagents & Kits, Instruments, Software), By Technology (Polymerase Chain Reaction (PCR), Next-Generation Sequencing (NGS), In Situ Hybridization, Microarray), By Application (Infectious Disease Diagnostics, Genetic Testing, Oncology, Blood Screening, Prenatal Testing), By End-User (Hospitals & Clinics, Diagnostic Laboratories, Academic & Research Institutions, Pharmaceutical Companies), and By Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the DNA Diagnostics Market is expected to grow from USD 15.2 billion in 2023 at a CAGR of 8.4% to touch USD 26.7 billion by 2030. The DNA Diagnostics Market is dominated by key players such as, Agilent Technologies, Abbott, Illumina, Roche, and Thermo Fisher Scientific.

Published: October, 2024
| Report ID: LI4178
| Life Sciences & Healthcare
Critical Limb Ischemia Treatment Market By Treatment Type (Procedures {Endovascular Procedures, Surgical Procedures}, Medications {Antiplatelet Drugs, Anticoagulants, Cholesterol-Lowering Drugs, Pain Relievers}), By End-Use (Hospitals, Ambulatory Surgical Centers) and By Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Critical Limb Ischemia Treatment Market is expected to grow from USD 3.1 billion in 2023 at a CAGR of 9.9% to touch USD 6.0 billion by 2030. The Critical Limb Ischemia Treatment Market is dominated by key players such as Abbott, AngioDynamics, B. Braun Medical Ltd, Boston Scientific Corporation and Cook Medical

Published: October, 2024
| Report ID: LI4170
| Life Sciences & Healthcare
Coronary Artery Bypass Graft Market By Type (Traditional Coronary Artery Bypass Graft, Off-Pump Coronary Artery Bypass Graft, Minimally Invasive Direct Coronary Artery Bypass (MIDCAB), Endoscopic Vessel Harvesting (EVH)), By Procedure (Single Bypass Surgery, Double Bypass Surgery, Triple Bypass Surgery, Quadruple Bypass Surgery), By Material (Saphenous Vein Grafts, Internal Thoracic Artery Grafts, Radial Artery Grafts), By End-User (Hospitals, Ambulatory Surgical Centers, Cardiac Centers, Research & Academic Institutions), and By Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Coronary Artery Bypass Graft Market is expected to grow from USD 14.5 billion in 2023 at a CAGR of 8.2% to touch USD 25.3 billion by 2030. The Coronary Artery Bypass Graft Market is dominated by key players such as, Artivion, Abbott, Edwards Lifesciences, Teleflex, and Johnson & Johnson.

Published: October, 2024
| Report ID: LI4167
| Life Sciences & Healthcare
Bispecific Antibodies Market By Type (Full-Length Bispecific Antibodies, Bi-Functional Antibodies, Fragment-Based Bispecific Antibodies), By Application (Oncology, Autoimmune Diseases, Infectious Diseases, Ophthalmic Diseases), By End-User (Hospitals, Research Institutes, Pharmaceutical & Biotechnology Companies, Diagnostic Laboratories), and By Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Bispecific Antibodies Market is expected to grow from USD 3.3 billion in 2023 at a CAGR of 15.6% to touch USD 9.0 billion by 2030. The Bispecific Antibodies Market is dominated by key players such as, AstraZeneca, Amgen, Chugai Pharmaceutical, Novartis, and Genentech

Published: October, 2024
| Report ID: LI4158
| Life Sciences & Healthcare
AI in Clinical Trials Market By Offering (Software, Services), By Phase (Phase I, Phase II, Phase III), By Technology (Machine Learning, Natural Language Processing), By Application (Patient Recruitment & Retention, Data Management & Analysis, Monitoring & Compliance), By Therapeutic Area (Oncology, Neurological Diseases & Conditions, Cardiovascular Diseases), By End User (Pharmaceutical & Biotechnology Companies, Contract Research Organizations) and By Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the AI in Clinical Trials Market is expected to grow from USD 1.8 billion in 2023 at a CAGR of 23.0% to touch USD 7.6 billion by 2030. The AI in Clinical Trials Market is dominated by key players such as Ardigen, BioSymetrics, Euretos, Exscientia, IBM Corporation and Insilico Medicine.

Published: October, 2024
| Report ID: LI4141
| Life Sciences & Healthcare
CAR T-Cell Therapy Market By Product (Abecma, Breyanzi, Carvykti, Yescarta, Tecartus, Kymriah), By Target (CD19, BCMA), By Indication (Multiple Myeloma, B-Cell Lymphoma, Acute Lymphoblastic Leukemia), By Demographic (Adult, Pediatric), and By End User (Hospitals, Long Term Care Facilities, Specialty Centres) and By Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the CAR T-Cell Therapy Market is expected to grow from USD 4.4 billion in 2023 at a CAGR of 32.5% to touch USD 31.2 billion by 2030. The CAR T-Cell Therapy Market is dominated by key players such as Autolus Therapeutics, Bristol-Myers Squibb Company, CARsgen Therapeutics Holdings Limited, CRISPR Therapeutics, Gilead Sciences and IASO Biotherapeutics.

Published: October, 2024
| Report ID: LI4122
| Life Sciences & Healthcare
Mice Model Market By Model Type & Service (Model Type, Service), By Therapeutic Area (Oncology, Metabolic Diseases, Immunology, Neurology, Cardiovascular Diseases), By Technology (CRISPR / CAS9, Microinjection, Embryonic Stem Cell Injection, Nuclear Transfer), By Application (Drug Discovery & Development, Research Application, Personalized Medicine), By End User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, CROs & CDMOs) and By Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Mice Model Market is expected to grow from USD 1.4 billion in 2023 at a CAGR of 8.8% to touch USD 2.6 billion by 2030. The Mice Model Market is dominated by key players such as Biocytogen, Charles River Laboratories, Cyagen, GemPharmatech, Harbour BioMed, Inotiv and Ozgene Pty Ltd.

Published: October, 2024
| Report ID: LI4119
| Life Sciences & Healthcare
Pressure Monitoring Market By Component (Monitors, Sensors, Transducers, Accessories), By Application (Blood Pressure Monitoring, Intracranial Pressure Monitoring, Intraocular Pressure Monitoring, Respiratory Pressure Monitoring, Cardiac Pressure Monitoring), By Procedure (Non-Invasive, Invasive), By End-User (Hospitals, Clinics, Home Healthcare, Veterinary Clinics), By Distribution Channel (Direct Sales, Online Sales, Retail Pharmacies), and By Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Pressure Monitoring Market is expected to grow from USD 13.4 billion in 2023 at a CAGR of 6.3% to touch USD 20.6 billion by 2030. The Pressure Monitoring Market is dominated by key players such as, GE Healthcare, A&D Company, Medtronic, Siemens, and Omron.

Published: October, 2024
| Report ID: LI4117
| Life Sciences & Healthcare
Rabies Vaccine Market By Vaccine Type (Inactivated Vaccines, Recombinant Vaccines), By Application (Humans, Animals), By End-User (Hospitals & Clinics, Veterinary Clinics), and By Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Rabies Vaccine Market is expected to grow from USD 1.6 billion in 2023 at a CAGR of 5.7% to touch USD 2.3 billion by 2030. The Rabies Vaccine Market is dominated by key players such as, Boehringer Ingelheim, Merck Animal Health, Elanco, Zoetis, and Serum Institute of India.

Published: October, 2024
| Report ID: LI4099
| Life Sciences & Healthcare
Remote Health Monitoring Market By Component (Devices, Software, Services), By Type (Wearable Devices, Implantable Devices, Standalone Monitoring Devices), By Application (Chronic Disease Monitoring, Post-Acute Care Monitoring, Fitness Monitoring, Geriatric Care), By End User (Hospitals & Clinics, Home Care Settings, Ambulatory Care Centers), and By Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Remote Health Monitoring Market is expected to grow from USD 83.8 billion in 2023 at a CAGR of 10.6% to touch USD 169.3 billion by 2030. The Remote Health Monitoring Market is dominated by key players such as, Medtronic, Abbott, GE Healthcare, ResMed, and iHealth Labs.

Published: October, 2024
| Report ID: LI4088
| Life Sciences & Healthcare
Patient Engagement Solutions Market By Component (Hardware, Software, Services), By Delivery Mode (On-Premise, Cloud-Based), By End User (Providers, Payers, Patients), and By Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Patient Engagement Solutions Market is expected to grow from USD 25.8 billion in 2023 at a CAGR of 11.8% to touch USD 56.4 billion by 2030. The Patient Engagement Solutions Market is dominated by key players such as, McKesson, Allscripts, eClinicalWorks, Oracle, and IBM.

Published: October, 2024
| Report ID: LI4081
| Life Sciences & Healthcare
Clinical Communication and Collaboration Market By Platform (Collaboration Platforms, Messaging Platforms, Voice Communication Platforms), By Component (Hardware, Software, Services), By Deployment (On-Premise Model, Cloud-Based Model), By Application (Lab & Radiology Communication, Nurse Communication, Patient Communication & Emergency Alerts, Physician Communication), and By End User (Hospitals & Clinics, Ambulatory Surgical Centers, Long-Term Care Facilities, Nursing Centers) and By Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Clinical Communication and Collaboration Market is expected to grow from USD 2.5 billion in 2023 at a CAGR of 11.1% to touch USD 5.1 billion by 2030. The Clinical Communication and Collaboration Market is dominated by key players such as Ascom, Avaya LLC, Baxter International, Cisco Systems, Everbridge and Hidden Brains InfoTech.

Published: October, 2024
| Report ID: LI4078
| Life Sciences & Healthcare
Medical Gas Equipment Market By Type (Medical Gases {Pure Medical Gases, Medical Gas Mixtures}, Medical Gas Equipment {Equipment Accessories, Gas Delivery Systems, Cryogenic Products}), By Application (Therapeutic Applications, Pharmaceutical Manufacturing & Research, Diagnostic Applications), By End User (Hospitals & Clinics, Home Healthcare, Pharmaceutical & Biotechnology Companies, Academic & Research Institutions) and By Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Medical Gas Equipment Market is expected to grow from USD 19.0 billion in 2023 at a CAGR of 5.7% to touch USD 28.0 billion by 2030. The Medical Gas Equipment Market is dominated by key players such as GCE Group, Genstar Technologies, Linde Plc, Messer SE & Co. KGaA, Norco, Rotarex and SOL Spa.

Published: October, 2024
| Report ID: LI4077
| Life Sciences & Healthcare
Dermocosmetics Market By Product Type (Cleansers, Moisturizers, Serums, Exfoliants, Masks & Treatments), By Application (Hair & Scalp Care, Anti-Aging, Acne-Prone Skin, Hydration, Skin Brightening & Hyperpigmentation, Sun Protection), By Distribution Channel (Supermarkets & Hypermarkets, Pharmacy & Drug Stores, Online), and By Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Dermocosmetics Market is expected to grow from USD 41.3 billion in 2023 at a CAGR of 10.7% to touch USD 84.4 billion by 2030. The Dermocosmetics Market is dominated by key players such as, Bioderma Laboratories, Beiersdorf, Johnson & Johnson, Procter & Gamble, and L'Oréal.

Published: October, 2024
| Report ID: LI4067
| Life Sciences & Healthcare
Atrial Fibrillation Drugs Market By Drug Class (Anticoagulants, Antiarrhythmic Drugs), By Route of Administration (Oral, Injectable, Intravenous), By Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies) and By Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Atrial Fibrillation Drugs Market is expected to grow from USD 16.0 billion in 2023 at a CAGR of 4.6% to touch USD 21.9 billion by 2030.

Published: October, 2024
| Report ID: LI4063
| Life Sciences & Healthcare
Anesthesia Information Management Systems Market By Component (Software, Hardware), By Application (Intraoperative Mode, Preoperative Mode), By End-User (Clinics & Hospitals, Ambulatory Surgery Centers) and By Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Anesthesia Information Management Systems Market is expected to grow from USD 850.2 million in 2023 at a CAGR of 7.6% to touch USD 1,421.2 million by 2030. The Anesthesia Information Management Systems Market is dominated by key players such as Cerner Corporation, DOCUSYS AE, Drägerwerk AG & Co. KGaA, Fukuda Denshi Co., Ltd., GE Healthcare and iMDsoft.

Published: October, 2024
| Report ID: LI4062
| Life Sciences & Healthcare
Anesthesia Devices Market By Component (Inhalational Delivery Systems, IV Delivery Systems, Monitoring Equipment, Breathing Apparatus), By Type (General Anesthesia, Regional Anesthesia, Local Anesthesia), By Application (Orthopedics, Neurology, Respiratory Care, Urology, Cardiology), By End User (Hospitals, Ambulatory Surgical Centers), and By Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Anesthesia Devices Market is expected to grow from USD 9.4 billion in 2023 at a CAGR of 7.6% to touch USD 15.7 billion by 2030. The Anesthesia Devices Market is dominated by key players such as, Drägerwerk, Medtronic, Fisher & Paykel, Stryker, and Hill-Rom.

Published: October, 2024
| Report ID: LI4061
| Life Sciences & Healthcare
Aesthetic Lasers Market By Type (Standalone Laser Devices, {Carbon Dioxide Lasers, Erbium YAG Lasers, Diode Lasers, Pulsed Dye Lasers}, Multiplatform Laser Devices), By Application (Vascular Lesions, Acne, & Scars, Pigmented Lesions & Tattoos, Hair Removal, Skin Rejuvenation), By End User (Hospitals & Clinics, Spas & Beauty Centers) and By Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Aesthetic Lasers Market is expected to grow from USD 1.2 billion in 2023 at a CAGR of 9.9% to touch USD 2.3 billion by 2030. The Aesthetic Lasers Market is dominated by key players such as Alma Lasers, Candela Corporation, Cutera, Inc., Cynosure and El.En. SpA.

Published: October, 2024
| Report ID: LI4056
| Life Sciences & Healthcare
3D Printed Surgical Models Market By Surgical Models (Cardiac Surgery, Gastroenterology, Neurosurgery, Orthopedic Surgery, Reconstructive Surgery), By Material (Plastics, Metals, Ceramics), By Technology (Fused Deposition Modeling, Stereolithography, Selective Laser Sintering, PolyJet Printing, Digital Light Processing), By End-User (Hospitals, Ambulatory Surgical Centers) and By Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the 3D Printed Surgical Models Market is expected to grow from USD 335.1 million in 2023 at a CAGR of 16.2% to touch USD 956.3 million by 2030. The 3D Printed Surgical Models Market is dominated by key players such as 3D Printlife, 3D Systems, Inc., Axial3D, Desktop Metal, Inc., Formlabs and Materialize.

Published: October, 2024
| Report ID: LI4047
| Life Sciences & Healthcare
Cannabis Testing Market By Product & Software (Analytical Instruments, Consumables, Cannabis Testing Software), By Service (Potency Testing, Terpene Profiling, Residual Solvent Analysis, Microbial Analysis, Pesticide Screening, Heavy Metal Testing), By End-Use (Cannabis Cultivators / Growers, Cannabis Drug Manufacturers) and By Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Cannabis Testing Market is expected to grow from USD 2.0 billion in 2023 at a CAGR of 12.1% to touch USD 4.4 billion by 2030. The Cannabis Testing Market is dominated by key players such as Agilent Technologies, Danaher Corporation, Merck, PerkinElmer, Restek Corporation and SC Labs.

Published: October, 2024
| Report ID: LI4044
| Life Sciences & Healthcare
Antihypertensive Drugs Market By Drug Class (Diuretics, ACE Inhibitors, Angiotensin II Receptor Blockers (ARBs), Calcium Channel Blockers, Beta Blockers, Vasodilators), By Application (Primary Hypertension, Secondary Hypertension), By Route of Administration (Oral, Injectable), By End User (Hospitals & Clinics, Retail Pharmacies, Online Pharmacies), and By Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Antihypertensive Drugs Market is expected to grow from USD 25.1 billion in 2023 at a CAGR of 3.6% to touch USD 32.2 billion by 2030. The Antihypertensive Drugs Market is dominated by key players such as, Bayer, AstraZeneca, Boehringer Ingelheim, Pfizer, and Merck & Co.

Published: October, 2024
| Report ID: LI4016
| Life Sciences & Healthcare
Pharmaceutical Analytical Testing Market By Service Type (Bioanalytical Testing, Method Development & Validation, Raw Material Testing, Microbial Testing), By End-User (Pharmaceutical & Biopharmaceutical Companies, Contract Research Organizations (CROs), Academic & Research Institutes, Government Agencies), and By Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Pharmaceutical Analytical Testing Market is expected to grow from USD 8.1 billion in 2023 at a CAGR of 7.2% to touch USD 13.2 billion by 2030. The Pharmaceutical Analytical Testing Market is dominated by key players such as, Charles River Laboratories, Thermo Fisher Scientific, Eurofins Scientific, WuXi AppTec, and Labcorp.

Published: October, 2024
| Report ID: LI3995
| Life Sciences & Healthcare
Acne Medication Market By Product (Retinoids, Antibiotics, Isotretinoin), By Administration Mode (Topical, Oral), By Acne Type (Non-Inflammatory Acne, Inflammatory Acne), By Distribution Channel (Hospital Pharmacies, Retail & Online Pharmacies) and By Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Acne Medication Market is expected to grow from USD 12.5 billion in 2023 at a CAGR of 5.5% to touch USD 18.2 billion by 2030. The Acne Medication Market is dominated by key players such as AbbVie Inc., Bausch Health Companies, Bayer, Botanix, GALDERMA and GSK.

Published: October, 2024
| Report ID: LI3988
| Life Sciences & Healthcare
Lyophilization Equipment Market By Component (Equipment, Consumables & Accessories), By Type (Tray-Style Freeze Dryers, Manifold Freeze Dryers, Rotary Freeze Dryers, Bench-Top Freeze Dryers), By Scale of Operation (Laboratory-Scale, Pilot-Scale, Industrial-Scale), By End Use (Pharmaceutical & Biopharmaceutical, Research Laboratories & Institutes, Food & Beverage, Hospitals & Medical Centers), and By Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Lyophilization Equipment Market is expected to grow from USD 7.2 billion in 2023 at a CAGR of 7.7% to touch USD 12.2 billion by 2030. The Lyophilization Equipment Market is dominated by key players such as, BUCHI, HOF Sonderanlagenbau, IMA S.p.A, Labconco, and Millrock Technology.

Published: October, 2024
| Report ID: LI3983
| Life Sciences & Healthcare
3D Printed Medical Implants Market By Product Type (Orthopedic, Dental, Cardiovascular), By Technology (SLA, FDM, SLS, DLP), By Material (Metals, Polymers, Ceramics, Composite Materials), By End User (Hospitals & Clinics, Surgical Centers), and By Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the 3D Printed Medical Implants Market is expected to grow from USD 3.5 billion in 2023 at a CAGR of 11.7% to touch USD 7.6 billion by 2030. The 3D Printed Medical Implants Market is dominated by key players such as, Allevi, Inc., 3D Systems, Formlabs, Stratasys, and HP Inc.

Published: October, 2024
| Report ID: LI3982
| Life Sciences & Healthcare
3D Bioengineered Skin Grafts Market By Type (Autologous Skin Grafts, Allogeneic Skin Grafts, Xenogeneic Skin Grafts), By Application (Burn Treatment, Chronic Wounds, Trauma Injuries), By End User (Hospitals, Ambulatory Surgical Centers), and By Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the 3D Bioengineered Skin Grafts Market is expected to grow from USD 156.3 million in 2023 at a CAGR of 24.3% to touch USD 718.2 million by 2030. The 3D Bioengineered Skin Grafts Market is dominated by key players such as, Tissue Regenix, AbbVie, MediWound, Organogenesis, and Tides Medical.

Published: October, 2024
| Report ID: LI3974
| Life Sciences & Healthcare
Sepsis Therapeutics Market By Drug Class (Antibiotics, Antifungals, Antivirals, Corticosteroids), By Route of Administration (Intravenous, Oral, Intramuscular), and By Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Sepsis Therapeutics Market is expected to grow from USD 2.7 billion in 2023 at a CAGR of 6.3% to touch USD 4.2 billion by 2030. The Sepsis Therapeutics Market is dominated by key players such as, AstraZeneca, Abbott, Eli Lilly and Company, Pfizer, and Merck & Co.

Published: October, 2024
| Report ID: LI3967
| Life Sciences & Healthcare
Immunotherapy Drugs Market By Type (Antibody Drugs, Cell Therapy, Cytokine Therapy, Cancer Vaccines, Other), By Indication (Cancer, Autoimmune Diseases, Infectious Diseases, Neurology), By Route of Administration (Intravenous, Subcutaneous), By End User (Hospitals, Long-Term Care Facilities), and By Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Immunotherapy Drugs Market is expected to grow from USD 247.2 billion in 2023 at a CAGR of 14.6% to touch USD 641.8 billion by 2030. The Immunotherapy Drugs Market is dominated by key players such as, Amgen, AbbVie, Bristol Myers Squibb, Regeneron Pharmaceuticals, Merck, Sanofi, Pfizer, Roche, Novartis, and Eli Lilly.

Published: October, 2024
| Report ID: LI3954
| Life Sciences & Healthcare
Epigenetics Diagnostics Market By Product Type (Reagents & Kits, Instruments & Accessories, Software & Services), By Application (Oncology, Cardiovascular Diseases, Metabolic Disorders, Neurological Disorders, Autoimmune Diseases, Prenatal Testing), By End User (Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Hospitals & Clinics), and By Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Epigenetics Diagnostics Market is expected to grow from USD 2.3 billion in 2023 at a CAGR of 13.9% to touch USD 5.8 billion by 2030. The Epigenetics Diagnostics Market is dominated by key players such as, Bio-Rad Laboratories, Agilent, Merck KGaA, Thermo Fisher Scientific, and Qiagen.

Published: October, 2024
| Report ID: LI3945
| Life Sciences & Healthcare
Digital PCR (dPCR) and Real-time PCR (qPCR) Market By Product Type (Digital PCR, Real-Time PCR), By Application (Clinical Applications, Research Applications, Pathogen Testing, Blood Screening), By End-Use (Hospitals & Diagnostic, Centers, Research Laboratories &, Academic Institutes, Pharmaceutical & Biotechnology Companies, Clinical Research Organizations, Forensic Laboratories), and By Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Digital PCR (dPCR) and Real-time PCR (qPCR) Market is expected to grow from USD 8.9 billion in 2023 at a CAGR of 7.9% to touch USD 15.2 billion by 2030. The Digital PCR (dPCR) and Real-time PCR (qPCR) Market is dominated by key players such as Danaher, Roche, Thermo Fisher Scientific, Merck, QIAGEN, Bio-Rad Laboratories, Becton, Dickinson and Company, and Abbott.

Published: October, 2024
| Report ID: LI3942
| Life Sciences & Healthcare
Acute Lymphocytic Leukemia Therapeutics Market By Type of Therapy (Chemotherapy, Targeted Therapy, Immunotherapy, Radiation Therapy, Stem Cell Transplantation), By Gender (Male, Female), By End User (Hospitals & Clinics, Cancer Care Centers, Research and Academic Institutes) and By Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Acute Lymphocytic Leukemia Therapeutics Market is expected to grow from USD 3.1 billion in 2023 at a CAGR of 7.4% to touch USD 5.1 billion by 2030. The Acute Lymphocytic Leukemia Therapeutics Market is dominated by key players such as Bristol-Myers Squibb Company, Novartis, Roche, Celgene Corporation, Amgen, Gilead Sciences, AstraZeneca, Janssen Pharmaceuticals, Sanofi, and Incyte Corporation.

Published: October, 2024
| Report ID: LI3930
| Life Sciences & Healthcare
Acute Care Telemedicine Market By Delivery (Clinician-to-Clinician, Clinician-to-Patients), By Application (Teleradiology, Telepsychiatry, Tele-ICU, Teleneurology, Telenephrology), By End User (Hospitals and Clinics, Home Care Providers) and By Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Acute Care Telemedicine Market is expected to grow from USD 21.6 billion in 2023 at a CAGR of 15.3% to touch USD 58.2 billion by 2030. The Acute Care Telemedicine Market is dominated by key players such as Eagle Telemedicine, Enghouse Video, Orbit Health, Relymd, Sciencesoft USA Corporation, SynergenX, and Teladoc Health.

Published: October, 2024
| Report ID: LI3929
| Life Sciences & Healthcare
Telehealth & Telemedicine Market By Type (Products, Services), By Application (Telecardiology, Teleradiology, Teledermatology, Telepsychiatry, Telepathology), By End Use (Healthcare Facilities, Homecare) and By Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Telehealth & Telemedicine Market is expected to grow from USD 115.2 billion in 2023 at a CAGR of 16.3% to touch USD 331.4 billion by 2030. The Telehealth & Telemedicine Market is dominated by key players such as Amwell, Cisco Systems, Encounter Telehealth, GE Healthcare, Global Med, MDLIVE Inc., MeMD Inc., Oracle, Siemens Healthcare, and Teladoc Health.

Published: October, 2024
| Report ID: LI3926
| Life Sciences & Healthcare
Biologics Market By Product Type (Monoclonal Antibodies Vaccines, Recombinant Proteins, Gene Therapy Products, Cell Therapy Products, Blood and Blood Products), By Application (Oncology, Autoimmune Diseases, Infectious Diseases, Metabolic Disorders, Cardiovascular Diseases, Neurological Disorders), By End User (Hospitals and Clinics, Pharmaceutical Companies) and By Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Biologics Market is expected to grow from USD 374.6 billion in 2023 at a CAGR of 9.1% to touch USD 689.6 billion by 2030. The Biologics Market is dominated by key players such as Roche Pharmaceuticals, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Eli Lilly, AstraZeneca, and Sanofi.

Published: October, 2024
| Report ID: LI3922
| Life Sciences & Healthcare
Computer Vision in Healthcare Market By Offering (Hardware, Software & Services), By Technology (AI & Machine Learning, Image Processing Technologies, 3D Imaging and Visualization, AR & VR), By Application (Medical Imaging, Surgical Assistance, Patient Monitoring, Drug Discovery and Development, Telehealth Solutions), By End-User (Hospitals & Clinics. Diagnostic Centers), and By Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Computer Vision in Healthcare Market is expected to grow from USD 4.2 billion in 2023 at a CAGR of 21.8% to touch USD 16.8 billion by 2030. The Computer Vision in Healthcare Market is dominated by key players such as, Canon, GE Healthcare, IBM, NVIDIA, Philips Healthcare, AMD, Siemens, and Microsoft.

Published: October, 2024
| Report ID: LI3920
| Life Sciences & Healthcare
Biosimilar Monoclonal Antibody Market By Product Type (Infliximab, Rituximab, Abciximab, Trastuzumab, Adalimumab, Bevacizumab), By Application (Oncology, Autoimmune Diseases, Infectious Diseases) and By Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Biosimilar Monoclonal Antibody Market is expected to grow from USD 374.6 billion in 2023 at a CAGR of 9.1% to touch USD 689.6 billion by 2030. The Biosimilar Monoclonal Antibody Market is dominated by key players such as Amgen, BIOCAD, Biocon, Biogen, Novartis, Pfizer, Shanghai Henlius Biotech, and Teva Pharmaceutical.

Published: October, 2024
| Report ID: LI3915
| Life Sciences & Healthcare
Neonatal Ventilators Market By Product (Invasive Ventilation, Non-Invasive Ventilation), By Mobility (Intensive Care Ventilators, Portable/Transportable Ventilators), By Technology (Mechanical, High Frequency, Volume Targeted, Hybrid), By Mode (Pressure Mode, Combined Mode, Volume Mode) and By Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Neonatal Ventilators Market is expected to grow from USD 358.5 million in 2023 at a CAGR of 5.2% to touch USD 512.5 million by 2030. The Neonatal Ventilators Market is dominated by key players such as Air Liquide Medical Systems, Becton, Dickinson and Company, Drägerwerk AG & Co., GE Healthcare, Getinge, HAMILTON MEDICAL, ICU Medical, Philips Healthcare, and Medtronic.

Published: October, 2024
| Report ID: LI3899
| Life Sciences & Healthcare
Biologics Contract Development Market By Service Type (Process Development, Analytical & Testing Services, Cell Line Development, Regulatory Support), By Product Type (Monoclonal Antibodies, Vaccines, Recombinant Proteins, Gene Therapy Products, Cell Therapy Products), By Phase (Preclinical, Clinical, Commercial Manufacturing), By End-User (Pharmaceutical & Biotechnology Companies, Research Organizations, Academic Institutions), and By Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Biologics Contract Development Market is expected to grow from USD 14.7 billion in 2023 at a CAGR of 7.3% to touch USD 24.1 billion by 2030. The Biologics Contract Development Market is dominated by key players such as, Charles River Laboratories, Boehringer Ingelheim, Lonza, Samsung Biologics, Rentschler Biopharma, and Parexel.

Published: October, 2024
| Report ID: LI3883
| Life Sciences & Healthcare
Monoclonal Antibody (mAB) Therapeutics Market By Production Method (In-Vitro, In-Vivo), By Sources (Human, Humanized, Chimeric), By Route of Administration (Intravenous, Subcutaneous), By Therapy Area (Autoimmune & Inflammatory Disorders, Oncology, Hematology, Ophthalmology), By End User (Hospitals, Long-term Care Facilities), and By Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Monoclonal Antibody (mAB) Therapeutics Market is expected to grow from USD 225.3 billion in 2023 at a CAGR of 13.5% to touch USD 547.3 billion by 2030. The Monoclonal Antibody (mAB) Therapeutics Market is dominated by key players such as, Biogen, Boehringer Ingelheim, Bristol Myers Squibb Company, Abbvie, Eli Lilly, Takeda, Roche, Sanofi, and Merck.

Published: October, 2024
| Report ID: LI3875
| Life Sciences & Healthcare
Rehabilitation Equipment Market By Type (Therapy Equipment, Daily Living Aids, Mobility Equipment, Exercise Equipment, Body Support Devices), By Application (Physical Rehabilitation & Training, Strength, Endurance, and Pain Reduction, Occupational Rehabilitation & Training), By End-Use (Hospitals & Clinics, Rehabilitation Centers, Home-Care Settings, Physiotherapy Centers), and By Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Rehabilitation Equipment Market is expected to grow from USD 12.3 billion in 2023 at a CAGR of 4.0% to touch USD 16.2 billion by 2030. The Rehabilitation Equipment Market is dominated by key players such as Arjo, Bioness, BioXtreme, Dynatronics, Halma, Honeywell, Invacare Corporation, Philips Healthcare, Medline Industries, and Medtronic.

Published: October, 2024
| Report ID: LI3872
| Life Sciences & Healthcare
Lacrimal Devices Market By Product Type (Lacrimal Cannula, Punctal Plugs, Lacrimal Stents, Lacrimal Dilator), By Material (Silicone, Stainless Steel), By Indication (Dry Eye, Epiphora, Glaucoma), By End-User (Hospitals, Specialty Clinics) and By Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Lacrimal Devices Market is expected to grow from USD 27.5 million in 2023 at a CAGR of 5.5% to touch USD 39.9 billion by 2030. The Lacrimal Devices Market is dominated by key players such as Alcon, Bausch and Lomb, Bess Medical Technology, BVI Medical, Cook Group, FCI Ophthalmics, Gunther Weiss Scientific, Kaneka Pharma America, and OASIS Medical.

Published: October, 2024
| Report ID: LI3861
| Life Sciences & Healthcare
ePrescribing Market Type of Service (Solutions {Integrated Solutions, Standalone Solutions}, Services {Support & Maintenance Services, Implementation Services, Network Services, Training and Education Services}, By Delivery Mode (Web and Cloud Based Solutions, On Premise Solutions), By End User (Hospitals & Clinics, Office Based Physicians, Pharmacies) and by Region; Global Insights & Forecasts (2024 - 2030)

According to Intent Market Research, the ePrescribing Market is expected to grow from USD 1.4 billion in 2023 at a CAGR of 25.4% to touch USD 6.6 billion by 2030. The ePrescribing Market is competitive; where the prominent players include Allscripts Healthcare Solutions, athenahealth, Cerner Corporation, DrFirst, Epic Systems Corporation, GE Healthcare, Henry Schein, NextGen Healthcare, RelayHealth, and Surescripts.

Published: October, 2024
| Report ID: LI3849
| Life Sciences & Healthcare
Contrast Enhanced Ultrasound Market By Product Type (Equipment, Contrast Agent), By Application (Hepatic, Echocardiography, Cerebrovascular, Thyroid & Parathyroid, Gallbladder & Biliary Tree, Renal, Prostate, Pancreatic, Vascular, Lymphatic), By End-Use (Hospitals and Surgical Centers, Diagnostic Imaging Clinics, Ambulatory Surgical Centers), and By Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Contrast Enhanced Ultrasound Market is expected to grow from USD 1.4 billion in 2023 at a CAGR of 6.0% to touch USD 2.1 billion by 2030. The Contrast Enhanced Ultrasound Market is dominated by key players such as Acusphere, Inc., Bracco, Canon Medical Systems, GE Healthcare, Philips Healthcare, and Siemens Healthineers.

Published: September, 2024
| Report ID: LI3843
| Life Sciences & Healthcare
Cell Isolation Market By Product (Consumables, Instruments), By Cell Type (Human Cells, Animal Cells), By Cell Source (Adipose Tissues, Bone Marrow, Cord Blood/ Embryonic Stem Cells), By Technique (Centrifugation-Based Cell Isolation, Surface-Based Cell Isolation, Filtration-Based Cell Isolation), By Application (Biomolecule Isolation, Cancer Research, Stem Cell Research, Tissue Regeneration & Regenerative Medicine, In-vitro Diagnostics), By End User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Hospitals & Diagnostic Laboratories), and By Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Cell Isolation Market is expected to grow from USD 4.1 billion in 2023 at a CAGR of 12.1% to touch USD 9.1 billion by 2030. The Cell Isolation Market is dominated by key players such as, Bio-Rad Laboratories, Becton, Dickinson and Company, QIAGEN, Agilent Technologies, Lonza, Sartorius AG, and Roche.

Published: September, 2024
| Report ID: LI3834
| Life Sciences & Healthcare
Brain Computer Interface Market By Component (Hardware, Software), By Product Type (Non-Invasive, Partially Invasive, Invasive), By Technology (Electroencephalography (EEG), Functional Magnetic Resonance Imaging (fMRI), Magnetoencephalography (MEG), Electrocorticography (ECoG), Functional Near-Infrared Spectroscopy (fNRIs)), By Application (Disabilities Restoration/ Rehabilitation, Assistive Technologies), By End User (Hospital & Clinics, Rehabilitation Centers, Home Care Settings), and By Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Brain Computer Interface Market is expected to grow from USD 2.7 billion in 2023 at a CAGR of 15.6% to touch USD 7.4 billion by 2030. The Brain Computer Interface Market is dominated by key players such as, EMOTIV, Advanced Brain Monitoring, Medtronic, Integra LifeSciences, Natus Medical, and Neuralink.

Published: September, 2024
| Report ID: LI3832
| Life Sciences & Healthcare
Ambulatory Cardiac Monitoring Devices Market By Device Type (Holter Monitors, Event Monitors, Mobile Cardiac Telemetry (MCT) Devices, Implantable Loop Recorders (ILRs), Smart Wearables), By Application (Atrial Fibrillation, Bradycardia, Tachycardia, Ventricular Fibrillation, Other Cardiac Arrhythmias), By End User (Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, Home Care Settings), and By Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Ambulatory Cardiac Monitoring Devices Market is expected to grow from USD 6.4 billion in 2023 at a CAGR of 11.2% to touch USD 13.4 billion by 2030. The Ambulatory Cardiac Monitoring Devices Market is dominated by key players such as, GE Healthcare, Abbott, Medtronic, Hill-Rom, Biotronik, Boston Scientific, and Nihon Kohden.

Published: September, 2024
| Report ID: LI3831
| Life Sciences & Healthcare
Antibody Therapeutics Market By Format (Monoclonal Antibody, Polyclonal Antibody Therapy, Bispecific Antibody, Antibody Fragment), By Therapy Area (Autoimmune & inflammatory Diseases, Oncology, Hematology, Infectious Diseases, Osteology, Immunology, Neurology), By Route of Administration (Intravenous, Subcutaneous), By Source (Human, Humanized, Chimeric), By End User (Hospitals, Long-term Care Facilities), and By Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Antibody Therapeutics Market is expected to grow from USD 293.3 billion in 2023 at a CAGR of 13.9% to touch USD 728.8 billion by 2030. The Antibody Therapeutics Market is dominated by key players such as, Biogen, Abbvie, Eli Lilly, Novartis, Sanofi, Takeda, and Merck.

Published: September, 2024
| Report ID: LI3825
| Life Sciences & Healthcare
Real World Evidence Solutions Market By Component (Services and Data Sets), By Application (Drug Development & Approvals, Medical Device Development & Approvals, Reimbursement/Coverage and Regulatory Decision Making, Post Market Safety & Adverse Events Monitoring), By End Use (Pharmaceutical and Medical Device Companies, Healthcare Payers, Healthcare Providers, Others) and by Region; Global Insights & Forecasts (2024 - 2030)

According to Intent Market Research, the Real World Evidence Solutions Market is expected to grow from USD 2.5 billion in 2023 at a CAGR of 8.4% to touch USD 4.4 billion by 2030. The Real World Evidence Solutions market is competitive; where the prominent players include Cegedim Health Data, IBM, IQVIA, Labcorp, Oracle, SAS Institute, Thermo Fisher Scientific, and Trinity.

Published: September, 2024
| Report ID: LI3793
| Life Sciences & Healthcare
Clinical Trial Imaging Market By Modality (CT, MRI, X-Ray, PET, Ultrasound, ECHO), By Therapeutic Area (Infectious, Oncology, CNS, CVD), By Software & Services (Operational Imaging, Trial Design), By End User (Pharma, Biotech, CROs), and By Region; Growth Trends & Forecasts (2024 - 2030)

According to Intent Market Research, the Clinical Trial Imaging Market is expected to grow from USD 1.2 billion in 2023 at a CAGR of 7.6% to touch USD 2.0 billion by 2030. The clinical trial imaging market is dominated by key players such as BioTelemetry, ICON plc, IXICO, Calyx Group, Biomedical Systems Corporation, and Medpace.

Published: September, 2024
| Report ID: LI3781
| Life Sciences & Healthcare
3D Cell Culture Market By Product (Scaffold-Based 3D Cell Cultures, Scaffold-Free 3D Cell Cultures, Microfluidics-Based 3D Cell Cultures, Magnetic & Bioprinted 3D Cell Cultures), By Application (Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing, Tissue Engineering & Regenerative Medicine), By End Use (Pharmaceutical & Biotechnology Companies, Research Institutes, Cosmetics Industry), and by Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the 3D Cell Culture Market is expected to grow from USD 1.2 billion in 2023 at a CAGR of 14.1% to touch USD 3.0 billion by 2030. The 3D Cell Culture Market is dominated by key players such as Avantor, Corning, Emulate, Kirkstall, Lonza, Merck, and Thermo Fisher Scientific.

Published: September, 2024
| Report ID: LI3754
| Life Sciences & Healthcare
Virtual Care Market By Service Type (Telemedicine, Remote Monitoring, Virtual Health Assistance, E-Pharmacy), By Platform Type (Web-Based Platforms, Mobile Apps, Standalone Devices), By Application (Chronic Disease Management, Mental Health, Health & Wellness, Acute Care), By End User (Healthcare Providers, Patients, Pharmacies) and By Region; Global Insights & Forecasts (2024 - 2030)

According to Intent Market Research, the Virtual Care Market is expected to grow from USD 8.5 billion in 2023 at a CAGR of 30.8% to touch USD 55.5 billion by 2030. The Virtual Care Market is competitive; where the prominent players include AMD Global Telemedicine, American Well Corporation, CHI Health, Aetna CVS Health, GE Healthcare, MDLIVE, Medocity, Oracle, Teladoc Health, and United HealthCare Services.

Published: September, 2024
| Report ID: LI3751
| Life Sciences & Healthcare
Radiation Shielding Material Market By Type (Electromagnetic Radiation, Particle Radiation), By Material (Lead Shielding, Lead Composite Shielding (Barium, PVC, Rubber), Non-Lead and Lead-Free Shielding (Copper, Tungsten, Concrete)), By Application (X-ray Room, CT Scan Facility, MRI Room, Nuclear Medicine Imaging Shielding, Radiation Protection Safety Aprons/Apparel/Equipment), and By Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Radiation Shielding Material Market is expected to grow from USD 688 million in 2023 at a CAGR of 5.8% to touch USD 1,022 million by 2030. The radiation shielding material market is dominated by key players such as ETS-LINDGREN, Infab Corporation, Gravita India, Mayco Industries, A&L Shielding, and Radiation Protection Products.

Published: September, 2024
| Report ID: LI3744
| Life Sciences & Healthcare
Remote Patient Monitoring (RPM) Market By Component (Software & Services, Devices (Respiratory Monitoring Devices, Neurological Monitoring Devices, Fetal & Neonatal Monitoring Devices, Blood Glucose Monitoring Devices)), By Application (Sleep Disorders, Cardiovascular Diseases, Diabetes, Oncology), By End Use (Providers, Patients, Payers), and By Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Remote Patient Monitoring Market is expected to grow from USD 15.9 billion in 2023 at a CAGR of 19.5% to touch USD 55.3 billion by 2030. The remote patient monitoring market is dominated by key players such as Biotronik SE, AliveCor, TytoCare, Brook, iRhythm Technologies, Bardy Diagnostics, and Aktiia.

Published: September, 2024
| Report ID: LI3743
| Life Sciences & Healthcare
Clinical Chemistry Analyzers Market By Test Type (Basic Metabolic, Liver, Renal, Lipid, Thyroid Function, Electrolyte Panels, Specialty Chemical Tests), By Product (Reagents, Analyzers, Other Products), By End User (Hospitals and Clinics, Diagnostic Laboratories, Research Laboratories & Institutes, Other End Users) and by Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Clinical Chemistry Analyzers Market is expected to grow from USD 12.3 billion in 2023 at a CAGR of 4.4% to touch USD 16.7 billion by 2030. The clinical chemistry analyzers market is dominated by key players such as Roche Diagnostics, Danaher, Abbott, Thermo Fisher Scientific, Siemens Healthineers, and Sysmex Corporation.

Published: September, 2024
| Report ID: LI3740
| Life Sciences & Healthcare
Contract Development & Manufacturing Market By Service Type (Development Services {Discovery, Preclinical, Clinical, Laboratory Services}, Manufacturing Services {API Manufacturing, FDF Manufacturing, Packaging & Labelling Services, Post-Commercialization Services}), By End-User (Pharmaceutical Companies, Biopharmaceutical Companies) and By Region; Global Insights & Forecasts (2024 - 2030)

According to Intent Market Research, the Contract Development & Manufacturing Market is expected to grow from USD 179.4 billion in 2023 at a CAGR of 10.4% to touch USD 359.3 billion by 2030. The Contract Development & Manufacturing Market is competitive; where the prominent players include Aenova Group, Baxter Biopharma Solutions, Boehringer Ingelheim, Catalent, Jubilant Biosys, Lonza Group, Patheon, PCI Services, Pfizer, and Recipharm

Published: September, 2024
| Report ID: LI3730
| Life Sciences & Healthcare
Research Antibodies & Reagents Market By Product (Antibodies, Reagents), By Technology (Immunoprecipitation, Immunohistochemistry, Immunofluorescence, Flow Cytometry, Enzyme-Linked Immunosorbent Assay (ELISA), Western Blotting), By Application (Proteomics, Genomics, Drug Development), By End Use (Pharmaceutical & Biological Industries, Biotech, CROs), and by Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Research Antibodies & Reagents Market is expected to grow from USD 11.2 billion in 2023 at a CAGR of 6.0% to touch USD 16.9 billion by 2030. The research antibodies & reagents market is dominated by key players such as Abcam, Merck, Cell Signaling Technology, Roche, Danaher, Lonza, Agilent, and Illumnia.

Published: September, 2024
| Report ID: LI3700
| Life Sciences & Healthcare
Preimplantation Genetic Testing Market by Procedure (Genetic Diagnosis, Genetic Screening), By Technology (Polymerase Chain Reaction, Next-Generation Sequencing, Fluorescence In Situ Hybridization, Comparative Genomic Hybridisation, Single Nucleotide Polymorphisms), By Product (Consumable, Reagents, Instruments, Software & Service), By Application (Aneuploidy, HLA Typing, Structural Chromosomal Abnormalities, Single Gene Disorder, Gender Identification), By End-users (Hospitals, Fertility Clinics, Diagnostic Centres), and by Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Preimplantation Genetic Testing Market is expected to grow from USD 667 million in 2023 at a CAGR of 10.9% to touch USD 1,374 million by 2030. The preimplantation genetic testing market is dominated by key players such as Agilent, Thermo Fisher Scientific, Illumina, Revvity, Abbott, Takara Bio, Qiagen, MedGenome, and Berry Genomics.

Published: September, 2024
| Report ID: LI3698
| Life Sciences & Healthcare
Respiratory Care Devices Market By Product (Therapeutic Respiratory Care Devices {PAP Devices, Ventilators, Nebulizers, Humidifiers, Oxygen Concentrators, Inhalers, Reusable Resuscitators}, Monitoring Devices, Diagnostic Respiratory Care Devices, Consumables & Accessories), By Disease Indication (Infectious Diseases, Sleep Apnea, Chronic Obstructive Pulmonary Diseases, Asthma), By End Use (Hospitals, Home Care Settings, Ambulatory Care Centers (ACCs)), and by Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Respiratory Care Devices Market is expected to grow from USD 20.7 billion in 2023 at a CAGR of 7.3% to touch USD 34.0 billion by 2030. The respiratory care devices market is dominated by key players such as Philips Healthcare, GE Healthcare, ResMed, Air Liquide Medical Systems, Medtronic, Baxter, and OMRON Healthcare.

Published: September, 2024
| Report ID: LI3697
| Life Sciences & Healthcare
Cystatin C Assay Market By Method (ELISA, PENIA, PETIA, IFA, CLIA), By Product (Reagents, Kits, Analyzers), By Application (Diagnostics, Research), By Sample Type (Blood, Urine), By End-Use Industry (Hospitals, Clinical Laboratories, Pharmaceutical and Biotechnology Companies, CROs & Academic Research Institutes), and By Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Cystatin C Assay Market is expected to grow from USD 357 million in 2023 at a CAGR of 6.9% to touch USD 571 million by 2030. The cystatin C assay market is dominated by key players such as Abbott, Roche Diagnostics, Siemens Healthineers, Thermo Fisher Scientific, Randox Laboratories, Diasys Diagnostic Systems, and Sino Biological.

Published: September, 2024
| Report ID: LI3693
| Life Sciences & Healthcare
Active Pharmaceutical Ingredients Market By Type (Innovative APIs, Generic APIs), By Therapeutic Applications (Diabetes, Communicable Diseases, Respiratory Diseases, Pain Management, Oncology, Cardiovascular Diseases), By End Use (Pharmaceutical & Biotechnology Industry, Contract Manufacturing Organization, Contract Research Organization) and by Region; Global Insights & Forecasts (2024 - 2030)

According to Intent Market Research, the Active Pharmaceutical Ingredients Market is expected to grow from USD 160.4 billion in 2023 at a CAGR of 5.4% to touch USD 231.1 billion by 2030. The Active Pharmaceutical Ingredients Market is competitive; where the prominent players include AstraZeneca, BASF, Boehringer Ingelheim, Dow Chemical, DuPont, Evonik, Roche, GSK, and Pfizer.

Published: September, 2024
| Report ID: LI3691
| Life Sciences & Healthcare
Radiotherapy Market By Type (Product, Service), By Technology (External Beam Radiotherapy, Conventional Cobalt-60 Teletherapy, Particle Therapy, Systemic Radiotherapy), By Procedure (External Beam Radiotherapy, Internal Beam Radiotherapy, Systemic Radiotherapy), By End Use (Hospital, Independent Radiotherapy Centres), By Application (External Beam Radiotherapy {Prostate Cancer, Breast Cancer, Colorectal Cancer}, Internal Beam Radiotherapy {Cervical Cancer, Gynecological Cancer, Penile Cancer}), and By Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Radiotherapy Market is expected to grow from USD 6.3 billion in 2023 at a CAGR of 4.6% to touch USD 8.7 billion by 2030. The radiotherapy market is dominated by key players such as Siemens Healthineers, IBA Dosimetry, Accuray Incorporated, Hitachi High-Tech Corporation, Philips Healthcare, Provision Healthcare, and Carl Zeiss Meditec.

Published: September, 2024
| Report ID: LI3684
| Life Sciences & Healthcare
RNA Therapeutics Market By Product (Vaccines, Drugs), By Type (mRNA Therapeutics, RNA Interference, Antisense Oligonucleotides), By Indication (Infectious Diseases, Metabolic Disorders, Oncology, Neurology, Pulmonary Disease, Rare Genetic Diseases), End Use (Hospitals, Clinics, Research Institutions), and By Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the RNA therapeutics market is expected to grow from USD 13.0 billion in 2023 at a CAGR of 5.1% to touch USD 18.5 billion by 2030. The RNA therapeutics market is dominated by key players such as Moderna, Novartis, Silence Therapeutics, CRISPR Therapeutics, Sirnaomics, Sanofi, and Ionis Pharmaceuticals.

Published: September, 2024
| Report ID: LI3680
| Life Sciences & Healthcare
Topical Drug Delivery Market By Product (Semi-Solid Formulations, Liquid Formulations, Solid Formulations, Transdermal Products), By Route of Administration (Dermal Drug Delivery, Nasal Drug Delivery, Vaginal Drug Delivery, Rectal Drug Delivery, Ophthalmic Drug Delivery), By End Use (Hospitals & Private Clinics, Home Care Settings) and by Region; Global Insights & Forecasts (2024 - 2030)

According to Intent Market Research, the Topical Drug Delivery Market is expected to grow from USD 90.3 billion in 2023 at a CAGR of 11.2% to touch USD 190.4 billion by 2030. The Topical Drug Delivery market is competitive; where the prominent players include 3M, Bayer, Cipla, Galderma, GlaxoSmithKline, Abbvie, Novartis, and Pfizer.

Published: September, 2024
| Report ID: LI3676
| Life Sciences & Healthcare
Single Use Assemblies Market By Product (Bottle, Filtration, Bag, Mixing Assemblies), By Application (Cell Culture, Filtration, Storage, Fill-finish, Sampling), By End Use (Pharma & Biopharma, Contract Research Organizations & Contract Manufacturing Organizations), and by Region; Global Insights & Forecast (2024 - 2030)

According to Intent Market Research, the Single Use Assemblies Market is expected to grow from USD 2.4 billion in 2023 at a CAGR of 15.1% to touch USD 6.4 billion by 2030. The Single Use Assemblies Market is dominated by key players such as, Thermo Fisher Scientific, Merck, Sartorius, Merck, Danaher, Parker Hannifin, and Newage Industries.

Published: September, 2024
| Report ID: LI3675
| Life Sciences & Healthcare
Mass Spectrometry Market By Product (Instruments {Hybrid Mass Spectrometry [Triple Quadrupole, Quadrupole ToF (Q-ToF)], Single Mass Spectrometry [Quadrupole, Ion Trap, Time-Of-Flight (ToF)]}, Software & Services), By End-Use (Research Labs & Academic Institutes, Pharmaceutical Companies, Biotechnology Companies, Environmental Testing Labs, F&B Industry, Petrochemical Industry, Forensic Labs), By Application (Environmental Testing, OMICS Research {Genomics, Proteomics and Metabolomics}, Drug Discovery, Pharma-Biopharma Manufacturing, Food Testing, Clinical Diagnostics, Applied Industries), and by Region; Growth Trends & Forecasts (2024 - 2030)

According to Intent Market Research, the Mass Spectrometry Market is expected to grow from USD 5.2 billion in 2023 at a CAGR of 7.0% to touch USD 8.3 billion by 2030. The Mass Spectrometry Market is competitive; where the prominent players include SCIEX, Thermo Fisher Scientific, Agilent Technologies, Waters Corporation, PerkinElmer, Analytik Jena Gmbh, JASCO, Bruker, and Shimadzu Corporation.

Published: September, 2024
| Report ID: LI3658
| Life Sciences & Healthcare
Single-Cell Analysis Market By Product (Consumables {Microplates, Beads, Reagents, Assay Kits}, Instruments {Flow Cytometers, Spectrophotometers, NGS Systems, PCR Instruments}), By Technique (Flow Cytometry, NGS, Microscopy, Mass Spectrometry, Polymerase Chain Reaction), By Application (Research Application {Cancer, Immunology, Neurology, Stem Cell}, Medical Application {Circulating Tumor Cell Detection, In-Vitro Fertilization, Non-Invasive Prenatal Diagnosis}), By End Use (Pharma, Biotech, Hospitals, Academic & Research Laboratories, Cell Banks & IVF Centers), and by Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Single-Cell Analysis Market is expected to grow from USD 3.3 billion in 2023 at a CAGR of 14.8% to touch USD 8.7 billion by 2030. The single cell analysis market is competitive; where the prominent players include Becton, Dickinson and Company, Danaher Corporation, Merck, QIAGEN, Thermo Fisher Scientific, Illumina, Agilent, and 10x Genomics.

Published: September, 2024
| Report ID: LI3651
| Life Sciences & Healthcare
Dental 3D Printing Market By Product & Service (Material, Equipment, Services), By Technology (VAT Photopolymerization (SLA, DLP, LCD), Polyjet, SLS, FDM), By Application (Implantology, Orthodontics, Prosthodontics), By End User (Dental Hospitals & Clinics, Dental Laboratories, Academic & Research Institutes), and by Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Dental 3D Printing Market is expected to grow from USD 2.8 billion in 2023 at a CAGR of 17.2% to touch USD 8.5 billion by 2030. The Dental 3D Printing Market is competitive; where the prominent players include SLM Solutions, 3D Systems, Formlabs, Desktop Metal, Dentsply Sirona, GE Additive, Align Technology, and Stratasys.

Published: September, 2024
| Report ID: LI3643
| Life Sciences & Healthcare
Laboratory Information Management System (LIMS) Market By Type (Broad-based LIMS, Industry-Specific LIMS), By Deployment (On Premise, Cloud (SaaS, PaaS, IaaS)), By End Use (Life Sciences (Pharmaceutical & Biotechnological Companies, Academic Research Institute, Toxicology Laboratories), Petrochemicals, Food & Beverage, Agriculture, Oil & Gas, Forensics, Environmental Testing), and by Region; Global Insights & Forecasts (2024 - 2030)

According to Intent Market Research, the Laboratory Information Management System (LIMS) Market is expected to grow from USD 1.6 billion in 2023 at a CAGR of 14.0% to touch USD 4.0 billion by 2030. The Laboratory Information Management System (LIMS) market is competitive; where the prominent players include LabWare, LabVantage Solutions, Thermo Fisher Scientific, Agilent Technologies, LabLynx, Labtrack, Illumina, Clinisys, and Blaze Systems.

Published: August, 2024
| Report ID: LI3637
| Life Sciences & Healthcare
Laboratory Information Systems (LIS) Market By Product (Standalone, Integrated), By Component (Services, Software), By End Use (Hospital Laboratories, Independent Laboratories, Biotechnology & Pharmaceutical Companies, POLs), and by Region; Global Insights & Forecasts (2024 - 2030)

According to Intent Market Research, the Laboratory Information System (LIS) Market is expected to grow from USD 2.3 billion in 2023 at a CAGR of 10.2% to touch USD 4.5 billion by 2030. The laboratory information system market is dominated by key players such as Orchard Software Corporation, Clinisys, Oracle, Veradigm, Aspyra, Labware, CompuGroup Medical, and Ligolab Information System.

Published: August, 2024
| Report ID: LI3633
| Life Sciences & Healthcare
Primary Cells Market By Type (Hematopoietic, Dermatocytes, Gastrointestinal, Hepatocytes, Lung, Renal, Musculoskeletal, Heart), By Origin (Human Primary Cells, Animal Primary Cells), By End Use (Pharma Biotech, CROs, Academia), and by Region; Global Insights & Forecasts (2024 - 2030)

According to Intent Market Research, the Primary Cells Market is expected to grow from USD 1.6 billion in 2023 at a CAGR of 10.0% to touch USD 3.1 billion by 2030. The primary cells market is competitive; where the prominent players include Thermo Fisher Scientific, Merck, Lonza, Corning, Allcells, Promocell, Charles River, and Creative Bioarray.

Published: August, 2024
| Report ID: LI3630
| Life Sciences & Healthcare
Veterinary Surgical Instruments Market By Product Type (Sutures and Staplers, Handheld Devices, Electrosurgery Instruments and Others), By Type (Spaying / Neutering, Soft Tissue Surgery, Orthopaedic, Dental, Urogenital and Others), By Animal Type (Small Animals, Large Animals), By End User (Veterinary Hospitals, Veterinary Clinics, and Others) and by Region; Global Insights & Forecast (2024 - 2030)

According to Intent Market Research, the veterinary surgical instruments market is expected to grow from USD 1.3 billion in 2023 at a CAGR of 7.1% to touch USD 2.1 billion by 2030. The beneficial insects market is competitive; where the prominent players include B. Braun Vet Care, Ethicon, Integra Lifesciences, Jorgen KRUUSE A/S (Henry Schein), Jorgensen Labs, Medtronic, and Neogen Corporation.

Published: August, 2024
| Report ID: LI3628
| Life Sciences & Healthcare
Chemiluminescence Immunoassay Market By Product (Instruments, Consumables), By Technology (Chemiluminescence Enzyme, Microparticle Chemiluminescence, Electrochemiluminescence Immunoassay (ECLI)), By Application (Infectious Diseases, Oncology, Cardiology, Allergy Diagnostics, Autoimmune Disorders, Blood Screening, Bone & Mineral Disorders, Toxicology, Newborn Screening, Oncology), By End Use (Hospitals, Clinical Laboratories, Pharmaceuticals & Biotechnology Companies, CROs), and by Region; Global Insights & Forecasts (2024 - 2030)

According to Intent Market Research, the Chemiluminescence Immunoassay Market is expected to grow from USD 12.6 billion in 2023 at a CAGR of 7.0% to touch USD 20.2 billion by 2030. The chemiluminescence immunoassay market is competitive; where the prominent players include Roche, Danaher, Siemens Healthineers, Abbott Laboratories, DiaSorin, Shenzhen Mindray, Wiener, and Sysmex Corporation.

Published: August, 2024
| Report ID: LI3625
| Life Sciences & Healthcare
Revenue Cycle Management Market By Product & Services (Solutions (Patient Access Solutions, Mid-Revenue Cycle Solutions, Back-end Revenue Cycle Solutions), Outsourcing Services)), By Delivery (Cloud Based Solutions, On-Premise Solutions), By End Use (Healthcare Providers, Outpatient Facilities, Hospitals, Physicians Practices, Ambulatory Surgical Centres), and by Region; Global Insights & Forecasts (2024 - 2030)

According to Intent Market Research, the Revenue Cycle Management Market is expected to grow from USD 47.2 billion in 2023 at a CAGR of 10.6% to touch USD 95.5 billion by 2030. The revenue cycle management market is competitive; where the prominent players include R1 RCM, Oracle, Optum, GE Healthcare, McKesson Corporation, 3M, Athena Health, and Plutus Health.

Published: August, 2024
| Report ID: LI3624
| Life Sciences & Healthcare
IVD Contract Manufacturing Market By Device Type (Equipment, Consumables), By Technology (Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation), By Service (Manufacturing, Assay Development), and by Region; Global Insights & Forecasts (2024 - 2030)

According to Intent Market Research, the IVD Contract Manufacturing Market is expected to grow from USD 14.7 billion in 2023 at a CAGR of 11.0% to touch USD 30.5 billion by 2030. The IVD contract manufacturing market is competitive; where the prominent players include Sanmina Corporation, Jabil, TE Connectivity, Celestica, West Pharmaceutical Services, Avioq, Namera, and Fujirebio.

Published: August, 2024
| Report ID: LI3622
| Life Sciences & Healthcare
CT/NG Testing Market By Product (Assays, Kits & Analysers), By Test Type (Laboratory, Point-of-Care Testing), By Technology (INAAT, PCR, Immunodiagnostics), By End Use (Diagnostic Labs, Hospitals & Clinics), and by Region; Global Insights & Forecasts (2024 – 2030)

According to Intent Market Research, the CT/NG Testing Market is expected to grow from USD 1.7 billion in 2023 at a CAGR of 8.1% to touch USD 2.9 billion by 2030. The CT/NG testing market is competitive; where the prominent players include Roche Diagnostics, Hologic, Thermo Fisher Scientific, Abbott, Bio-Rad Laboratories, Siemens Healthineers, and Danaher.

Published: August, 2024
| Report ID: LI3620
| Life Sciences & Healthcare
CRISPR Market By Product (Enzymes, Libraries, Kits), By Services (Cell Line Engineering, gRNA Design, Screening), By Application (Agriculture, Drug Discovery & Development), By End Use (Biotech, CROs, Pharma, Research Institutes), and by Region; Global Insights & Forecasts (2024 - 2030)

According to Intent Market Research, the CRISPR Market is expected to grow from USD 3.3 billion in 2023 at a CAGR of 15.0% to touch USD 8.7 billion by 2030. The CRISPR market is competitive; where the prominent players include Thermo Fisher Scientific, Merck, Agilent Technologies, Lonza, PerkinElmer, CRISPR Therapeutics, Intellia Therapeutics, Beam Therapeutics, and Danaher.

Published: August, 2024
| Report ID: LI3610
| Life Sciences & Healthcare
Near Infrared Imaging Market By Product (Devices, NIR Imaging Agents, NIR Dyes), By Procedure (Cancer Surgeries, Cardiovascular Surgeries, GIT Surgeries, Plastic/Reconstructive Surgeries, OB/GYN Surgeries), By Application (Clinical, Preclinical, Medical), and by Region; Global Insights & Forecast (2024 - 2030)

According to Intent Market Research, the Near Infrared Imaging Market is expected to grow from USD 0.9 billion in 2023 at a CAGR of 9.7% to touch USD 1.8 billion by 2030. The Near Infrared Imaging Market is competitive; where the prominent players include Stryker, KARL STORZ, Carl Zeiss Meditec, Thermo Fisher Scientific, Medtronic, Leica Microsystems, Olympus Corporation and PerkinElmer.

Published: August, 2024
| Report ID: LI3608
| Life Sciences & Healthcare
Preparative and Process Chromatography Market by Type (Preparative Chromatography, Process Chromatography), by End-User Industry (Pharmaceuticals and Biotechnology Companies, Food & Nutraceutical Companies, Research Laboratories), and By Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Preparative and Process Chromatography Market is expected to grow from USD 10.7 billion in 2023 at a CAGR of 6.3% to touch USD 16.4 billion by 2030. The preparative and process chromatography market is dominated by key players such as Merck, Agilent, Danaher, Sartorius, Bio-Rad Laboratories, Thermo Fisher Scientific, PerkinElmer, Bruker, Shimadzu, and Waters Corporation.

Published: August, 2024
| Report ID: LI3601
| Life Sciences & Healthcare
Breast Imaging Market By Technology (Non-ionizing, Ionizing), By Product (Software & Services, Breast Imaging Systems, Accessories), By End-use Industry (Hospitals and Clinics, Diagnostic Imaging Centers, Breast Care Centers), and by Region; Global Insights & Forecasts (2024 - 2030)

According to Intent Market Research, the Breast Imaging Market is expected to grow from USD 4.2 billion in 2023 at a CAGR of 8.0% to touch USD 7.1 billion by 2030. The Breast Imaging Market is competitive; where the prominent players include GE Healthcare, Hologic, Canon, Siemens Healthineers, Philips Healthcare, FUJIFILM Holdings Corporation, among others.

Published: August, 2024
| Report ID: LI3590
| Life Sciences & Healthcare
Cell-based Assays Market By Offering (Consumables (Cell Lines, Reagents, Assays Kits, Microplates, Probes & Labels), Instruments & Software, Services), By Application (Drug Discovery (Pharmacokinetics, Toxicity, Pharmacodynamics), Basic Research), By End User (CROs, Pharmaceutical & Biopharmaceutical Companies, Research Institutes), and by Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Cell Based Assays Market is expected to grow from USD 17.9 billion in 2023-e at a CAGR of 7.9% to touch USD 30.5 billion by 2030. The Cell Based Assays Market is competitive; where the prominent players include Merck, Becton, Dickinson and Company, Lonza, Thermo Fisher Scientific, PerkinElmer, Abbott, Roche, and Danaher.

Published: August, 2024
| Report ID: LI3589
| Life Sciences & Healthcare
Temperature Management Systems Market By Product (Patient Cooling Systems, Patient Warming Systems, Accessories And Patient Warming & Cooling Systems), By Application (Acute Care, Perioperative, Newborn Care), By Medical Speciality (Neurology, Cardiology, Pediatrics, Orthopedics), and By Region; Global Insights & Forecast (2024 - 2030)

According to Intent Market Research, the Temperature Management Systems Market is expected to grow from USD 2.9 billion in 2023-e at a CAGR of 4.4% to touch USD 4.0 billion by 2030. The Temperature Management Systems Market is dominated by key players such as 3M, Asahi-Kasei Corporation, Becton, Dickinson and Company, ICU Medical, Gentherm Incorporated, GE Healthcare, Medtronic, Stryker, and Dragerwerk.

Published: August, 2024
| Report ID: LI3569
| Life Sciences & Healthcare
Particle Size Analysis Market By Dispersion (Wet, Dry, Spray), By Technology (Laser Diffraction, Dynamic Light Scattering, Imaging, NTA, Sieve Analysis, Coulter Principle), By End-Use (Healthcare, Chemicals & Petroleum, Mining, Minerals & Cement, Food & Beverages, Cosmetics), and By Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Particle Size Analysis Market is expected to grow from USD 400 million in 2023-e at a CAGR of 5.4% to touch USD 600 million by 2030. The particle size analysis market is dominated by key players such as Danaher, HORIBA, Bettersize Instruments, Spectris, Verder Scientific, METTLER TOLEDO, Sympatec, and Shimadzu Corporation.

Published: July, 2024
| Report ID: LI3561
| Life Sciences & Healthcare
Particle Therapy Market By Type (Heavy Ion, Proton Therapy), By System (Single-room, Multi-room), By Application (Treatment Application, Research Application), and By Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Particle Therapy Market is expected to grow from USD 0.7 billion in 2023-e at a CAGR of 7.6% to touch USD 1.2 billion by 2030. The particle therapy market is dominated by key players such as IBA Worldwide, ProTom International, Hitachi, Varian Medical Systems, Toshiba Medical Systems, Advanced Oncotherapy, Optivus Proton Therapy, and Danfysik.

Published: July, 2024
| Report ID: LI3560
| Life Sciences & Healthcare
Diagnostic Imaging Market By Application (X-ray, Magnetic Resonance Imaging (MRI), Ultrasound, Computed Tomography (CT), Nuclear Imaging, Mammography), By Technology (2D Imaging Technology, 3D/4D Imaging Technology), By End-Use (Hospitals, Diagnostic Centers, Ambulatory Care Centers, Research and Academia), and By Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Diagnostic Imaging Market is expected to grow from USD 25.1 billion in 2023-e at a CAGR of 5.0% to touch USD 35.4 billion by 2030. The diagnostic imaging market is dominated by key players such as GE Healthcare, Siemens Healthineers, Canon, Philips Healthcare, Hologic, Agfa-Gevaert Group, Planmed, and Fujifilm.

Published: July, 2024
| Report ID: LI3554
| Life Sciences & Healthcare
Nucleic Acid Isolation and Purification Market By Product Type (Instruments, Kits, Reagents), By Type (Circulating Nucleic Acid Isolation and Purification, Genomic DNA Isolation and Purification, Messenger RNA Isolation and Purification, Plasmid DNA Isolation and Purification), By Application Type (Agriculture & Animal Research, Diagnostics, Drug Discovery & Development, Personalized Medicine), By End-Use (Hospitals & Diagnostic Centers, Pharmaceutical & Biotechnology Companies, Academic & Government Research Institutes, CROs), and By Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Nucleic Acid Isolation and Purification Market is expected to grow from USD 6.0 billion in 2023-e at a CAGR of 7.6% to touch USD 10.1 billion by 2030. The nucleic acid isolation and purification market is dominated by key players such as Agilent Technologies, Danaher, Bio-Rad Laboratories, Thermo Fisher Scientific, Roche, Merck, Illumina, and Takara Bio.

Published: July, 2024
| Report ID: LI3550
| Life Sciences & Healthcare
Patient-Derived Xenograft / PDX Model Market By Implantation Method (Orthotopic, Subcutaneous), By Type (Rat, Mice), By Application (Biomarker Analysis, Preclinical Drug Development, Translational Research, Biobanks), and by Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Patient-Derived Xenograft / PDX Model Market is expected to grow from USD 356 million in 2023-e at a CAGR of 13.7% to touch USD 818 million by 2030. The patient-derived xenograft model market is dominated by key players such as Wuxi Apptec, Charles River Laboratories, The Jackson Laboratory, Taconic Biosciences, Urosphere, Xentech, Inotiv, and Oncodesign Precision Medicine.

Published: July, 2024
| Report ID: LI3549
| Life Sciences & Healthcare
Peptide Synthesis Market By Product & Service (Reagents, Equipment, Services), By Technology (Solid-Phase, Solution-Phase, Hybrid & Recombinant Technology), By End-User (Pharmaceutical & Biotechnology Companies, CDMOs & CROs, Academic & Research Institutes), and by Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Peptide Synthesis Market is expected to grow from USD 0.6 billion in 2023-e at a CAGR of 6.9% to touch USD 0.9 billion by 2030. The peptide synthesis market is competitive; where the prominent players include Thermo Fisher Scientific, Merck, Kaneka Corporation, GenScript Biotech Corporation, Bachem Holding, Biotage, Syngene, Mesa Labs, ProteoGenix, and Bio-Synthesis Inc.

Published: July, 2024
| Report ID: LI3547
| Life Sciences & Healthcare
Medical Aesthetics Market By Product (Cosmetics Implant, Facial Aesthetic Products, Skin Aesthetic Devices, Physician-dispensed Cosmeceuticals, Body Contouring Devices, Nail Treatment Laser Devices), By Procedure (Surgical Procedures, Non-Surgical Procedures), By End-use Industry (Beauty Centers, Clinics, Hospitals & Medicals Spas, Home Care Settings), and by Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Medical Aesthetics Market is expected to grow from USD 14.6 billion in 2023-e at a CAGR of 10.5% to touch USD 29.4 billion by 2030. The medical aesthetics market is dominated by key players such as AbbVie, Ipsen, Alma Lasers, Cynosure, Galderma, Medytox, Merz, Cutera Inc., Fotona, amongst others.

Published: July, 2024
| Report ID: LI3543
| Life Sciences & Healthcare
Biomedical Textiles Market By Fiber Type (Biodegradable Fiber (Cotton, Collagen, Chitin, Polylactic Acid), Non-Biodegradable Fiber (Viscose, Polyester, Polyamide)), By Fabric Type (Woven, Non-Woven), By Application (Surgical Sutures, Non-Implantable), and By Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Biomedical Textiles Market is expected to grow from USD 18.8 billion in 2023-e at a CAGR of 15.9% to touch USD 52.7 billion by 2030. The Biomedical Textiles Market is dominated by key players such as Cardinal Health, Smith & Nephew, Integra LifeSciences, Johnson & Johnson, Medline, DSM, Becton, Dickinson & Company, and Medtronic.

Published: July, 2024
| Report ID: LI3542
| Life Sciences & Healthcare
Healthcare Cloud Computing Market By Component (Software, Services), By Deployment (Public, Hybrid, Private), By End Use (Healthcare Providers, Healthcare Payers), By Products (Healthcare Provider Solutions, Healthcare Payer Solutions), and by Region; Global Insights & Forecasts (2024 - 2030)

According to Intent Market Research, the Healthcare Cloud Computing Market is expected to grow from USD 43.9 billion in 2023-e at a CAGR of 17.1% to touch USD 133.1 billion by 2030. The healthcare cloud computing market is dominated by key players such as Microsoft, AWS, IBM, Carecloud, Siemens Healthineers, GE Healthcare, Allscripts, Fujifilm, and Dell.

Published: July, 2024
| Report ID: LI3541
| Life Sciences & Healthcare
Digital Pathology Market By Product (Scanners, Software, Storage Systems), By Type (Veterinary Pathology, Human Pathology), By End Use (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Hospitals & Reference Laboratories), By Application (Disease Diagnostics, Drug Discovery, Disease Diagnosis) and by Region; Global Insights & Forecasts (2024 - 2030)

According to Intent Market Research, the Digital Pathology Market is expected to grow from USD 1.2 billion in 2023-e at a CAGR of 11.1% to touch USD 2.5 billion by 2030. The digital pathology market is dominated by key players such as Philips, Hamamatsu Photonics, Indica Labs, Roche, Hologic, Fujifilm, Paige AI, and Danaher.

Published: July, 2024
| Report ID: LI3519
| Life Sciences & Healthcare
Vascular Access Device Market by Type (Central Vascular Access Device, Peripheral Vascular Access Device, Accessories), By Application (Drug Administration, Blood Transfusion, Fluid & Nutrition Administration, Diagnostic), By End User (Hospitals & Clinics, Diagnostic Centers), and by Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Vascular Access Device Market is expected to grow from USD 5.2 billion in 2023-e at a CAGR of 7.1% to touch USD 8.9 billion by 2030. The vascular access device market is dominated by key players such as 3M, ICU Medical, Teleflex, AngioDynamics, Medtronic, Argon Medical Devices, and B. Braun.

Published: July, 2024
| Report ID: LI3516
| Life Sciences & Healthcare
Ultrasound Market By Technology (Diagnostic, Therapeutic), By Display (Color, Black & White), By Application (Obstretic/Gynecological, Urology, Orthopedic, Vascular, Cardiology), By End-user (Hospitals, Maternity Center, Ambulatory Centers), and by Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Ultrasound Market is expected to grow from USD 8.1 billion in 2023-e at a CAGR of 5.8% to touch USD 12.1 billion by 2030. The ultrasound market is dominated by key players such as GE Healthcare, Philips, Samsung, Neusoft, Canon Medical Systems, Siemens, and Fujifilm.

Published: July, 2024
| Report ID: LI3500
| Life Sciences & Healthcare
Digital Dentistry Market By Application (Diagnostic, Therapeutic), By Product (Software, Equipment), By End-Use (Hospital, Dental Clinics, Labs), and by Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Digital Dentistry Market is expected to grow from USD 6.9 billion in 2023-e at a CAGR of 10.4% to touch USD 13.8 billion by 2030. The Digital Dentistry Market is dominated by key players such as Dentsply Sirona, Envista Holdings Corporation, 3M, Planmeca, Vatech, Roland DG Corporation, 3D Systems, and Ivoclar Vivadent.

Published: July, 2024
| Report ID: LI3495
| Life Sciences & Healthcare
Diagnostic Electrocardiograph Market By Lead Type (5-lead, 3-lead, 6-lead, 12-lead, Single Lead), By Product (Devices, Software and Services), By End-Use (Hospitals & Clinics, Cardiac Centers, Ambulatory Surgical Centers), and by Region; Growth Trends & Forecasts (2024 - 2030)

According to Intent Market Research, the Diagnostic Electrocardiograph Market is expected to grow from USD 7.7 billion in 2023-e at a CAGR of 6.4% to touch USD 11.9 billion by 2030. The diagnostic electrocardiograph market is dominated by key players such as GE HealthCare, Philips Healthcare, Nihon Kohden, OSI Systems, Medtronic, Mindray, Schiller AG, and Hill-Rom Holdings.

Published: July, 2024
| Report ID: LI3490
| Life Sciences & Healthcare
Digital Pharmacy Market By Platform (Websites, Apps), By Drug Type (Over-the-counter Products, Prescription Medicines), By Products (Medicines & Treatments, Vitamins & Supplements, Personal Care Products), By Business Model (Franchise, Captive, Aggregator), By Geographic Coverage (Rural Areas, Urban Areas) and By Region; Global Insights & Forecasts (2024 - 2030)

According to Intent Market Research, the Digital Pharmacy Market is expected to grow from USD 19.4 billion in 2023-e at a CAGR of 9.5% to touch USD 35.9 billion by 2030. The digital pharmacy market is dominated by key players such as Cigna, CVS Health, Walmart, Walgreen, Pharmeasy, Apollo Pharmacy, Amazon, Apex Pharmacy, and Optum, Inc.

Published: July, 2024
| Report ID: LI3487
| Life Sciences & Healthcare
Optometry Equipment Market By Application (Glaucoma, Age-related Macular Degeneration (AMD), General Examination, Cataracts), By Type (General Examination Products, Cornea and Cataract Examination Products, Retina and Glaucoma Examination Products), By End Use (Hospitals, Eye Clinics), and by Region; Global Insights & Forecasts (2024 - 2030)

According to Intent Market Research, the Optometry Equipment Market is expected to grow from USD 4.3 billion in 2023-e at a CAGR of 6.5% to touch USD 6.7 billion by 2030. The optometry equipment industry market is dominated by key players such as Carl Zeiss Meditec, Alcon, Canon, Bausch Health, Johnson & Johnson, Revenio Group, and NIDEK CO.

Published: July, 2024
| Report ID: LI3483
| Life Sciences & Healthcare
Spatial Genomics & Transcriptomics Market By Product (Consumables, Instruments, Software), By Technique (In-Situ Hybridization, Immunohistochemistry (IHC), Microscopy based RNA Imaging, Sequencing Techniques, Microscopy based RNA Imaging), By End-Use (Pharmaceutical and Biotechnology Companies, Academic & Research Institutes, Contract Research Organization), By Application (Translational Research, Drug Discovery & Development), and by Region; Global Insights & Forecasts (2024 - 2030)

According to Intent Market Research, the Spatial Genomics & Transcriptomics Market is expected to grow from USD 4.5 billion in 2023-e at a CAGR of 11.9% to touch USD 9.9 billion by 2030. The spatial genomics & transcriptomics market is competitive; where the prominent players include Illumina, 10X Genomics, Bruker, Bio-Rad Laboratories, Seven Bridges Genomics, Danaher, and PerkinElmer.

Published: July, 2024
| Report ID: LI3482
| Life Sciences & Healthcare
ERCP (Endoscopic Retrograde Cholangiopancreatography) Market By Product (Energy Devices, Visualization Systems, Endoscopes, Endotherapy Devices, Endoscopes), By Procedure (Biliary Sphincterotomy, Pancreatic Sphincterotomy, Biliary Sphincterotomy, Biliary Stenting, Biliary Dilatation, Pancreatic Duct Stenting), By End Use (Ambulatory Surgery Centres & Clinics, Hospitals), and by Region; Global Insights & Forecasts (2024 - 2030)

According to Intent Market Research, the ERCP market is expected to grow from USD 1.9 billion in 2023-e at a CAGR of 4.0% to touch USD 2.5 billion by 2030. The ERCP market is dominated by key players such as CONMED Corporation, Boston Scientific, B. Braun, Medtronic, Telemed Systems, Steris, Medi-Globe, Olympus, and Fujifilm.

Published: July, 2024
| Report ID: LI3480
| Life Sciences & Healthcare
Veterinary Infectious Disease Diagnostics Market By Technology (Immunodiagnostics, Molecular Diagnostics), By Animal Type (Food Producing Animals, Companion Animals), By Infection Type (Bacterial, Viral, Other Infections), By End Use (Point of Care, Reference Laboratories, Veterinary Hospitals and Clinics, Research Institutes and Universities), and by Region; Global Insights & Forecasts (2024 - 2030)

According to Intent Market Research, the veterinary infectious disease diagnostics market is expected to grow from USD 2.3 billion in 2023-e at a CAGR of 9.5% to touch USD 4.3 billion by 2030. The veterinary infectious disease diagnostics market is dominated by key players such as Zeotis, bioMérieux, Qiagen, Heska Corporation, Idexx Laboratories, INDICAL Bioscience, Thermo Fisher Scientific, and MEGACOR.

Published: July, 2024
| Report ID: LI3479
| Life Sciences & Healthcare
Positron Emission Tomography Market By Application (Cardiovascular, Oncology, Neurological), By Product (PET/CT Systems, PET/MRI Systems, Standalone PET System), By End Use (Ambulatory Care Centers, Hospital & Surgical Centers, Diagnostics & Imagining Clinics), and by Region; Global Insights & Forecasts (2024 - 2030)

According to Intent Market Research, the Positron Emission Tomography Market is expected to grow from USD 2.7 billion in 2023-e at a CAGR of 5.0% to touch USD 3.8 billion by 2030. The positron emission tomography market is dominated by key players such as Siemens Healthineers, GE Healthcare, Canon, Philips, Mediso, Oncovision, Kindsway Biotech, and Prescient Medical Imaging.

Published: July, 2024
| Report ID: LI3478
| Life Sciences & Healthcare
Oncology Information System Market By Application (Medical Oncology, Surgical Oncology, Radiation Oncology), By Product and Services (Software, Professional Service), By End Use (Government Institutions, Hospitals & Diagnostics Imaging Centers, Research Facilities, Ablation Care Centers and Cancer Care Centers), and by Region; Global Insights & Forecasts (2024 - 2030)

According to Intent Market Research, the Oncology Information System Market is expected to grow from USD 7.8 billion in 2023 at a CAGR of 7.9% to touch USD 13.3 billion by 2030. The oncology information system market is dominated by key players such as Siemens Healthineers, Philips Healthcare, GE Healthcare, Allscripts Healthcare, IBM, Accuray Incorporated, Epic systems, and Roche.

Published: July, 2024
| Report ID: LI3469
| Life Sciences & Healthcare
Medical Supplies Market By Application (Cardiology, Infection Control, Urology, Wound Care, IVD, Respiratory, Radiology), By Type (Sterilization Consumables, Personal Protective Equipment, Disinfectants, Diagnostic Supplies, Infusion & Injectable Supplies, Sleep Apnea Consumables, Radiology Consumables, Wound Care Consumables, Dialysis Consumables, Catheters), By End Use (Clinics, Hospitals), and by Region; Global Insights & Forecasts (2024 - 2030)

According to Intent Market Research, the Medical Supplies Market is expected to grow from USD 141.1 billion in 2023-e at a CAGR of 4.1% to touch USD 186.4 billion by 2030. The medical supplies market is dominated by key players such as Cardinal Health, Medtronic, Becton, Dickinson and Company, B. Braun, Abbott, Stryker, 3M, Smith & Nephew, and Thermo Fisher Scientific.

Published: July, 2024
| Report ID: LI3462
| Life Sciences & Healthcare
Microcatheters Market By Product Design (Single-Lumen, Dual and Multi-Lumen), By Type (Aspiration, Delivery, Diagnostic, Steerable), By Application (Oncology, Cardiovascular, Neurovascular, Peripheral Vascular), By End Use (Hospitals, Surgical Centres, & Specialty Clinics, and Ambulatory Care Centres), and by Region; Global Insights & Forecasts (2024 - 2030)

According to Intent Market Research, the Microcatheters Market is expected to grow from USD 0.8 billion in 2023 at a CAGR of 9.2% to touch USD 1.3 billion by 2030. The microcatheters market is competitive; where the prominent players include Boston Scientific, Stryker Corporation, Teleflex Incorporated, Kaneka Corporation, Becton Dickinson and Company, Asahi Intecc, Johnson & Johnson, and Medtronic.

Published: July, 2024
| Report ID: LI3451
| Life Sciences & Healthcare
Molecular Diagnostics Market By Test Type (Lab, PoC), By Product & Service (Reagents & Kits, Instruments, Services & Software), By Sample Type (Urine, Blood, Serum & Plasma), By Technology (Polymerase Chain Reaction, DNA Sequencing & Next-Generation Sequencing, In-situ Hybridization, Isothermal Nucleic Acid Amplification Technology, DNA Microarray), By Application (Infectious Diseases, Oncology Testing, Genetic Testing, COVID-19), By End Use (Diagnostic Laboratories Hospitals & Clinics), and by Region; Global Insights & Forecasts (2024 - 2030)

According to Intent Market Research, the Molecular Diagnostics Market is expected to grow from USD 15.8 billion in 2023 at a CAGR of 10.9% to touch USD 32.6 billion by 2030. The molecular diagnostics market is competitive; where the prominent players include Abbott, Illumina, Danaher, Roche Diagnostics, Hologic, Thermo Fisher Scientific, Siemens Healthineers, Becton, Dickinson and Company, and Qiagen.

Published: July, 2024
| Report ID: LI3450
| Life Sciences & Healthcare
Smart Pills Market By Application (Targeted Drug Delivery, Capsule Endoscopy, Vital Sign Monitoring), By Target Area (Esophagus, Stomach, Small Intestine, Large Intestine), By End User (Hospitals, Diagnostic Centers), and by Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Smart Pills Market is expected to grow from USD 0.6 billion in 2023 at a CAGR of 11.7% to touch USD 1.3 billion by 2030. The Smart Pills Market is competitive; where the prominent players include Medtronic, ElectRx, BodyCap, CapsoVision, IntroMedic, Check-Cap, IntroMedic, AnX Robotica, Olympus, and Otsuka America Pharmaceutical.

Published: July, 2024
| Report ID: LI3446
| Life Sciences & Healthcare
Stem Cell Therapy Market By Therapy Type (Allogeneic, Autologous), By Cell Source (Embryonic Stem Cells, Adult Stem Cells, Induced Pluripotent Stem Cells , Others), By Application (Oncology Disorders, Cardiovascular Disorders, Neurological Disorders, Orthopedic Disease, Others), and By Region; Global Insights & Forecasts (2024 - 2030)

According to Intent Market Research, the Stem Cell Therapy Market is expected to grow from USD 5.1 billion in 2023 at a CAGR of 19.3% to touch USD 17.7 billion by 2030. The stem cell therapy market is dominated by key players such as AllCells, ANTEROGEN, Becton, Dickinson, & Company, Takeda Pharmaceutical, RTI Surgical, Merck, Pharmicell, and Thermo Fisher Scientific.

Published: July, 2024
| Report ID: LI3439
| Life Sciences & Healthcare
Amniotic Products Market By Type (Cryopreserved Amniotic Membranes, Dehydrated Amniotic Membranes), By Application (Wound Care, Ophthalmology, Orthopaedics), By End Use (Hospital & Ambulatory Surgical Centers), and by Region; Global Insights & Forecasts (2024 - 2030)

According to Intent Market Research, the Amniotic Products Market is expected to grow from USD 0.9 billion in 2023 at a CAGR of 6.9% to touch USD 1.4 billion by 2030. The amniotic products market is competitive; where the prominent players include Organogenesis, Smith+Nephew, Integra LifeSciences, MIMEDX, Stryker, Tides Medical, and MTF Biologics.

Published: July, 2024
| Report ID: LI3435
| Life Sciences & Healthcare
High Throughput Screening Market By Product & Service (Software, Instrument, Consumable, Service), By Technology (Cell-based Assays, Label-free, Lab-on-a-Chip), By Application (Biochemical Screening, Drug Discovery, Life Sciences Research), By End-Use (Pharmaceutical & Biotechnology Companies, Contract Research Organizations, Academic & Research Institutes), and by Region; Global Insights and Forecast (2024 - 2030)

According to Intent Market Research, the High Throughput Screening Market is expected to grow from USD 24.4 billion in 2023 at a CAGR of 11.1% to touch USD 51.0 billion by 2030. The High Throughput Screening Market is competitive; where the prominent players include Thermo Fisher Scientific, Lonza, Agilent Technologies, Eurofins Scientific, Merck, Danaher Corporation, and PerkinElmer.

Published: July, 2024
| Report ID: LI3428
| Life Sciences & Healthcare
ATP Assays Market By Product (Consumables (Microplates, Reagents & Kits), Instruments (Luminometer, Spectrophotometer)), By Application (Disease Testing, Drug Discovery, Contamination), By End-use (Academics, Hospitals, Pharmaceuticals, F&B), and by Region; Global Insights & Forecast (2024 - 2030)

According to Intent Market Research, the ATP Assays Market is expected to grow from USD 0.3 billion in 2023 at a CAGR of 7.1% to touch USD 0.5 billion by 2030. The ATP Assays Market is competitive; where the prominent players include Thermo Fisher Scientific, Promega Corporation, Merck, PerkinElmer, Agilent Technologies, 3M, and Agilent.

Published: July, 2024
| Report ID: LI3427
| Life Sciences & Healthcare
Digital Health Market By Offering (Software, Services, Hardware), By Technology (mHealth, Telehealth, Healthcare Analytics, Digital Health Systems), By Application (Health & Fitness, Disease Monitoring, Behavioral Health), By End-user (Hospitals & Clinics, Fitness Enthusiasts) and By Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Digital Health Market is expected to grow from USD 181.0 billion in 2023-e at a CAGR of 6.4% to touch USD 279.4 billion by 2030. The digital health market is dominated by key players such as Abbott, Beckman Coulter, Boston Scientific, Medtronic, J&J MedTech, Philips Healthcare, GE Healthcare, Siemens Healthineers, Teladoc, Samsung Healthcare, and McKesson.

Published: April, 2024
| Report ID: LI3216
| Life Sciences & Healthcare
Pen Needles Market By Type (Safety Pen, Standard Pen), By Setting (Home Care Settings, Hospitals), By Application (Insulin, GLP 1, Growth Hormone), and by Region; Growth Trends & Forecasts (2024 - 2030)

According to Intent Market Research, the Pen Needles Market is expected to grow from USD 1.5 billion in 2023-e at a CAGR of 8.6% to touch USD 2.7 billion by 2030.The Pen Needles market is dominated by key players such as Novo Nordisk, B.Braun, Nipro, Owen Mumford, Arkray and Ultimed.

Published: March, 2024
| Report ID: HC3390
| Life Sciences & Healthcare
Softgel Capsules Market By Material Type (Gelatin, Other Materials), By Source (Porcine, Bovine), By Application (Pharmaceuticals, Nutraceutical and Dietary Supplements), and By Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Softgel Capsules Market is expected to grow from USD 1.1 billion in 2023-e at a CAGR of 5.8% to touch USD 1.6 billion by 2030. The Softgel Capsules Market is dominated by key players such as United Laboratories, CAPTEK, Fuji Capsule, Softgel Technologies, Sirio Pharma, and Gelita.

Published: March, 2024
| Report ID: HC3371
| Life Sciences & Healthcare
Feminine Hygiene Products Market By Nature (Disposable, Reusable), By Type (Menstrual Cups, Sanitary Napkins, Panty Liners, Tampons), and By Region; Global Insights & Forecast (2024 - 2030)

According to Intent Market Research, the Feminine Hygiene Products Market is expected to grow from USD 23.4 billion in 2023-e at a CAGR of 5.0% to touch USD 33.0 billion by 2030. The Feminine Hygiene Products market is dominated by key players such as Kimberly-Clark Corporation, Procter & Gamble, Kao Corporation, Johnson & Johnson, Essity Aktiebolag, and Daio Paper Corporation.

Published: March, 2024
| Report ID: HC3362
| Life Sciences & Healthcare
Vaccine Adjuvants Market By Product (Particulate Adjuvants, Saponin-based Adjuvants, Adjuvant Emulsions, Pathogen Components), By Route of Administration (Intramuscular, Subcutaneous), By Application (Research Applications, Commercial Applications), By Type (Human Vaccine, Veterinary Vaccine), and By Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Vaccine Adjuvants Market is expected to grow from USD 0.8 billion in 2023-e at a CAGR of 6.5% to touch USD 1.3 billion by 2030. The vaccine adjuvants market is dominated by key players such as Agenus, Dynavax Technologies, Merck, Eubiologics, Hawaii, Aurorium, and Seppic.

Published: March, 2024
| Report ID: HC3361
| Life Sciences & Healthcare
Vaccines Market By Technology (Live Attenuated Vaccines, Recombinant Vaccines, Viral Vector Vaccines, m-RNA Vaccines, Inactivated & Subunit Vaccines), By Disease Indication (Combination Vaccines, Meningococcal Disease, Herpes Zoster, MMR, Polio, DTP, Pneumococcal Disease), By End-Use (Pediatric, Adult), and By Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Vaccines Market is expected to grow from USD 47.7 billion in 2023-e at a CAGR of 9.7% to touch USD 91.2 billion by 2030. The vaccines market is dominated by key players such as Pfizer, Panacea Biotec, Novovax, Daiichi Sankyo, Emergent, CSL, Sanofi, and Bharat Biotec.

Published: March, 2024
| Report ID: HC3360
| Life Sciences & Healthcare
Analytical Standards Market By Technique (Chromatography, Spectroscopy), By Method (Bioanalytical Testing, Raw Material Testing), By Category (Organic Analytical Standards, Inorganic Analytical Standards), By Application (Pharmaceutical Standards, Food & Beverages Standards, Forensic Standards), and by Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Analytical Standards Market is expected to grow from USD 1.4 billion in 2023-e at a CAGR of 6.5% to touch USD 2.2 billion by 2030. The Analytical Standards market is dominated by key players such as Merck, Agilent Technologies, Waters Corporation, LGC Standards, Restek Corporation, and PerkinElmer.

Published: March, 2024
| Report ID: HC3346
| Life Sciences & Healthcare
Clinical Trials Market By Phase (Phase I, II, III), By Service Type (Analytical Testing, Laboratory, Patient Recruitment, Clinical Trial Data Management, Protocol Designing), By Therapeutic Area (Oncology, Autoimmune Disease, Pain Management, Nephrology, Metabolic Disorders, Cardiology, Neurology), By Application (Vaccine, Small Molecule, Monoclonal Antibodies, Cell & Gene Therapy), and By Region; Global Insights & Forecast (2024 - 2030)

According to Intent Market Research, the Clinical Trials Market is expected to grow from USD 45.8 billion in 2023-e at a CAGR of 8.2% to touch USD 79.6 billion by 2030. The clinical trials market is dominated by key players such as Laboratory Corporation of America Holdings, Parexel International Corporation, Icon PLC, IQVIA, Charles River Laboratories, Advanced Clinical, ACM Global Laboratories, and WuXi AppTec.

Published: March, 2024
| Report ID: HC3343
| Life Sciences & Healthcare
Pharmaceutical Packaging Equipment Market By Product (Primary Packaging, Secondary Packaging, Labelling and Serialization), By Formulation (Liquid Packaging Equipment, Solid Packaging Equipment, Semi-solid Packaging Equipment), By End User (Pharmaceutical Manufacturing Companies, Pharmaceutical CMOs), and by Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Pharmaceutical Packaging Equipment Market is expected to grow from USD 8.4 billion in 2023-e at a CAGR of 6.5% to touch USD 13.1 billion by 2030. The pharmaceutical packaging equipment market is dominated by key players such as Vanguard Pharmaceutical Machinery, Syntegon Technology, ACG Worldwide, Optima Packaging Group, Trustar Pharma Pack Equipment, MG2 s.r.l., Marchesini Group, Romaco, and Multivac.

Published: March, 2024
| Report ID: HC3337
| Life Sciences & Healthcare
Cardiac Safety Services Market by Type (Integrated, Standalone), By Services (Blood Pressure Measurement, ECG/Holter Measurement, Cardiac Imaging, Thorough QT Studies), By End-use (Cardiovascular Imaging Services, Pharmaceutical & Biopharma), and by Region; Global Insights & Forecast (2024 - 2030)

According to Intent Market Research, the Cardiac Safety Services Market is expected to grow from USD 700 million in 2023-e at a CAGR of 11.2% to touch USD 1,471 million by 2030. The cardiac safety services market is dominated by key players such as Laboratory Corporation of America Holdings, Medpace, Certara, Ncardia, SGS, Icon, Charles River Laboratories and Philips.

Published: March, 2024
| Report ID: HC3331
| Life Sciences & Healthcare
Antimicrobial Resistance Surveillance Market By Solution (Diagnostic Kits, Diagnostic System, Surveillance Software, Service), By Application (Public Health Surveillance, Clinical Diagnostics), By End-users (Hospitals & Clinics, Academic & Research Institutes), and By Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Antimicrobial Resistance Surveillance Market is expected to grow from USD 5.6 billion in 2023-e at a CAGR of 5.1% to touch USD 7.9 billion by 2030. The antimicrobial resistance surveillance market is dominated by key players such as Luminex Corporation, Thermo Fisher, Danaher, Becton, Dickinson and Company, Accelerate Diagnostics, BioSpace, Bio-Rad, Roche, Merck, and Bruker

Published: February, 2024
| Report ID: HC3292
| Life Sciences & Healthcare
Blood Screening Market By Product (Reagent & Kits, Services & Software, Instrument), By Technology (NAT, NGS, Rapid Test, Western Blot), By End-use (Blood Banks, Hospitals), and by Region; Global Insight & Forecasts (2024 - 2030)

According to Intent Market Research, the Blood Screening Market is expected to grow from USD 2.3 billion in 2023-e at a CAGR of 6.7% to touch USD 3.6 billion by 2030. The blood screening market is dominated by key players such as Roche, Abbott, bioMérieux, Bio-Rad Laboratories, Siemens Healthineers, Danaher, and Thermo Fisher Scientific.

Published: February, 2024
| Report ID: HC3291
| Life Sciences & Healthcare
Gene Therapy Market By Type (Cell Replacement, Gene Silencing, Gene Augmentation), By Vector (Viral, Non-viral), By Therapeutic Area (Neurology, Hepatology, Oncology), By Route of Administration (Intravenous, Other Routes), and By Region; Global Insights & Forecast (2024 - 2030)

The Gene Therapy market is projected to grow from USD 8.6 billion in 2023-e to USD 32.4 billion by 2030, registering a CAGR of 20.9% during the forecast period. The Gene Therapy market is dominated by key players such as Novartis, Uniqure, Johnson & Johnson, Orchard Therapeutics, Biogen, Gilead Sciences, Bristol-Myers Squibb, and Sarepta Therapeutics.

Published: February, 2024
| Report ID: HC3284
| Life Sciences & Healthcare
Antibody Drug Conjugates (ADC) Market By Product (Adcetris, Enhertu, Kadcyla, Trodelvy, Padcev, Polivy), By Linker Type (Cleavable, Non-Cleavable), By Payload Type (MMAE/Auristatin, Maytansinoids, Calicheamicin), By Disease Type (Blood Cancer, Breast Cancer), and by Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Antibody Drug Conjugates Market is expected to grow from USD 9.3 billion in 2023-e at a CAGR of 14.7% to touch USD 24.2 billion by 2030. The antibody drug conjugates market is dominated by key players such as Pfizer, Daiichi Sankyo, Seagen, Takeda, Gilead Sciences, Roche, Astellas, ADC Therapeutics, ImmunoGen, AbbVie.

Published: February, 2024
| Report ID: HC3275
| Life Sciences & Healthcare
Wound Care Market By Product (Advanced Wound Care Products, Traditional Wound Care Products, Surgical Wound Care Products), By Wounds (Chronic Wound, Acute Wound), By End Use (Hospitals, Clinics, Home Care Settings), and by Region; Global Insights & Forecast (2024 - 2030)

According to Intent Market Research, the Wound Care Market is expected to grow from USD 20.4 billion in 2023-e at a CAGR of 5.4%to touch USD 29.5 billion by 2030. The Wound Care Market is dominated by key players such as Medtronic, 3M, Cardinal Health, Convatec, B. Braun, Paul Hartmann, and Organogenesis.

Published: February, 2024
| Report ID: HC3273
| Life Sciences & Healthcare
Stem Cell Manufacturing Market By Product (Consumables, Stem Cell Lines, Instruments), By Application (Clinical, Cell Tissue & Banking, Research), By End-use (Pharmaceutical & Biotechnology Companies, Academic Institutes, Research Laboratories & Contract Research Organizations, Hospitals & Surgical Centers, Cell & Tissue Banks), and By Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Stem Cell Manufacturing Market is expected to grow from USD 12.1 billion in 2023-e at a CAGR of 10.8% to touch USD 24.8 billion by 2030. The stem cell manufacturing market is competitive; where the prominent players include Thermo Fisher Scientific, Merck, Lonza, Danaher, Sartorius, Becton, Dickinson, and Company, Takara Bio, Getinge, and Eppendorf.

Published: February, 2024
| Report ID: HC3259
| Life Sciences & Healthcare
Advance Directives Market By Component (Services, Software), By Demographics (Young Adults (18-39 yrs), Middle Aged (40-64 yrs), Elderly Population (65 yrs & above)), By End-use Industry (B2B (Providers, Payers), B2C), and By Region; Global Insights & Forecast (2024 - 2030)

According to Intent Market Research, the Advance Directives Market is expected to grow from USD 116.9 billion in 2023-e at a CAGR of 18.3% to touch USD 378.0 billion by 2030. The advance directives market is dominated by key players such as Iris Healthcare, Bronson Healthcare, Thoroughcare, New Century Health, ADvault, Vynca, WiserCare, and Sharp HealthCare.

Published: February, 2024
| Report ID: HC3257
| Life Sciences & Healthcare
Molecular Quality Controls Market By Product (Instrument Specific Control (PCR, DNA Sequencing), Independent Control), By Application (Oncology Testing, Infectious Disease Diagnostics, Genetic Testing), By End-use (Hospitals, Diagnostic Labs, Academic & Research Institutes), and By Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Molecular Quality Controls Market is expected to grow from USD 0.2 billion in 2023-e at a CAGR of 5.6% to touch USD 0.3 billion by 2030. The Molecular Quality Controls Market is competitive; where the prominent players include Abbott, Danaher, Bio-Rad, Roche, Thermo Fisher Scientific, Grifols, QuidelOrtho, and Randox Laboratories.

Published: February, 2024
| Report ID: HC3253
| Life Sciences & Healthcare
Multimodal Imaging Market By Technology (PET/MR, PET/CT, SPECT/CT, OCT/FMT), By Application (Cardiology, Brain, Oncology, Ophthalmology), By End-use (Diagnostic Centers, Hospitals, Academia, Research), and By Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Multimodal Imaging Market is expected to grow from USD 4.0 billion in 2023-e at a CAGR of 5.2% to touch USD 5.6 billion by 2030. The Multimodal Imaging Market is dominated by key players such as Philips, GE Healthcare, Canon, Siemens Healthineers, Neusoft Corporation, Fujifilm, Bruker, and Topcon Corporation.

Published: February, 2024
| Report ID: HC3248
| Life Sciences & Healthcare
MRI Systems Market By Field Strength (Low-to-Mid, Ultra-High), By Architecture (Open, Closed), By Application (Spinal, Neuro, Pelvic, Breast, Cardiology), By End-use (Diagnostic Centers, Hospitals), and By Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the MRI Systems market is expected to grow from USD 4.9 billion in 2023-e at a CAGR of 4.5% to touch USD 6.7 billion by 2030. The MRI Systems market is dominated by key players such as Philips, Siemens Healthineers, GE Healthcare, Fonar Corporation, Fujifilm, Canon, and Neusoft Medical Systems.

Published: February, 2024
| Report ID: HC3245
| Life Sciences & Healthcare
Metagenomic Sequencing Market By Products & Services (Sequencing Services, Reagents & Consumables), By Technology (Whole-genome, Shotgun, 16S rRNA Sequencing), By Application (Clinical Diagnostic, Drug Discovery, Industrial), and by Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Metagenomic Sequencing Market is expected to grow from USD 1.9 billion in 2023-e at a CAGR of 17.0% to touch USD 5.7 billion by 2030. The Metagenomic Sequencing Market is competitive; where the prominent players include Thermo Fisher Scientific, QIAGEN, PerkinElmer, Illumina, Pacific Biosciences, and Eurofins Scientific.

Published: February, 2024
| Report ID: HC3233
| Life Sciences & Healthcare
Metabolism Assays Market By Product (Instruments, Assays), By Technology (Spectrometry, Colorimetry, Fluorimetry), By Application (Diagnostics, Research), By End-use (Pharmaceutical & Biotechnology Companies, CROs, Hospitals, Diagnostic Laboratories), and by Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Metabolism Assays Market is expected to grow from USD 1.4 billion in 2023-e at a CAGR of 7.3% to touch USD 2.2 billion by 2030. The Metabolism Assays Market is dominated by key players such as, Abcam, Thermo Fisher, Merck, Agilent Technologies, Sartorius, and Mitsubishi Corporation.

Published: February, 2024
| Report ID: HC3231
| Life Sciences & Healthcare
Medical Equipment Maintenance Market By Product (Medical Lasers, Surgical Equipment, Patient Monitoring & Life Support Devices), By Service Type (Corrective Maintenance, Preventive Maintenance, Operational Maintenance), By Service Provider (Independent Service Organization, Single-Vendor OEMs, In-house Maintenance), By End-use (Diagnostic Imaging Centers, Hospitals, Dialysis Centers), and by Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Medical Equipment Maintenance Market is expected to grow from USD 46.3 billion in 2023-e at a CAGR of 10.1% to touch USD 90.8 billion by 2030. The Medical Equipment Maintenance Market is dominated by key players such as GE Healthcare, Siemens Healthineers, Philips, Medtronic, Hitachi, and B. Braun.

Published: February, 2024
| Report ID: HC3227
| Life Sciences & Healthcare
Leukapheresis Market By Product Type (Leukapheresis Devices, Leukapheresis Disposables), By Application (Research, Therapeutic), By End-use (Hospitals & Transfusion Centers, Pharmaceutical & Biotechnology Companies, Blood Centers, Academic & Research Institutes), and by Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Leukapheresis Market is expected to grow from USD 62 million in 2023-e at a CAGR of 7.9% to touch USD 105 million by 2030. The leukapheresis market is dominated by key players such as Asahi Kasei, Fresenius, Terumo BCT, Haemonetics Corporation, Lonza, ZenBio, Macopharma, and Miltenyi Biotec.

Published: February, 2024
| Report ID: HC3225
| Life Sciences & Healthcare
Medical Radiation Shielding Market By Product (Lead Sheet, Doors, Windows, Shields, Booths, Curtain, X-Ray), By Solution (Cyclotron, PET, Radiation Therapy, CT, MRI), By End-use (Hospitals, Diagnostic Centers, Clinics & ASCs), and by Region; Global Insights & Forecast (2024 – 2030)

Medical Radiation Shielding Market By Product (Lead Sheet, Doors, Windows, Shields, Booths, Curtain, X-Ray), By Solution (Cyclotron, PET, Radiation Therapy, CT, MRI), By End-use (Hospitals, Diagnostic Centers, Clinics & ASCs), and by Region; Global Insights & Forecast (2024 – 2030)

Published: February, 2024
| Report ID: HC3224
| Life Sciences & Healthcare
Medical Device Testing Market By Service (Inspection, Testing, Certification), By Sourcing (Outsourced, In-house), By Device Class (I, II, III), By Technology (Active Medical Devices, Active Implant, Non-active Medical Devices, IVD), and By Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Medical Device Testing Market is expected to grow from USD 10.1 billion in 2023-e at a CAGR of 4.4% to touch USD 13.7 billion by 2030. The Medical Device Testing Market is dominated by key players such as Intertek Group, Eurofins Scientific, SGS, Bureau Veritas, Charles River Laboratories, and TÜV SÜD.

Published: February, 2024
| Report ID: HC3223
| Life Sciences & Healthcare
Label Free Detection Market By Product & Service (Instruments, Software & Services, Consumables), By Technology (Surface Plasmon Resonance, Bio-Layer Interferometry, Isothermal Titration Calorimetry), By Application (Binding Kinetics, Binding Thermodynamics, HIT Confirmation), and by Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Label Free Detection Market is expected to grow from USD 0.5 billion in 2023-e at a CAGR of 8.2% to touch USD 0.9 billion by 2030. The label free detection market is competitive; where the prominent players include Danaher, Sartorius, Waters Corporation, PerkinElmer, Attana, Spectris, and Shimadzu Corporation.

Published: February, 2024
| Report ID: HC3219
| Life Sciences & Healthcare
Insulin Delivery Devices Market By Type (Insulin Pens, Insulin Pen Needles, Insulin Pumps, Insulin Syringes), By End-use (Hospitals & Specialty Clinics, Patients / Home-care), and by Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Insulin Delivery Devices Market is expected to grow from USD 29.2 billion in 2023-e at a CAGR of 8.0% to touch USD 50.0 billion by 2030. The insulin delivery devices market is dominated by key players such as Becton & Dickinson, Eli Lilly, Cerur Corporation, Biocon, Wockhardt, Medtronic, Roche, and Owen Mumford.

Published: February, 2024
| Report ID: HC3215
| Life Sciences & Healthcare
Intensity Modulated Radiotherapy Market By Radiation Type (Proton, Electron Beam, Photon, Carbon-Ion Radiation), By Application (Prostate Cancer, Brain Cancer, Lung Cancer, Breast Cancer), By End-use (Hospitals, Independent Radiotherapy Centers), and by Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Intensity Modulated Radiotherapy Market is expected to grow from USD 2.1 billion in 2023-e at a CAGR of 4.8% to touch USD 2.8 billion by 2030. The intensity modulated radiotherapy market is dominated by key players such as Elekta, Siemens Healthineers, Accuray Incorporated, Varian Medical Systems, Brainlab, Philips, and Hitachi.

Published: February, 2024
| Report ID: HC3208
| Life Sciences & Healthcare
Breast Lesion Localization Market By Type (Magnetic Localization, Wire Localization, Radioisotope Localization, Electromagnetic Localization), By Usage (Lumpectomy, Breast Biopsy), By End-use (Hospitals & Clinics, Ambulatory Surgical Centers, Diagnostic Imaging Centers) and by Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Breast Lesion Localization Market is expected to grow from USD 0.3 billion in 2023-e at a CAGR of 6.1% to touch USD 0.4 billion by 2030. The Breast Lesion Localization Market is dominated by key players such as Intramedical Imaging, GE Healthcare, Becton & Dickinson, Argon Medical, Medline Industries, Hologic, and Dragerwerk.

Published: February, 2024
| Report ID: HC3206
| Life Sciences & Healthcare
Bone Cement & Glue Market by Bone Cement (PMMA, Glass Polyalkenoate Cement, Calcium Phosphate), By Bone Glue (Synthetic, Natural), By Application (Arthroplasty, Vertebroplasty, Kyphoplasty), By End-use (Hospitals, Clinics, ASCS), and by Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Bone Cement & Glue Market is expected to grow from USD 1.6 billion in 2023-e at a CAGR of 6.0% to touch USD 2.3 billion by 2030. The Bone Cement & Glue Market is dominated by key players such as Stryker, Zimmer Biomet, Smith+Nephew, Medtronic, Cardinal Health, DePuy Synthes, and Enovis.

Published: February, 2024
| Report ID: HC3205
| Life Sciences & Healthcare
Intraoral/ IOL Scanners Market By Modality (Wired, Wireless), By Application (Prosthodontics, Endodontics, Orthodontics,), By End-user (Dental Hospitals & Clinics, Dental Research Institutes), and by Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Intraoral/ IOL Scanners Market is expected to grow from USD 0.6 billion in 2023-e at a CAGR of 10.6% to touch USD 1.1 billion by 2030. The Intraoral/ IOL scanners market is competitive; where the prominent players include DENTSPLY SIRONA, Align Technology, Envista, 3shape, Fussen, Launca, 3DISC, and Medit Corp.

Published: February, 2024
| Report ID: HC3204
| Life Sciences & Healthcare
Blood Culture Tests Market By Method (Automated, Conventional), By Product (Instruments, Consumables), By Technology (Molecular, Culture-Based, Proteomics), By End-use (Hospitals, Academic & Research Institutes, Reference Labs), and by Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Blood Culture Tests Market is expected to grow from USD 4.9 billion in 2023-e at a CAGR of 7.5% to touch USD 8.2 billion by 2030. The Blood Culture Tests Market is dominated by key players such as Roche Diagnostics, Becton, Dickinson and Company, Biomérieux, Himedia Laboratories, Scenker Biological Technology, Thermo Fisher Scientific, and Danaher.

Published: February, 2024
| Report ID: HC3202
| Life Sciences & Healthcare
Incontinence Care Products (ICP) Market By Product (Absorbents, Non-absorbents), By Usage (Reusable, Disposable), By Distribution Channel (Retail Pharmacies, E-commerce, Hospital Pharmacies), By End-use (Hospitals & Clinics, Home-based Patients), and By Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Incontinence Care Products Market is expected to grow from USD 11.9 billion in 2023-e at a CAGR of 5.1% to touch USD 16.9 billion by 2030. The Incontinence Care Products Market is dominated by key players such as Essity Aktiebolag, Procter & Gamble, Kimberly-Clark, Hartmann, Unicharm, Ontex BV, amongst others

Published: February, 2024
| Report ID: HC3196
| Life Sciences & Healthcare
Bioimpedance Analyzers Market By Type (Multi & Dual Frequency, Single), By Modality (Wireless, Wired), By Application (Whole Body Measurement, Segmental Body Measurement), By End-use (Home Users, Fitness Clubs, Hospitals), and by Region; Growth Trends & Forecasts (2024 - 2030)

According to Intent Market Research, the Bioimpedance Analyzers Market is expected to grow from USD 0.5 billion in 2023-e at a CAGR of 9.7% to touch USD 1.0 billion by 2030. The Bioimpedance Analyzers Market is dominated by key players such as Tanita Corporation, InBody, EVOLT, OMRON Corporation, RJL Systems, and Seca GmbH.

Published: February, 2024
| Report ID: HC3195
| Life Sciences & Healthcare
In Vitro Toxicology Testing Market By Product & Service (Assays, Consumables, Services, Equipment, Software), By Toxicity Endpoints & Test (Genotoxicity, Cytotoxicity, ADME, Dermal Toxicity, Phototoxicity), By Technology (High-throughput, Cell Culture, Toxic Genomics), By End-Use (Consumer Care, Pharmaceutical & Biopharmaceutical, Food), and By Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the In Vitro Toxicology Testing Market is expected to grow from USD 10.3 billion in 2023-e at a CAGR of 9.0% to touch USD 18.9 billion by 2030. The In Vitro Toxicology Testing Market is dominated by key players such as Thermo Fisher Scientific, SGS, Merck, Eurofins Scientific, Intertek, Laboratory Corporation of America Holdings, Agilent, amongst others.

Published: February, 2024
| Report ID: HC3190
| Life Sciences & Healthcare
Immunoassay Market By Product (Analyzers, Reagents & Kits), By Technology (Fluoroimmnoassay, ELISA, Radioimmunoassay, Rapid Tests, CLIA, Western Blotting), By Application (Endocrinology, Bone & Mineral Disorders, Infectious Diseases, Blood Screening, Allergy Diagnostics), By End-use (Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and CROs, Clinical Laboratories), and by Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Immunoassay Market is expected to grow from USD 33.3 billion in 2023-e at a CAGR of 5.4% to touch USD 48.2 billion by 2030. The Immunoassay Market is dominated by key players such as Abbott, Roche, Qiagen, Agilent, Thermo Fisher Scientific, Merck, Danaher, Siemens Healthineers, amongst others.

Published: February, 2024
| Report ID: HC3189
| Life Sciences & Healthcare
Humanized Mouse and Rat Model Market By Type (Humanized Mouse Model, Humanized Rat Model), By Application (Oncology, Immunology, Neuroscience, Toxicology, Infectious Diseases, Hematopoiesis), By End Use (Pharmaceutical & Biotechnology Companies, CROs & CDMOs, Academic & Research Institutes), and by Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Humanized Mouse and Rat Model Market is expected to grow from USD 0.2 billion in 2023-e at a CAGR of 6.0% to touch USD 0.4 billion by 2030. The Humanized Mouse and Rat Model Market is competitive; where the prominent players include Charles River Laboratories, Taconic Biosciences, Crown Bioscience, Amgen, Champions Oncology, Hera BioLabs, among others.

Published: February, 2024
| Report ID: HC3175
| Life Sciences & Healthcare
Cleanroom Technologies Market By Product (Consumable, Equipment), By Type (Mobile, Standard, Modular), By End-Use (Biotechnology, Pharmaceutical, Medical Device Manufacturers, Hospitals, Other End Users), and by Region; Growth Trends & Forecasts (2024 - 2030)

According to Intent Market Research, the Cleanroom Technologies Market is expected to grow from USD 7.8 billion in 2023-e at a CAGR of 6.3% to touch USD 12.0 billion by 2030. The cleanroom technologies market is dominated by key players such as Dynarex, Colandis, ABN Cleanroom Technology, Clean Rooms International, Kimberly-Clark, DuPont, and Illinois Tool Works.

Published: February, 2024
| Report ID: HC3153
| Life Sciences & Healthcare
Cellulose Ether & Derivatives Market By Product Type (Methyl Cellulose, Ethyl Cellulose, HEC, HPC), By End-use Industry (Pharmaceutical, Personal Care, Food & Beverage), and by Region; Growth Trends & Forecasts (2024 - 2030)

According to Intent Market Research, the Cellulose Ether & Derivatives Market is expected to grow from USD 7.7 billion in 2023-e at a CAGR of 8.6% to touch USD 13.7 billion by 2030. The cellulose ether & derivatives market is dominated by key players such as Dow, Ashland, Fenchem, Shandong Head, Rayonier Advanced Materials, Shin-Etsu Chemical, LOTTE Fine Chemicals, and DKS Co. Ltd.

Published: February, 2024
| Report ID: HC3151
| Life Sciences & Healthcare
Cell Culture Media Market By Type (Serum-free Media, Classical Media & Salts, Stem Cell Culture Media), By Application (Biopharmaceutical Production, Diagnostics, Drug Screening & Development, Tissue Engineering), By End-use (Pharmaceutical & Biotechnology Companies, Hospitals & Diagnostic Laboratories, Research Institutes), and by Region; Growth Trends & Forecasts (2024 - 2030)

According to Intent Market Research, the Cell Culture Media Market is expected to grow from USD 5.9 billion in 2023-e at a CAGR of 15.5% to touch USD 16.1 billion by 2030. The cell culture media market is dominated by key players such as Thermo Fisher Scientific, Merck KGaA, Corning Incorporated, Becton & Dickinson, FUJIFILM Irvine Scientific, and Danaher Corporation.

Published: February, 2024
| Report ID: HC3149
| Life Sciences & Healthcare
HLA Typing for Transplant Market By Technology (Non-molecular, Molecular), By Transplant Type (Soft Tissue, Solid Organ), By Product & Service (Instruments, Reagents & Consumables, Software & Services) By End Use (Hospitals and Clinics, Research Laboratories) and by Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the HLA Typing for Transplant Market is expected to grow from USD 767 million in 2023-e at a CAGR of 5.8% to touch USD 1,138 million by 2030. The HLA Typing for Transplant Market is dominated by key players such as Thermo Fisher Scientific, Illumina, Roche, Immucor, QIAGEN, CareDX, Bio-Rad Laboratories, among others.

Published: February, 2024
| Report ID: HC3148
| Life Sciences & Healthcare
Cell Analysis Market By Products & Service (Instruments, Reagents & Consumables, Accessories, Software, Services), By Technique (Flow Cytometry, PCR, Cell Microarrays, Microscopy, Spectrophotometry), By End-use (Pharmaceutical & Biotechnology Companies, Hospitals and Clinical Laboratories, Research Institutes), and by Region; Growth Trends & Forecasts (2024 - 2030)

According to Intent Market Research, the Cell Analysis Market is expected to grow from USD 19.2 billion in 2023-e at a CAGR of 10.4% to touch USD 38.4 billion by 2030. The cell analysis market is dominated by key players such Agilent Technologies, Bio-Rad, Illumina, Thermo Fisher Scientific, PerkinElmer, Becton & Dickinson, Standard Biotools, amongst others.

Published: February, 2024
| Report ID: HC3147
| Life Sciences & Healthcare
Hemostats Market By Type (Oxidized Regenerated Cellulose, Thrombin, Gelatin, Collagen), By Formulation (Matrix & Gel, Sponge, Powder, Sheet & Pad), By Application (General Surgery, Orthopaedic, Cardiovascular Surgery, Reconstructive Surgery), and By Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Hemostats Market is expected to grow from USD 2.5 billion in 2023-e at a CAGR of 6.2%to touch USD 3.9 billion by 2030. The Hemostats Market is dominated by key players such as Johnson & Johnson, Baxter, Becton & Dickinson, Pfizer, B. Braun, Medtronic, Stryker, among others.

Published: February, 2024
| Report ID: HC3146
| Life Sciences & Healthcare
Cell Therapy Technologies Market By Product (Cell Engineering, Cell Culture Vessels, Cell Therapy Equipment, System, Software), By Cell Type (Stem Cells, T-cells), By End-use (Biopharmaceutical & Biotechnology Companies, CMO’s, Research Institutes & Cell Banks), and by Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Cell Therapy Technologies Market is expected to grow from USD 4.0 billion in 2023-e at a CAGR of 12.8% to touch USD 9.2 billion by 2030. The cell therapy technologies market is dominated by key players such as Thermo Fisher Scientific, Merck, Danaher, Terumo, Becton & Dickinson, Lonza, amongst others.

Published: February, 2024
| Report ID: HC3142
| Life Sciences & Healthcare
Glycated Albumin Assay Market By Application (Type 1 Diabetes, Prediabetes, Type 2 Diabetes), By End User (Hospitals, Diagnostic Centres, Diabetic Care Centres), and by Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Glycated Albumin Assay Market is expected to grow from USD 0.2 billion in 2023-e at a CAGR of 8.6% to touch USD 0.3 billion by 2030. The Glycated Albumin Assay Market is competitive; where the prominent players include Asahi Kasei, PerkinElmer, Tecan Lifesciences, Agilent, Beijing Strong Biotechnologies, Diazyme Laboratories, DxGen Corp., Weldon Biotech, among others.

Published: February, 2024
| Report ID: HC3140
| Life Sciences & Healthcare
Animal Genetics Market By Products (Live Animals (Porcine, Bovine, Canine), Genetic Material (Semen, Embryo)), By Testing Services (Genetic Disease Tests, Genetic Trait Tests), and by Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Animal Genetics Market is expected to grow from USD 6.3 billion in 2023-e at a CAGR of 6.9% to touch USD 10.1 billion by 2030. The animal genetics market is dominated by key players such as Neogen Corporation, Genus, Urus, EW Group, Groupe Grimaud, Topigs Norsvin, CRV Holding, amongst others.

Published: February, 2024
| Report ID: HC3138
| Life Sciences & Healthcare
AI in Pathology Market By Offering (Scanners, Software), By Application (Disease Diagnosis, Drug Discovery, Clinical Workflow), By End-use (Pharmaceutical & Biotechnology Companies, Hospitals & Clinical Laboratories, Research Institutes), and by Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the AI in Pathology Market is expected to grow from USD 0.01 billion in 2023-e at a CAGR of 14.6% to touch USD 0.1 billion by 2030. The AI in pathology market is dominated by key players such as Koninklijke Philips, Tribun Health, Lumea, Hoffmann-La Roche Ltd, and Hologic.

Published: February, 2024
| Report ID: HC3129
| Life Sciences & Healthcare
Blood Group Typing Market By Product (Consumables, Instruments, Services & Software), By Test Type (Antigen Typing, Antibody Screening, HLA Typing), By Technique (PCR-based & Microarray Techniques, Massively Parallel Sequencing), By End-use (Hospitals, Clinical Laboratories, Blood Banks), and By Region; Global Insights & Forecast (2024 - 2030)

According to Intent Market Research, the Blood Group Typing Market is expected to grow from USD 1.9 billion in 2023-e at a CAGR of 8.2% to touch USD 3.3 billion by 2030. The blood group typing market is dominated by key players such as Bio-Rad Laboratories, Grifols, QuidelOrtho Corporation, Merck, Quotient, Danaher, Thermo Fisher Scientific, and Immucor.

Published: February, 2024
| Report ID: HC3123
| Life Sciences & Healthcare
Flow Cytometry Market by Technology (Bead-based, Cell-based), By Product (Reagents and Consumables, Instruments, Software), By Application (Research, Clinical), By End Use (Pharmaceutical & Biotechnology Companies, Hospitals & Clinical Testing Laboratories, Research Institutes) and by Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Flow Cytometry Market is expected to grow from USD 4.5 billion in 2023-e at a CAGR of 7.8% to touch USD 7.5 billion by 2030. The Flow Cytometry Market is dominated by key players such as Danaher, Thermo Fisher Scientific, Agilent, bioMérieux, Bio-Rad Laboratories, Becton & Dickinson, among others.

Published: February, 2024
| Report ID: HC3122
| Life Sciences & Healthcare
Gene Editing Market By Product (Systems, Software, Consumables, Reagents), By Technology (TALEN, ZFN, CRISPR, Antisense), By Application (Genetic Engineering, Cell Line Engineering, Drug Discovery), By End Use (Pharma & Biotech, Research Institutes), and by Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Gene Editing Market is expected to grow from USD 5.0 billion in 2023-e at a CAGR of 14.5% to touch USD 12.9 billion by 2030. The Gene Editing Market is competitive; where the prominent players include Merck, Thermo Fisher Scientific, GenScript, Tecan Life Sciences, Agilent, Lonza, PerkinElmer, among others.

Published: February, 2024
| Report ID: HC3120
| Life Sciences & Healthcare
Adhesion Barrier Market By Product (Synthetic Products (Hyaluronic Acid, Regenerated Cellulose, Polyethylene Glycol), Natural Products), By Formulation (Gel, Film, Liquid), By Application (General/Abdominal, Gynaecological, Urological, Cardiovascular), By End-use (Hospitals and Specialty Clinics, Ambulatory Surgical Centers), and by Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Adhesion Barrier Market is expected to grow from USD 0.6 billion in 2023-e at a CAGR of 6.9% to touch USD 1.0 billion by 2030. The adhesion barrier market is dominated by key players such as Johnson & Johnson, Becton & Dickinson, Integra LifeSciences, Baxter, Bioscompass, Atrium Medical, Anika Therapeutics, MAST Biosurgery, amongst others.

Published: February, 2024
| Report ID: HC3118
| Life Sciences & Healthcare
Biotechnology Contract Manufacturing Market By Service (Manufacturing, Formulation & Fill-Finish, Packaging & Labelling), By Type (Biologic Drug Product Manufacturing, Biologic Drug Substance Manufacturing), By Scale of Operation (Clinical Operations, Commercial Operations), By Therapeutic Area (Autoimmune Diseases, Oncology, Neurology, Metabolic Diseases, Cardiovascular Diseases, Infectious Diseases) and By Region; Global Insights & Forecast (2024 - 2030)

According to Intent Market Research, the Biotechnology Contract Manufacturing Market is expected to grow from USD 15.8 billion in 2023-e at a CAGR of 7.8% to touch USD 26.8 billion by 2030. The biotechnology contract manufacturing market is dominated by key players such as Catalent, Samsung Biologics, Fujifilm Holdings, Eurofins Scientific, Thermo Fisher Scientific, Lonza, Merck and WuXi Biologics.

Published: February, 2024
| Report ID: HC3117
| Life Sciences & Healthcare
Biopsy Devices Market By Product (Core Needle Biopsy, Aspiration Biopsy, Localization Wire), By Application (Kidney Biopsy, Lung Biopsy, Bone Marrow Biopsy), By Guidance Technique (Stereotactic, Ultrasound, Liquid Biopsy), By End-Use (Hospital, Research Institutes, Diagnostic Centers), and By Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Biopsy Devices Market is expected to grow from USD 6.2 billion in 2023-e at a CAGR of 13.5% to touch USD 15.1 billion by 2030. The biopsy devices market is dominated by key players such as Becton & Dickinson, Cook Group Incorporated, Hologic, B. Braun, Stryker, Devicor Medical Products, and Olympus Corporation.

Published: February, 2024
| Report ID: HC3115
| Life Sciences & Healthcare
AI in Medical Diagnostics Market By Components (Software, Services, Hardware), By Modality (CT, X-Ray, MRI, Ultrasound), By Application (In Vivo Diagnostics, Modality, In Vitro Diagnostics), By End-Use (Hospitals & Specialty Clinics, Diagnostics Imaging Centers, Diagnostic Laboratories), and By Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the AI in Medical Diagnostics Market is expected to grow from USD 1.2 billion in 2023-e at a CAGR of 22.6% to touch USD 5.2 billion by 2030. The AI in Medical Diagnostics market is dominated by key players such as Microsoft, Alphabet, NVIDIA Corporation, Merative, GE Healthcare, Digital Diagnostics, Siemens Healthineers, Philips, amongst others.

Published: February, 2024
| Report ID: HC3089
| Life Sciences & Healthcare
Precision Medicine Market By Type (Inhibitor Drugs, Monoclonal Antibodies, Cell & Gene Therapy, Antiviral & Anti-retroviral Drugs), By Indication (Oncology, Cardiovascular Diseases, Rare Diseases, Gastric Disorder, Infectious Diseases, Hematological Disorders, Psychiatry), By Distribution Channel (Hospitals & Clinics, Home Care Settings, Pharmacy) and By Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Precision Medicine Market is expected to grow from USD 30.7 billion in 2023-e at a CAGR of 11.4% to touch USD 59.3 billion by 2030. The precision medicine market is competitive, the prominent players in the global market include AbbVie, Amgen, AstraZeneca, Bristol Myers Squibb, Catalent, Eli Lilly, Gilead Sciences, Johnson & Johnson, Lonza, Merck, Novartis, Parexel, Pfizer, Roche, Sanofi, Takeda Pharmaceutical, amongst others.

Published: February, 2024
| Report ID: HC3068
| Life Sciences & Healthcare
AI in Drug Discovery Market, By Offering (Software, Service), By Technology (Machine Learning (Deep Learning, Supervised Learning, Reinforcement Learning, Unsupervised Learning), Natural Language Processing), By Therapeutic Area (Oncology, Neurology, Cardiovascular, Infectious Disease, Immunology), By Application (Target Identification, HIT Generation & Lead Identification, Lead Optimization), By End-Use Industry (Pharmaceutical & Biotechnology Companies, Contract Research Organization, Research Centers & Government Institutes) and By Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the AI in Drug Discovery Market is expected to grow from USD 850 million in 2023-e at a CAGR of 40.5% to touch USD 4,500 million by 2030. The AI in drug discovery market is a competitive market, the prominent players in the global market include BenevolentAI, BioXcel Therapeutics, Deep Genomics, Exscientia, Google, Insilico Medicine, IQVIA, Labcorp, Microsoft, NVIDIA, and Recursion.

Published: February, 2024
| Report ID: HC3048
| Life Sciences & Healthcare
AI in Cell and Gene Therapy Market; By Technology (Machine Learning (ML) {Deep Learning, Supervised Learning, Unsupervised Learning}, Generative AI, Natural Language Processing), By Indication (Oncology, Immunology, Cardiology & Neurology, Infectious Disease), By Application (Clinical Trials, Drug Discovery, Precision Medicine), By End-User (Biopharmaceutical Companies, Research Institutes, Healthcare Providers) and By Region; Global Insights & Forecast (2024 - 2030)

AI in Cell and Gene Therapy Market; By Technology (Machine Learning (ML) {Deep Learning, Supervised Learning, Unsupervised Learning}, Generative AI, Natural Language Processing), By Indication (Oncology, Immunology, Cardiology & Neurology, Infectious Disease), By Application (Clinical Trials, Drug Discovery, Precision Medicine), By End-User (Biopharmaceutical Companies, Research Institutes, Healthcare Providers) and By Region; Global Insights & Forecast (2024 - 2030)

Published: February, 2024
| Report ID: HC3010
| Life Sciences & Healthcare
Related Thought Leadership

AI-Based Predictive Maintenance Market Size Analysis, By Components (Software {Integrate, Standalone}, Service {Cloud}

Published Date: 30 May , 2024


Related Blogs

AI-Based Predictive Maintenance Market Size Analysis, By Components (Software {Integrate, Standalone}, Service {Cloud}

Published Date: 02 June , 2024